<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Lifenome — Precision Health Intelligence Partner Selector</title>
<link href="https://fonts.googleapis.com/css2?family=Sora:wght@300;400;500;600;700;800&family=DM+Mono:wght@300;400;500&family=DM+Sans:ital,wght@0,300;0,400;0,500;0,600;1,300&display=swap" rel="stylesheet">
<style>



*{margin:0;padding:0;box-sizing:border-box}
:root{
  --ink:#0a0e1a;--ink2:#2c3550;--ink3:#5a6a8a;--ink4:#9aaccc;
  --paper:#fff;--sheet:#f3f6fb;--border:#dde6f0;--border2:#c4d4e8;
  --blue:#1452d4;--blue-lt:#e8effe;
  --s1:0 1px 4px rgba(10,14,26,.06);
  --s2:0 2px 12px rgba(10,14,26,.09),0 8px 32px rgba(10,14,26,.07);
  --r:10px;
}
html,body{height:100%;font-family:'DM Sans',sans-serif;background:var(--sheet);color:var(--ink);font-size:14px;line-height:1.5}

/* ─── ONBOARDING ─────────────────────────────────────────────────────── */
.ob-page{display:flex;flex-direction:column;align-items:center;justify-content:center;
  min-height:100vh;padding:40px 20px;
  background:linear-gradient(145deg,#f0f4ff 0%,#fff8fc 50%,#f0fff8 100%)}
.ob-card{background:#fff;border-radius:18px;box-shadow:var(--s2);
  padding:48px 52px;width:100%;max-width:700px}
.ob-logo{height:52px;display:block;margin:0 auto 24px;object-fit:contain}
.ob-title{font-family:'Sora',sans-serif;font-size:22px;font-weight:800;color:var(--ink);
  text-align:center;margin-bottom:6px}
.ob-sub{font-size:13px;color:var(--ink3);text-align:center;margin-bottom:36px;line-height:1.65}
.ob-row{display:grid;grid-template-columns:1fr 1fr;gap:14px}
.ob-fieldset{margin-bottom:20px}
.ob-label{font-size:12px;font-weight:600;color:var(--ink2);display:block;margin-bottom:6px}
.ob-input{width:100%;padding:11px 14px;border:1.5px solid var(--border);border-radius:8px;
  font-family:'DM Sans',sans-serif;font-size:14px;color:var(--ink);background:#fff;
  transition:border-color .15s,box-shadow .15s;outline:none}
.ob-input:focus{border-color:var(--blue);box-shadow:0 0 0 3px rgba(20,82,212,.12)}
.ob-input::placeholder{color:var(--ink4)}
.ob-types-label{font-size:12px;font-weight:600;color:var(--ink2);margin-bottom:12px;display:block}
/* 4-column grid of thumbnail tiles */
.ob-types-grid{display:grid;grid-template-columns:repeat(4,1fr);gap:10px;margin-bottom:28px}
.ob-type{display:flex;flex-direction:column;align-items:center;gap:0;
  border:2px solid var(--border);border-radius:12px;cursor:pointer;
  transition:all .15s;text-align:center;background:#fff;user-select:none;overflow:hidden}
.ob-type:hover{border-color:var(--blue);transform:translateY(-2px);box-shadow:var(--s1)}
.ob-type.sel{border-color:var(--blue);box-shadow:0 0 0 3px rgba(20,82,212,.15)}
.ob-type-img{width:100%;height:56px;object-fit:cover;display:block;transition:opacity .15s}
.ob-type.sel .ob-type-img{opacity:.85}
.ob-type-lbl{font-size:10.5px;font-weight:600;color:var(--ink2);line-height:1.3;
  padding:7px 6px;display:block}
.ob-type.sel .ob-type-lbl{color:var(--blue)}
.ob-type-check{width:16px;height:16px;border-radius:50%;background:var(--blue);
  color:#fff;font-size:9px;display:none;align-items:center;justify-content:center;
  position:absolute;top:4px;right:4px}
.ob-type{position:relative}
.ob-type.sel .ob-type-check{display:flex}
.ob-btn{width:100%;padding:14px;border-radius:10px;background:var(--blue);color:#fff;
  border:none;cursor:pointer;font-family:'Sora',sans-serif;font-size:14px;font-weight:700;
  transition:all .15s;display:flex;align-items:center;justify-content:center;gap:8px}
.ob-btn:hover{background:#1045b8;box-shadow:0 4px 16px rgba(20,82,212,.3)}
.ob-btn:disabled{opacity:.4;cursor:not-allowed}
.ob-err{font-size:11.5px;color:#c03030;margin-top:8px;display:none}
.ob-err.show{display:block}
.ob-sel-count{font-size:11px;color:var(--blue);font-weight:600;margin-bottom:10px;
  display:block;min-height:16px}

/* ─── MAIN APP ────────────────────────────────────────────────────────── */
.hdr{background:#fff;border-bottom:1px solid var(--border);height:64px;
  display:flex;align-items:center;justify-content:space-between;padding:0 24px;
  box-shadow:var(--s1);position:sticky;top:0;z-index:300}
.hdr-left{display:flex;align-items:center;gap:14px}
.hdr-logo{height:44px;object-fit:contain;cursor:pointer}
.hdr-sep{width:1px;height:26px;background:var(--border2)}
.hdr-title{font-family:'Sora',sans-serif;font-size:12.5px;font-weight:700;color:var(--ink);display:block;line-height:1.2}
.hdr-sub{font-size:11px;color:var(--ink3);display:block;margin-top:1px}
.hdr-org{font-family:'DM Mono',monospace;font-size:10.5px;padding:3px 10px;border-radius:20px;
  background:var(--blue-lt);border:1px solid rgba(20,82,212,.2);color:var(--blue);font-weight:500;max-width:180px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}
.hdr-right{display:flex;align-items:center;gap:8px}
.hdr-pill{font-family:'DM Mono',monospace;font-size:11px;padding:3px 10px;border-radius:20px;
  background:var(--sheet);border:1px solid var(--border);color:var(--ink3)}
.cart-btn{display:flex;align-items:center;gap:7px;padding:7px 14px;border-radius:8px;
  background:var(--ink);color:#fff;border:none;cursor:pointer;
  font-family:'Sora',sans-serif;font-size:12px;font-weight:700;transition:all .15s}
.cart-btn:hover{background:#1a2a4a}
.cart-count{background:rgba(255,255,255,.2);color:#fff;font-family:'DM Mono',monospace;
  font-size:10px;padding:1px 7px;border-radius:10px;min-width:20px;text-align:center}
.cart-btn.has-items{background:#c03030}
.layout{display:grid;grid-template-columns:268px 1fr;min-height:calc(100vh - 64px)}
.sidebar{background:#fff;border-right:1px solid var(--border);padding:10px 6px;
  overflow-y:auto;position:sticky;top:64px;max-height:calc(100vh - 64px)}
.sb-lbl{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;letter-spacing:.14em;
  text-transform:uppercase;color:var(--ink4);padding:0 8px;margin:12px 0 5px;display:block}
.all-btn{display:flex;align-items:center;gap:9px;width:100%;padding:8px 9px;
  border-radius:8px;border:2px solid transparent;background:transparent;
  cursor:pointer;text-align:left;transition:all .13s;margin-bottom:5px}
.all-btn:hover{background:#f0f4ff;border-color:rgba(20,82,212,.2)}
.all-btn.active{background:var(--blue-lt);border-color:var(--blue)}
.all-thumb{width:40px;height:40px;border-radius:7px;overflow:hidden;flex-shrink:0;
  background:linear-gradient(135deg,#1452d4,#7a40d4)}
.all-thumb img{width:100%;height:100%;object-fit:cover}
.all-name{font-family:'Sora',sans-serif;font-size:12.5px;font-weight:700;color:var(--ink);display:block}
.all-sub{font-size:10.5px;color:var(--ink3);display:block;margin-top:1px}
.cat-btn{display:flex;align-items:center;gap:9px;width:100%;padding:6px 9px;
  border-radius:7px;border:1.5px solid transparent;background:transparent;
  cursor:pointer;text-align:left;transition:all .13s;margin-bottom:2px}
.cat-btn:hover{background:rgba(255,255,255,.9);border-color:var(--border)}
.cat-btn.active{background:#fff;border-color:var(--cc,var(--blue));
  box-shadow:0 0 0 3px color-mix(in srgb,var(--cc,var(--blue)) 10%,transparent)}
.cat-thumb{width:34px;height:34px;border-radius:6px;overflow:hidden;flex-shrink:0;border:1px solid var(--border)}
.cat-thumb img{width:100%;height:100%;object-fit:cover;display:block}
.cat-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.cat-sub-text{font-size:10px;color:var(--ink3);display:block;margin-top:1px;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.sb-more-toggle{width:calc(100% - 16px);margin:4px 8px;padding:7px 10px;
  border-radius:7px;border:1px dashed var(--border2);background:transparent;
  cursor:pointer;font-size:11px;font-weight:600;color:var(--ink3);
  display:flex;align-items:center;gap:6px;transition:all .13s}
.sb-more-toggle:hover{background:var(--sheet);color:var(--ink)}
.sb-more-arrow{transition:transform .2s;font-size:10px;margin-left:auto}
.sb-more-toggle.open .sb-more-arrow{transform:rotate(180deg)}
.sb-more-section{overflow:hidden;max-height:0;transition:max-height .35s ease}
.sb-more-section.open{max-height:800px}
.main{padding:20px 24px;overflow-y:auto}
.prog-hdr{display:flex;gap:18px;align-items:flex-start;margin-bottom:18px;
  padding-bottom:16px;border-bottom:2px solid var(--border)}
.prog-hdr-thumb{width:72px;height:72px;border-radius:10px;overflow:hidden;
  flex-shrink:0;border:1px solid var(--border);box-shadow:var(--s1)}
.prog-hdr-thumb img{width:100%;height:100%;object-fit:cover}
.prog-crumb{font-family:'DM Mono',monospace;font-size:8.5px;font-weight:600;
  letter-spacing:.12em;text-transform:uppercase;color:var(--ink4);margin-bottom:3px;display:block}
.prog-title{font-family:'Sora',sans-serif;font-size:22px;font-weight:800;color:var(--ink);
  letter-spacing:-.3px;margin-bottom:4px}
.prog-title em{font-style:normal;color:var(--ac,var(--blue))}
.prog-desc{font-size:12px;color:var(--ink2);line-height:1.6;margin-bottom:7px;max-width:580px}
.prog-tags{display:flex;flex-wrap:wrap;gap:4px;margin-bottom:8px}
.prog-tag{font-size:10px;font-weight:500;padding:2px 8px;border-radius:20px;
  background:color-mix(in srgb,var(--ac,var(--blue)) 8%,white);
  color:var(--ac,var(--blue));border:1px solid color-mix(in srgb,var(--ac,var(--blue)) 16%,transparent)}
.prog-stats{display:flex;gap:6px;flex-wrap:wrap}
.prog-stat{display:flex;align-items:center;gap:6px;padding:6px 11px;border-radius:8px;
  border:1px solid var(--border);background:var(--sheet)}
.ps-num{font-family:'Sora',sans-serif;font-size:17px;font-weight:800;color:var(--ac,var(--blue));line-height:1}
.ps-lbl{font-size:10px;color:var(--ink3);font-weight:500;line-height:1.2}

/* competitor badge */
.comp-badge{font-size:9px;font-weight:700;padding:2px 6px;border-radius:4px;
  display:inline-flex;align-items:center;gap:3px;margin-left:4px;
  background:#fff3e0;border:1px solid #f0a030;color:#b06010}

.body-grid{display:grid;grid-template-columns:1fr 330px;gap:16px;align-items:start}
.ds-panel{background:#fff;border:1px solid var(--border);border-radius:var(--r);
  padding:14px;position:sticky;top:calc(64px + 14px);box-shadow:var(--s1)}
.ds-panel-title{font-family:'Sora',sans-serif;font-size:12px;font-weight:700;color:var(--ink);margin-bottom:2px}
.ds-panel-sub{font-size:10.5px;color:var(--ink3);margin-bottom:10px;line-height:1.5}
.ds-item{border:1px solid var(--border);border-radius:7px;background:var(--sheet);
  margin-bottom:3px;overflow:hidden;cursor:pointer;transition:all .12s;user-select:none}
.ds-item:hover{border-color:var(--border2);background:#fff}
.ds-item.on{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 4%,white)}
.ds-row{display:flex;align-items:center;gap:7px;padding:7px 9px}
.ds-num{font-family:'DM Mono',monospace;font-size:8.5px;font-weight:600;width:14px;color:var(--ink4);flex-shrink:0}
.ds-ico{font-size:13px;flex-shrink:0;width:16px;text-align:center}
.ds-info{flex:1;min-width:0}
.ds-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block}
.ds-hint{font-size:10px;color:var(--ink3);display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.ds-chk{width:14px;height:14px;border-radius:3px;border:1.5px solid var(--border2);
  display:flex;align-items:center;justify-content:center;font-size:8px;flex-shrink:0;
  transition:all .12s;background:transparent;color:transparent}
.ds-item.on .ds-chk{background:var(--ac,var(--blue));border-color:var(--ac,var(--blue));color:#fff}
.ds-badge{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;padding:1px 5px;
  border-radius:10px;background:var(--ac,var(--blue));color:#fff;display:none;flex-shrink:0}
.ds-item.on .ds-badge{display:inline}
.blood-sub{border-top:1px solid var(--border);background:#fff;padding:7px 9px;display:none}
.ds-item.on .blood-sub{display:block}
.blood-sub-lbl{font-size:9.5px;font-weight:700;color:var(--ink3);margin-bottom:5px;
  text-transform:uppercase;letter-spacing:.07em}
.bt{display:flex;align-items:flex-start;gap:6px;padding:4px 7px;border-radius:4px;
  border:1px solid transparent;cursor:pointer;transition:all .1s;background:var(--sheet);margin-bottom:2px}
.bt:hover{border-color:var(--border2)}
.bt.sel{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 5%,white)}
.bt-radio{width:11px;height:11px;border-radius:50%;border:1.5px solid var(--border2);
  flex-shrink:0;margin-top:2px;transition:all .1s;display:flex;align-items:center;justify-content:center}
.bt.sel .bt-radio{border-color:var(--ac,var(--blue))}
.bt-dot{width:5px;height:5px;border-radius:50%;background:var(--ac,var(--blue));display:none}
.bt.sel .bt-dot{display:block}
.bt-name{font-size:11px;font-weight:600;color:var(--ink);display:block}
.bt-items{font-size:9.5px;color:var(--ink3);display:block;margin-top:1px;line-height:1.4}
.no-src{text-align:center;padding:40px 16px;color:var(--ink4)}
.no-src-icon{font-size:26px;margin-bottom:8px}
.no-src-p{font-size:12px;line-height:1.6}
.total-bar{display:flex;align-items:center;gap:12px;flex-wrap:wrap;padding:10px 14px;
  border-radius:8px;margin-bottom:14px;
  background:linear-gradient(135deg,color-mix(in srgb,var(--ac,var(--blue)) 7%,white),white);
  border:1px solid color-mix(in srgb,var(--ac,var(--blue)) 12%,transparent)}
.t-num{font-family:'Sora',sans-serif;font-size:19px;font-weight:800;color:var(--ac,var(--blue));line-height:1}
.t-lbl{font-size:10px;color:var(--ink3);font-weight:500;margin-top:2px}
.t-sep{width:1px;height:22px;background:var(--border);margin:0 2px;flex-shrink:0}
.src-block{margin-bottom:14px;animation:fu .2s ease both}
@keyframes fu{from{opacity:0;transform:translateY(4px)}to{opacity:1;transform:translateY(0)}}
.src-hdr{display:flex;align-items:center;gap:8px;padding:8px 12px;border-radius:7px 7px 0 0;color:#fff}
.src-hdr-ico{font-size:14px}
.src-hdr-name{font-family:'Sora',sans-serif;font-size:12px;font-weight:700;flex:1}
.src-hdr-count{font-family:'DM Mono',monospace;font-size:10px;background:rgba(255,255,255,.15);padding:2px 7px;border-radius:9px}
.ins-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(230px,1fr));gap:5px;
  padding:6px;background:var(--sheet);border:1px solid var(--border);border-top:none;border-radius:0 0 7px 7px}
.ins-card{background:#fff;border:1px solid var(--border);border-radius:6px;padding:10px 12px;
  transition:all .12s;position:relative}
.ins-card:hover{box-shadow:var(--s2);border-color:var(--border2)}
.ins-card.carted{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 3%,white)}
.ic-cart{position:absolute;top:8px;right:8px;width:17px;height:17px;border-radius:4px;
  border:1.5px solid var(--border2);display:flex;align-items:center;justify-content:center;
  font-size:9px;cursor:pointer;transition:all .12s;background:#fff;color:transparent}
.ic-cart:hover{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 8%,white)}
.ins-card.carted .ic-cart{background:var(--ac,var(--blue));border-color:var(--ac,var(--blue));color:#fff}
.ic-src{font-family:'DM Mono',monospace;font-size:8px;font-weight:500;letter-spacing:.08em;
  text-transform:uppercase;padding:2px 5px;border-radius:3px;margin-bottom:4px;display:inline-block}
.ic-cat{font-size:9px;font-weight:600;padding:1px 7px;border-radius:20px;
  display:inline-block;margin-bottom:3px;margin-right:20px}
.ic-name{font-size:11.5px;font-weight:700;color:var(--ink);margin-bottom:2px;
  line-height:1.3;padding-right:20px}
.ic-desc{font-size:10px;color:var(--ink3);line-height:1.5;margin-bottom:4px}
.ic-unit{font-family:'DM Mono',monospace;font-size:9px;color:var(--ink2);background:var(--sheet);
  padding:2px 5px;border-radius:3px;border:1px solid var(--border);display:inline-block;margin-bottom:2px}
.ic-range{font-size:9px;color:#0a7c6e;font-style:italic;line-height:1.4;display:block;margin-bottom:3px}
.ic-markers{display:flex;flex-wrap:wrap;gap:2px}
.ic-m{font-family:'DM Mono',monospace;font-size:8.5px;padding:1px 5px;border-radius:3px;
  background:var(--sheet);border:1px solid var(--border);color:var(--ink3)}
.api-block{margin-top:14px;background:var(--ink);border-radius:8px;padding:14px 16px}
.api-title{font-family:'Sora',sans-serif;font-size:11.5px;font-weight:700;color:#fff;margin-bottom:7px}
.api-eps{display:flex;flex-direction:column;gap:3px}
.api-ep{display:flex;align-items:center;gap:8px;background:rgba(255,255,255,.04);
  border:1px solid rgba(255,255,255,.08);border-radius:4px;padding:5px 9px}
.api-method{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;padding:2px 5px;border-radius:3px;flex-shrink:0}
.api-method.get{background:rgba(20,200,150,.18);color:#0dd9a0}
.api-method.post{background:rgba(80,120,250,.18);color:#7095fd}
.api-path{font-family:'DM Mono',monospace;font-size:9.5px;color:rgba(255,255,255,.5);flex:1}
.api-note{margin-top:7px;font-size:9.5px;color:rgba(255,255,255,.25);font-family:'DM Mono',monospace}

/* competitor insight callout box */
.comp-callout{background:linear-gradient(135deg,#fff8e8,#fffaf2);
  border:1px solid #e8c060;border-radius:6px;padding:8px 11px;margin:8px 0 6px;
  font-size:10px;color:#7a5010;line-height:1.5}
.comp-callout strong{color:#5a3800}

/* ─── CART OVERLAY ────────────────────────────────────────────────────── */
.cart-overlay{display:none;position:fixed;inset:0;z-index:500;
  background:rgba(10,14,26,.5);backdrop-filter:blur(4px)}
.cart-overlay.open{display:flex;justify-content:flex-end}
.cart-panel{background:#fff;width:min(760px,100vw);height:100%;
  display:flex;flex-direction:column;box-shadow:-8px 0 40px rgba(10,14,26,.15);
  animation:slideIn .25s ease both}
@keyframes slideIn{from{transform:translateX(40px);opacity:0}to{transform:translateX(0);opacity:1}}
.cart-hdr{display:flex;align-items:center;justify-content:space-between;
  padding:18px 22px;border-bottom:1px solid var(--border);background:var(--ink)}
.cart-hdr-title{font-family:'Sora',sans-serif;font-size:15px;font-weight:800;color:#fff}
.cart-hdr-sub{font-size:10.5px;color:rgba(255,255,255,.5);margin-top:2px}
.cart-close{width:30px;height:30px;border-radius:6px;background:rgba(255,255,255,.1);
  border:none;cursor:pointer;color:#fff;font-size:16px;
  display:flex;align-items:center;justify-content:center;transition:all .12s}
.cart-close:hover{background:rgba(255,255,255,.2)}
.cart-body{flex:1;overflow-y:auto;padding:18px 22px}
.cart-empty{text-align:center;padding:48px 20px;color:var(--ink4)}
.cart-sec-title{font-family:'Sora',sans-serif;font-size:10.5px;font-weight:700;
  letter-spacing:.06em;text-transform:uppercase;color:var(--ink3);margin-bottom:10px;
  display:flex;align-items:center;gap:8px}
.cart-sec-title::after{content:'';flex:1;height:1px;background:var(--border)}
.modality-block{border:1px solid var(--border);border-radius:9px;overflow:hidden;margin-bottom:8px}
.modality-hdr{display:flex;align-items:center;gap:10px;padding:11px 14px;color:#fff}
.mod-ico{font-size:16px;flex-shrink:0}
.mod-hdr-name{font-family:'Sora',sans-serif;font-size:13px;font-weight:700;flex:1}
.mod-hdr-count{font-family:'DM Mono',monospace;font-size:10px;background:rgba(255,255,255,.15);padding:2px 8px;border-radius:9px}
.modality-biomarkers{padding:10px 14px;background:var(--sheet)}
.mod-bm-lbl{font-size:10px;font-weight:700;color:var(--ink3);text-transform:uppercase;
  letter-spacing:.07em;margin-bottom:7px}
.mod-bm-list{display:flex;flex-wrap:wrap;gap:4px}
.mod-bm{font-family:'DM Mono',monospace;font-size:9.5px;padding:2px 7px;border-radius:4px;
  background:#fff;border:1px solid var(--border);color:var(--ink2)}
.cart-ins-prog{margin-bottom:10px}
.cart-prog-hdr{font-family:'Sora',sans-serif;font-size:11px;font-weight:700;
  display:flex;align-items:center;gap:6px;margin-bottom:5px}
.cart-dot{width:8px;height:8px;border-radius:50%;flex-shrink:0;margin-top:1px}
.cart-item{display:flex;align-items:flex-start;gap:9px;padding:8px 11px;
  border:1px solid var(--border);border-radius:6px;background:var(--sheet);margin-bottom:4px}
.cart-item-info{flex:1;min-width:0}
.cart-item-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block;line-height:1.3}
.cart-item-meta{font-size:10px;color:var(--ink3);margin-top:2px;display:block}
.cart-item-range{font-size:9px;color:#0a7c6e;margin-top:2px;display:block;font-style:italic}
.cart-rm{background:none;border:none;cursor:pointer;color:var(--ink4);font-size:13px;
  padding:2px 4px;border-radius:4px;transition:all .1s;flex-shrink:0}
.cart-rm:hover{background:#fee;color:#c33}
.cart-footer{padding:14px 22px;border-top:1px solid var(--border);background:#fff;
  display:flex;flex-direction:column;gap:8px}
.send-btn{width:100%;padding:13px;border-radius:9px;
  background:linear-gradient(135deg,#1452d4,#7a30c8);color:#fff;
  border:none;cursor:pointer;font-family:'Sora',sans-serif;font-size:13px;font-weight:700;
  transition:all .15s;display:flex;align-items:center;justify-content:center;gap:8px}
.send-btn:hover{filter:brightness(1.1);box-shadow:0 4px 16px rgba(20,82,212,.35)}
.export-btn{width:100%;padding:10px;border-radius:9px;
  background:var(--sheet);color:var(--ink);
  border:1.5px solid var(--border);cursor:pointer;font-family:'DM Sans',sans-serif;
  font-size:12px;font-weight:600;transition:all .15s;display:flex;align-items:center;
  justify-content:center;gap:7px}
.export-btn:hover{border-color:var(--border2);background:#fff}


/* Subcategory group headers in insight grid */
.subcat-hdr{
  grid-column:1/-1;
  display:flex;align-items:center;gap:8px;
  margin:10px 0 4px;
  padding:6px 10px;
  background:linear-gradient(90deg,color-mix(in srgb,var(--ac,#1452d4) 8%,white),transparent);
  border-left:3px solid var(--ac,#1452d4);
  border-radius:0 6px 6px 0;
}
.subcat-hdr-ico{font-size:14px}
.subcat-hdr-name{
  font-family:'Sora',sans-serif;font-size:11.5px;font-weight:800;
  color:var(--ac,#1452d4);letter-spacing:.01em;
}
.subcat-hdr-count{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 6px;border-radius:9px;
  background:color-mix(in srgb,var(--ac,#1452d4) 10%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 18%,transparent);
  color:var(--ac,#1452d4);margin-left:auto;
}
/* Subcategory badge on insight card */
.ic-subcat{
  font-size:8.5px;font-weight:700;padding:1px 5px;border-radius:3px;
  display:inline-block;margin-bottom:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  color:var(--ac,#1452d4);border:1px solid color-mix(in srgb,var(--ac,#1452d4) 12%,transparent);
  text-transform:uppercase;letter-spacing:.05em;
}


/* ─── INSIGHT TYPE FILTER ────────────────────────────────────────── */
.filter-bar{
  display:flex;align-items:center;gap:8px;flex-wrap:wrap;
  padding:10px 14px;background:#fff;border:1px solid var(--border);
  border-radius:9px;margin-bottom:14px;
  box-shadow:var(--s1);
}
.filter-bar-lbl{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  letter-spacing:.12em;text-transform:uppercase;color:var(--ink4);
  margin-right:4px;flex-shrink:0;
}
.filter-chip{
  display:flex;align-items:center;gap:5px;padding:5px 11px;
  border-radius:20px;border:1.5px solid var(--border2);
  background:#fff;cursor:pointer;user-select:none;
  transition:all .13s;font-size:11.5px;font-weight:600;color:var(--ink3);
}
.filter-chip:hover{border-color:var(--chip-color,var(--blue));color:var(--chip-color,var(--blue))}
.filter-chip.active{
  background:color-mix(in srgb,var(--chip-color,var(--blue)) 10%,white);
  border-color:var(--chip-color,var(--blue));
  color:var(--chip-color,var(--blue));
}
.filter-chip-ico{font-size:12px;line-height:1}
.filter-chip-cnt{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 5px;border-radius:8px;
  background:color-mix(in srgb,var(--chip-color,var(--blue)) 12%,white);
  color:var(--chip-color,var(--blue));
  display:none;
}
.filter-chip.active .filter-chip-cnt{display:inline}
.filter-sep{width:1px;height:18px;background:var(--border2);margin:0 2px;flex-shrink:0}

/* ─── SUBCATEGORY HEADERS (enhanced) ─────────────────────────────── */
.subcat-hdr{
  grid-column:1/-1;
  display:flex;align-items:center;gap:8px;
  margin:10px 0 4px;
  padding:6px 10px;
  background:linear-gradient(90deg,color-mix(in srgb,var(--ac,#1452d4) 8%,white),transparent);
  border-left:3px solid var(--ac,#1452d4);
  border-radius:0 6px 6px 0;
}
.subcat-hdr-ico{font-size:14px}
.subcat-hdr-name{
  font-family:'Sora',sans-serif;font-size:11.5px;font-weight:800;
  color:var(--ac,#1452d4);letter-spacing:.01em;
}
.subcat-hdr-count{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 6px;border-radius:9px;
  background:color-mix(in srgb,var(--ac,#1452d4) 10%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 18%,transparent);
  color:var(--ac,#1452d4);margin-left:auto;
}

/* ─── RECOMMENDATION CARD STYLING ────────────────────────────────── */
.ins-card[data-itype="recommendation"]{
  border-color:color-mix(in srgb,#16a34a 25%,var(--border));
  background:linear-gradient(135deg,#f0fdf4,#fff);
}
.ins-card[data-itype="recommendation"].carted{
  border-color:#16a34a;
  background:linear-gradient(135deg,color-mix(in srgb,#16a34a 6%,white),white);
}
.ins-card[data-itype="recommendation"] .ic-cart:hover{
  border-color:#16a34a;
  background:color-mix(in srgb,#16a34a 10%,white);
}
.ins-card[data-itype="recommendation"].carted .ic-cart{
  background:#16a34a;border-color:#16a34a;
}
.rec-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8.5px;font-weight:700;padding:2px 6px;border-radius:3px;
  background:linear-gradient(135deg,#dcfce7,#bbf7d0);
  border:1px solid #86efac;color:#15803d;
  text-transform:uppercase;letter-spacing:.05em;margin-bottom:3px;
}
.rec-type-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8px;font-weight:600;padding:1px 5px;border-radius:3px;
  margin-left:4px;
}
.rec-type-badge.program{background:#dbeafe;border:1px solid #93c5fd;color:#1d4ed8}
.rec-type-badge.product{background:#fef9c3;border:1px solid #fcd34d;color:#92400e}

/* ─── ASSESSMENT CARD SUBTLE INDICATOR ──────────────────────────── */
.ins-card[data-itype="biomarker_assessment"]{
  border-left:2px solid color-mix(in srgb,var(--ac,#1452d4) 30%,var(--border));
}
.assess-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8.5px;font-weight:700;padding:2px 6px;border-radius:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 15%,transparent);
  color:var(--ac,#1452d4);text-transform:uppercase;
  letter-spacing:.05em;margin-bottom:3px;
}

/* ─── EMPTY STATE FOR FILTERS ────────────────────────────────────── */
.filter-empty{
  grid-column:1/-1;text-align:center;padding:32px 20px;color:var(--ink4);
}
.filter-empty-ico{font-size:24px;margin-bottom:6px}
.filter-empty-p{font-size:12px;line-height:1.6}

/* Subcat badge */
.ic-subcat{
  font-size:8.5px;font-weight:700;padding:1px 5px;border-radius:3px;
  display:inline-block;margin-bottom:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  color:var(--ac,#1452d4);border:1px solid color-mix(in srgb,var(--ac,#1452d4) 12%,transparent);
  text-transform:uppercase;letter-spacing:.05em;
}
.comp-badge{font-size:9px;font-weight:700;padding:2px 6px;border-radius:4px;
  display:inline-flex;align-items:center;gap:3px;margin-left:4px;
  background:#fff3e0;border:1px solid #f0a030;color:#b06010}
.comp-callout{background:linear-gradient(135deg,#fff8e8,#fffaf2);
  border:1px solid #e8c060;border-radius:6px;padding:8px 11px;margin:8px 0 6px;
  font-size:10px;color:#7a5010;line-height:1.5}

</style>
</head>
<body>
</head>
<body>
</head>
<body>

<!-- ═══════ ONBOARDING PAGE ═══════ -->
<div class="ob-page" id="ob-page">
  <div class="ob-card">
    <img class="ob-logo" src="data:image/jpeg;base64,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" alt="Lifenome">
    <div class="ob-title">Precision Health Intelligence</div>
    <div class="ob-sub">Partner API &amp; Testing Selector — Tell us about your organization to get a curated, relevant view of available health verticals and biomarker insights.</div>
    <div class="ob-row">
      <div class="ob-fieldset">
        <label class="ob-label" for="ob-name">Organization Name *</label>
        <input class="ob-input" id="ob-name" type="text" placeholder="e.g. WellnessFirst Clinic" oninput="updateObBtn()">
      </div>
      <div class="ob-fieldset">
        <label class="ob-label" for="ob-email">Contact Email *</label>
        <input class="ob-input" id="ob-email" type="email" placeholder="name@organization.com" oninput="updateObBtn()">
      </div>
    </div>
    <div class="ob-fieldset">
      <label class="ob-label" for="ob-url">Organization Website</label>
      <input class="ob-input" id="ob-url" type="url" placeholder="https://yourorganization.com">
    </div>
    <span class="ob-types-label">Which best describes your organization? (select all that apply) *</span>
    <span class="ob-sel-count" id="ob-sel-count"></span>
    <div class="ob-types-grid" id="ob-types-grid"></div>
    <div class="ob-err" id="ob-err"></div>
    <button class="ob-btn" id="ob-submit" onclick="submitOnboarding()" disabled>
      &#x27A1;&nbsp; Explore Your Precision Health Verticals
    </button>
  </div>
</div>

<!-- ═══════ MAIN APP ═══════ -->
<div class="app-page" id="app-page" style="display:none">
  <header class="hdr">
    <div class="hdr-left">
      <img class="hdr-logo" src="data:image/jpeg;base64,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" alt="Lifenome"
        onclick="document.getElementById('ob-page').style.display='flex';document.getElementById('app-page').style.display='none';"
        title="Back to start">
      <div class="hdr-sep"></div>
      <div>
        <span class="hdr-title">Precision Health Intelligence</span>
        <span class="hdr-sub">Partner API and Testing Selector</span>
      </div>
      <span class="hdr-org" id="hdr-org-name"></span>
    </div>
    <div class="hdr-right">
      <span class="hdr-pill">v6.0</span>
      <span class="hdr-pill" style="background:#e5f4f2;border-color:rgba(10,124,110,.2);color:#0a7c6e">&#11044; API Live</span>
      <button class="cart-btn" id="hdr-cart-btn" onclick="openCart()">
        &#128722; API Cart <span class="cart-count" id="hdr-cart-count">0</span>
      </button>
    </div>
  </header>
  <div class="layout">
    <nav class="sidebar" id="sidebar">
      <div style="padding:20px;text-align:center;color:var(--ink4);font-size:12px">Loading...</div>
    </nav>
    <main class="main" id="main">
      <div style="display:flex;flex-direction:column;align-items:center;justify-content:center;min-height:60vh;text-align:center">
        <div style="font-family:Sora,sans-serif;font-size:18px;font-weight:800;color:var(--ink2);margin-bottom:8px">Welcome to Your Precision Health Platform</div>
        <div style="font-size:13px;color:var(--ink3);max-width:420px;line-height:1.65">Select a vertical from the left sidebar, then toggle data sources to explore available insights. New: Mental Health & Brain Wellness vertical + Function Health and InsideTracker-inspired indices.</div>
      </div>
    </main>
  </div>
</div>

<!-- CART OVERLAY -->
<div class="cart-overlay" id="cart-overlay" onclick="if(event.target===this)closeCart()">
  <div class="cart-panel">
    <div class="cart-hdr">
      <div>
        <div class="cart-hdr-title">&#128722; API Cart</div>
        <div class="cart-hdr-sub">Selected insights, required testing modalities &amp; biomarkers</div>
      </div>
      <button class="cart-close" onclick="closeCart()">&#10005;</button>
    </div>
    <div class="cart-body" id="cart-body"></div>
    <div class="cart-footer" id="cart-footer"></div>
  </div>
</div>

<script>
const CLIENT_TYPES = [
  {
    "id": "longevity_clinic",
    "label": "Longevity Clinic / Brand",
    "thumb": "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=120&q=70",
    "primary": [
      "longevity",
      "prevention",
      "supplements"
    ],
    "secondary": [
      "precision_medicine",
      "weightloss",
      "glp1",
      "athlete",
      "mental_health"
    ]
  },
  {
    "id": "womens_health",
    "label": "Women's Health Brand",
    "thumb": "https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=120&q=70",
    "primary": [
      "fertility",
      "menopause",
      "weightloss"
    ],
    "secondary": [
      "supplements",
      "skincare",
      "hairloss",
      "prevention",
      "mental_health",
      "precision_medicine"
    ]
  },
  {
    "id": "supplement_brand",
    "label": "Supplementation Brand",
    "thumb": "data:image/jpeg;base64,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",
    "primary": [
      "supplements",
      "longevity"
    ],
    "secondary": [
      "prevention",
      "weightloss",
      "athlete",
      "mental_health"
    ]
  },
  {
    "id": "hospitality",
    "label": "Hospitality Brand",
    "thumb": "https://images.unsplash.com/photo-1566073771259-6a8506099945?w=120&q=70",
    "primary": [
      "longevity",
      "skincare",
      "weightloss"
    ],
    "secondary": [
      "menopause",
      "supplements",
      "prevention",
      "mental_health"
    ]
  },
  {
    "id": "medspa",
    "label": "MedSpa",
    "thumb": "https://images.unsplash.com/photo-1540555700478-4be289fbecef?w=120&q=70",
    "primary": [
      "skincare",
      "hairloss",
      "longevity"
    ],
    "secondary": [
      "menopause",
      "weightloss",
      "glp1",
      "mental_health"
    ]
  },
  {
    "id": "gym_fitness",
    "label": "Gym / Fitness Organization",
    "thumb": "https://images.unsplash.com/photo-1534438327276-14e5300c3a48?w=120&q=70",
    "primary": [
      "athlete",
      "weightloss",
      "longevity"
    ],
    "secondary": [
      "supplements",
      "prevention",
      "glp1"
    ]
  },
  {
    "id": "skin_hair",
    "label": "Skin & Hair Care Brand",
    "thumb": "https://images.unsplash.com/photo-1522335789203-aabd1fc54bc9?w=120&q=70",
    "primary": [
      "skincare",
      "hairloss"
    ],
    "secondary": [
      "supplements",
      "menopause",
      "longevity"
    ]
  },
  {
    "id": "glp1_brand",
    "label": "GLP-1",
    "thumb": "https://images.unsplash.com/photo-1576765607924-3f7b8410a787?w=120&q=70",
    "primary": [
      "glp1",
      "weightloss"
    ],
    "secondary": [
      "prevention",
      "longevity",
      "supplements",
      "mental_health"
    ]
  },
  {
    "id": "health_app",
    "label": "Health & Fitness App",
    "thumb": "https://images.unsplash.com/photo-1605296867304-46d5465a13f1?w=120&q=70",
    "primary": [
      "longevity",
      "prevention",
      "weightloss"
    ],
    "secondary": [
      "athlete",
      "supplements",
      "skincare",
      "mental_health",
      "precision_medicine"
    ]
  },
  {
    "id": "healthcare_system",
    "label": "Healthcare System",
    "thumb": "https://images.unsplash.com/photo-1551601651-2a8555f1a136?w=120&q=70",
    "primary": [
      "precision_medicine",
      "prevention",
      "longevity",
      "fertility",
      "menopause",
      "mental_health"
    ],
    "secondary": [
      "glp1",
      "weightloss",
      "supplements"
    ]
  },
  {
    "id": "mental_health_org",
    "label": "Mental Health Organization",
    "thumb": "https://images.unsplash.com/photo-1499209974431-9dddcece7f88?w=120&q=70",
    "primary": [
      "mental_health",
      "longevity",
      "prevention"
    ],
    "secondary": [
      "supplements",
      "weightloss",
      "menopause",
      "precision_medicine"
    ]
  },
  {
    "id": "other",
    "label": "Other (Show All Categories)",
    "thumb": "https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?w=120&q=70",
    "primary": [
      "longevity",
      "fertility",
      "menopause",
      "athlete",
      "prevention",
      "weightloss",
      "glp1",
      "supplements",
      "skincare",
      "hairloss",
      "mental_health",
      "precision_medicine"
    ],
    "secondary": []
  }
];;

const DATA_SOURCES = [
  { id:'lifestyle',     ico:'📋', name:'Lifestyle Assessment',       hint:'SAQ / health history / psychometrics',  ep:'/api/v1/stateless/lifestyle',          method:'POST' },
  { id:'wearable',      ico:'⌚', name:'Wearable Data',               hint:'Activity, sleep, HRV, HR, SpO2',        ep:'/api/v1/stateless/wearable',           method:'POST' },
  { id:'physiological', ico:'📸', name:'Physiological (YHealth)',     hint:'Imaging / smartphone camera',           ep:'/api/v1/stateless/physiological',      method:'POST' },
  { id:'blood',         ico:'🩸', name:'Blood Biomarkers',            hint:'Select panel tier below',               ep:'/api/v1/stateless/biomarkers',         method:'POST', hasBlood:true },
  { id:'dna_array',     ico:'🧬', name:'DNA — Genotyping Array',      hint:'SNP array / 23andMe / Ancestry',        ep:'/api/v1/samples/{id}/traits',          method:'GET'  },
  { id:'dna_exome',     ico:'🔬', name:'DNA — Exome (WES)',           hint:'Whole exome sequencing VCF',            ep:'/api/v1/exome/report',                 method:'POST' },
  { id:'dna_wgs',       ico:'🧪', name:'DNA — WGS',                   hint:'Whole genome sequencing VCF',           ep:'/api/v1/samples/{id}/traits?mode=wgs', method:'GET'  },
  { id:'micro_16s',     ico:'🦠', name:'Gut Microbiome 16S',          hint:'Amplicon sequencing / diversity',       ep:'/api/v1/stateless/microbiome-16s',     method:'POST' },
  { id:'micro_wgs',     ico:'🔭', name:'Gut Microbiome Shotgun',      hint:'Functional metagenomics',               ep:'/api/v1/stateless/microbiome-wgs',     method:'POST' },
  { id:'epigenetics',   ico:'⚗️', name:'Epigenetics / Methylation',  hint:'DNAm clocks / methylation array',       ep:'/api/v1/stateless/epigenetics',        method:'POST' }
];
const BLOOD_TIERS = {
  basic:         { name:'Basic Panel',     items:['CBC','CMP','Fasting Glucose','HbA1c','Lipid Panel (TC/LDL/HDL/TG)','TSH'] },
  standard:      { name:'Standard Panel',  items:['All Basic +','hs-CRP','Homocysteine','Ferritin','Vitamin B12','Folate','25-OH Vitamin D','Fasting Insulin','ALT/AST/GGT','Free T3/T4'] },
  advanced:      { name:'Advanced Panel',  items:['All Standard +','ApoB','Lp(a)','oxidized LDL','IGF-1','DHEA-S','Cortisol AM','SHBG','Total/Free Testosterone','Estradiol','Magnesium RBC','Zinc','Selenium','CoQ10','NAD+','IL-6','TNF-α','Cystatin-C','Omega-3 Index'] },
  comprehensive: { name:'Comprehensive',   items:['All Advanced +','p-tau217','GFAP','NfL','Aβ42/40 ratio','Amino acid panel (tryptophan, tyrosine, branched-chain)','8-OHdG','Total antioxidant capacity','Heavy metals (Pb, Hg, As, Cd)','ANA screen','anti-dsDNA','TPO Ab','TgAb','LPS/Endotoxin','Zonulin','ACTH','Aldosterone','Full autoimmune panel','Adiponectin','NT-proBNP'] }
};

var orgName='', orgEmail='', orgUrl='', orgTypes=[];
var program=null, activeSources=new Set(), bloodTier='standard', cart=[];

function hesc(s){ return String(s||'').replace(/&/g,'&amp;').replace(/</g,'&lt;').replace(/>/g,'&gt;').replace(/"/g,'&quot;'); }
function srcBg(id){
  var m={lifestyle:'#1a3060',wearable:'#005870',physiological:'#6a3000',blood:'#7a0020',
    dna_array:'#3520a0',dna_exome:'#1a0880',dna_wgs:'#080460',
    micro_16s:'#2a4010',micro_wgs:'#182808',epigenetics:'#084840'};
  return m[id]||'#1a2a4a';
}
function tierIdx(t){ return ['basic','standard','advanced','comprehensive'].indexOf(t); }
function insActive(ins){ if(ins.src!=='blood'||!ins.tier) return true; return tierIdx(ins.tier)<=tierIdx(bloodTier); }
function cartKey(progId,insName){ return progId+'~~'+insName; }
function ds(id){ for(var i=0;i<DATA_SOURCES.length;i++) if(DATA_SOURCES[i].id===id) return DATA_SOURCES[i]; return null; }

/* ── ONBOARDING ─────────────────────────────────────────────────────── */
function initOnboarding(){
  var grid=document.getElementById('ob-types-grid');
  var h='';
  for(var i=0;i<CLIENT_TYPES.length;i++){
    var ct=CLIENT_TYPES[i];
    h+='<div class="ob-type" data-id="'+ct.id+'" onclick="toggleType(this,\''+ct.id+'\')">';
    h+='<div class="ob-type-check">&#10003;</div>';
    h+='<img class="ob-type-img" src="'+hesc(ct.thumb)+'" alt="" loading="lazy">';
    h+='<span class="ob-type-lbl">'+hesc(ct.label)+'</span>';
    h+='</div>';
  }
  grid.innerHTML=h;
}
function toggleType(el,id){
  el.classList.toggle('sel');
  var idx=orgTypes.indexOf(id);
  if(idx>=0) orgTypes.splice(idx,1); else orgTypes.push(id);
  updateObBtn();
  var cnt=document.getElementById('ob-sel-count');
  if(cnt) cnt.textContent=orgTypes.length>0?orgTypes.length+' type'+(orgTypes.length!==1?'s':'')+' selected':'';
}
function updateObBtn(){
  var btn=document.getElementById('ob-submit');
  var n=document.getElementById('ob-name').value.trim();
  var e=document.getElementById('ob-email').value.trim();
  btn.disabled=(!n||!e||orgTypes.length===0);
}
function submitOnboarding(){
  var n=document.getElementById('ob-name').value.trim();
  var e=document.getElementById('ob-email').value.trim();
  var u=document.getElementById('ob-url').value.trim();
  var err=document.getElementById('ob-err');
  if(!n||!e||orgTypes.length===0){err.textContent='Please fill in name, email, and select at least one organization type.';err.classList.add('show');return;}
  if(!/^[^\s@]+@[^\s@]+\.[^\s@]+$/.test(e)){err.textContent='Please enter a valid email address.';err.classList.add('show');return;}
  err.classList.remove('show');
  orgName=n;orgEmail=e;orgUrl=u;
  document.getElementById('ob-page').style.display='none';
  document.getElementById('app-page').style.display='block';
  document.getElementById('hdr-org-name').textContent=n;
  buildSidebar();
}

/* ── SIDEBAR ─────────────────────────────────────────────────────────── */
function getPrimaryProgIds(){
  var primary=new Set(), secondary=new Set();
  for(var i=0;i<orgTypes.length;i++){
    for(var j=0;j<CLIENT_TYPES.length;j++){
      if(CLIENT_TYPES[j].id===orgTypes[i]){
        CLIENT_TYPES[j].primary.forEach(function(id){primary.add(id);});
        CLIENT_TYPES[j].secondary.forEach(function(id){if(!primary.has(id))secondary.add(id);});
      }
    }
  }
  return{primary:[...primary],secondary:[...secondary].filter(function(id){return !primary.has(id);})};
}
function buildSidebar(){
  var sb=document.getElementById('sidebar'); if(!sb) return;
  var ids=getPrimaryProgIds();
  var h='<span class="sb-lbl">Overview</span>';
  h+='<button class="all-btn active" id="btn-all" onclick="selAll()">';
  h+='<div class="all-thumb"><img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=80&q=70" alt="" loading="lazy"></div>';
  h+='<div style="flex:1;min-width:0"><span class="all-name">All Categories</span><span class="all-sub">Browse all '+PROGRAMS.length+' verticals</span></div>';
  h+='</button>';
  h+='<span class="sb-lbl">Recommended for You</span>';
  for(var i=0;i<PROGRAMS.length;i++){
    var p=PROGRAMS[i];
    if(ids.primary.indexOf(p.id)<0) continue;
    h+=makeCatBtn(p);
  }
  if(ids.secondary.length>0){
    h+='<button class="sb-more-toggle" id="sb-more-btn" onclick="toggleSbMore()">';
    h+='<span>Additional Categories</span><span class="sb-more-arrow">&#x25BC;</span></button>';
    h+='<div class="sb-more-section" id="sb-more-sec">';
    for(var i=0;i<PROGRAMS.length;i++){
      var p=PROGRAMS[i];
      if(ids.secondary.indexOf(p.id)<0) continue;
      h+=makeCatBtn(p);
    }
    h+='</div>';
  }
  sb.innerHTML=h;
}
function makeCatBtn(p){
  return '<button class="cat-btn" id="btn-'+p.id+'" style="--cc:'+p.color+'" onclick="selProg(\''+p.id+'\')">'+
    '<div class="cat-thumb"><img src="'+hesc(p.img)+'" alt="" loading="lazy"></div>'+
    '<div style="flex:1;min-width:0"><span class="cat-name">'+hesc(p.name)+'</span>'+
    '<span class="cat-sub-text">'+hesc(p.sub)+'</span></div>'+
    '</button>';
}
function toggleSbMore(){
  var btn=document.getElementById('sb-more-btn'), sec=document.getElementById('sb-more-sec');
  if(!btn||!sec) return;
  var open=sec.classList.contains('open');
  sec.classList.toggle('open',!open); btn.classList.toggle('open',!open);
}
function setActiveSidebarBtn(id){
  var all=document.querySelectorAll('.cat-btn,.all-btn');
  for(var i=0;i<all.length;i++) all[i].classList.remove('active');
  var btn=document.getElementById('btn-'+id); if(btn) btn.classList.add('active');
}
function selAll(){ program=null; activeSources=new Set(); bloodTier='standard'; setActiveSidebarBtn('all'); render(); }
function selProg(id){
  for(var i=0;i<PROGRAMS.length;i++) if(PROGRAMS[i].id===id){program=PROGRAMS[i];break;}
  activeSources=new Set(); bloodTier='standard'; setActiveSidebarBtn(id); render();
}

/* ── RENDER ──────────────────────────────────────────────────────────── */
function render(){
  var main=document.getElementById('main'); if(!main) return;
  var ac=program?program.color:'#1452d4';
  main.style.setProperty('--ac',ac);
  var hdr='';
  if(!program){
    var totalIns=0, totalMkrs=new Set();
    for(var i=0;i<PROGRAMS.length;i++){
      totalIns+=PROGRAMS[i].insights.length;
      for(var j=0;j<PROGRAMS[i].insights.length;j++)
        (PROGRAMS[i].insights[j].markers||[]).forEach(function(m){totalMkrs.add(m);});
    }
    hdr='<div class="prog-hdr"><div class="prog-hdr-thumb"><img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=160&q=75" alt="" loading="lazy"></div>';
    hdr+='<div style="flex:1"><span class="prog-crumb">All Categories</span>';
    hdr+='<div class="prog-title">All <em>Health Verticals</em></div>';
    hdr+='<div class="prog-desc">Select data sources to explore insights across all '+PROGRAMS.length+' verticals. Includes indices inspired by Function Health and InsideTracker healthspan categories.</div>';
    hdr+='<div class="prog-stats"><div class="prog-stat"><div><div class="ps-num">'+PROGRAMS.length+'</div><div class="ps-lbl">Verticals</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num">'+totalIns+'</div><div class="ps-lbl">Total Insights</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num">'+totalMkrs.size+'</div><div class="ps-lbl">Unique Biomarkers</div></div></div>';
    hdr+='</div></div></div>';
  } else {
    var p=program;
    var tags=''; for(var t=0;t<p.tags.length;t++) tags+='<span class="prog-tag">'+hesc(p.tags[t])+'</span>';
    var mkrSet=new Set();
    for(var i=0;i<p.insights.length;i++) (p.insights[i].markers||[]).forEach(function(m){mkrSet.add(m);});
    hdr='<div class="prog-hdr"><div class="prog-hdr-thumb"><img src="'+hesc(p.img)+'" alt="" loading="lazy"></div>';
    hdr+='<div style="flex:1"><span class="prog-crumb">Health Vertical &middot; '+hesc(p.sub)+'</span>';
    hdr+='<div class="prog-title"><em>'+hesc(p.name)+'</em></div>';
    hdr+='<div class="prog-desc">'+hesc(p.desc)+'</div>';
    hdr+='<div class="prog-tags">'+tags+'</div>';
    hdr+='<div class="prog-stats">';
    hdr+='<div class="prog-stat"><div><div class="ps-num" style="color:'+p.color+'">'+p.insights.length+'</div><div class="ps-lbl">Health Insights</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num" style="color:'+p.color+'">'+mkrSet.size+'</div><div class="ps-lbl">Max Biomarkers</div></div></div>';
    hdr+='</div></div></div>';
  }
  main.innerHTML=hdr+'<div class="body-grid"><div id="ins-col">'+renderInsights()+'</div><div id="ds-col" style="--ac:'+ac+'">'+renderDsPanel(ac)+'</div></div>';
  bindDS();
}

/* ── DATA SOURCES PANEL ──────────────────────────────────────────────── */
function renderDsPanel(ac){
  var h='<div class="ds-panel" style="--ac:'+ac+'">';
  h+='<div class="ds-panel-title">&#9889; Data Sources</div>';
  h+='<div class="ds-panel-sub">Toggle to unlock insights. Check cards to add to API Cart.</div>';
  for(var i=0;i<DATA_SOURCES.length;i++){
    var d=DATA_SOURCES[i],on=activeSources.has(d.id),cnt=countIns(d.id);
    var num=(i+1<10?'0':'')+(i+1);
    h+='<div class="ds-item'+(on?' on':'')+'" data-src="'+d.id+'">';
    h+='<div class="ds-row"><span class="ds-num">'+num+'</span><span class="ds-ico">'+d.ico+'</span>';
    h+='<div class="ds-info"><span class="ds-name">'+hesc(d.name)+'</span>';
    h+='<span class="ds-hint">'+hesc(on&&d.hasBlood?BLOOD_TIERS[bloodTier].name:d.hint)+'</span></div>';
    h+='<span class="ds-badge">'+cnt+'</span>';
    h+='<div class="ds-chk">&#10003;</div></div>';
    if(d.hasBlood){
      h+='<div class="blood-sub"><div class="blood-sub-lbl">Panel Comprehensiveness</div>';
      var tkeys=['basic','standard','advanced','comprehensive'];
      for(var ti=0;ti<tkeys.length;ti++){
        var tk=tkeys[ti],td=BLOOD_TIERS[tk],sel=bloodTier===tk;
        h+='<div class="bt'+(sel?' sel':'')+'" data-tier="'+tk+'">';
        h+='<div class="bt-radio"><div class="bt-dot"></div></div>';
        h+='<div><span class="bt-name">'+hesc(td.name)+'</span>';
        h+='<span class="bt-items">'+hesc(td.items.slice(0,3).join(', '))+'...</span></div></div>';
      }
      h+='</div>';
    }
    h+='</div>';
  }
  h+='</div>'; return h;
}
function countIns(srcId){
  var progs=program?[program]:PROGRAMS,n=0;
  for(var i=0;i<progs.length;i++) for(var j=0;j<progs[i].insights.length;j++){
    var ins=progs[i].insights[j];
    if(ins.src===srcId&&insActive(ins)) n++;
  } return n;
}

/* ── INSIGHTS ─────────────────────────────────────────────────────────── */

// Competitor-inspired insight names for callout badges
var COMPETITOR_INSIGHTS = {
  'InnerAge Biological Age Score': 'InsideTracker InnerAge 2.0',
  'Endurance Healthspan Category Score': 'InsideTracker',
  'Recovery & Muscle Damage Index': 'InsideTracker',
  'Metabolism Healthspan Score': 'InsideTracker',
  'Gut-Brain Axis Health Score': 'InsideTracker',
  'Advanced Cardiovascular Risk Score': 'Function Health + InsideTracker',
  'Insulin Resistance & Pre-Diabetes Index': 'InsideTracker metabolism',
  'Organ Function Surveillance Panel': 'Function Health',
  'Heavy Metal & Toxin Burden Index': 'Function Health',
  'Autoimmune Surveillance Index': 'Function Health',
  'Brain Aging & Alzheimer\'s Risk Score': 'Function Health',
  'Omega-3 Index & Essential Fatty Acid Profile': 'Function Health',
  'Electrolyte & Mineral Optimization Panel': 'InsideTracker Ultimate',
  'Mood-Nutrient Deficiency Panel': 'Function Health',
  'Thyroid-Mood Connection Score': 'Function Health',
  'Neuroinflammation Index': 'Function Health + InsideTracker'
};

function renderInsights(){
  if(activeSources.size===0&&!activeFilters.has('recommendation'))
    return '<div class="no-src"><div class="no-src-icon">&#9655;</div><div class="no-src-p">Select data sources on the right<br>to see available insights.</div></div>';
  var progs=program?[program]:PROGRAMS, ac=program?program.color:'#1452d4';
  var srcArr=[]; activeSources.forEach(function(s){srcArr.push(s);});
  // Add recommendation source if filter active
  var srcArrFull = srcArr.slice();
  if (activeFilters.has('recommendation')) srcArrFull.push('recommendation');
  
  var groups=[];
  for(var si=0;si<srcArrFull.length;si++){
    var srcId=srcArrFull[si],d2=ds(srcId),items=[];
    for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++){
      var ins=progs[pi].insights[ii];
      if(ins.src!==srcId) continue;
      if(srcId!=='recommendation'&&!insActive(ins)) continue;
      // Apply insight type filter
      var itype=ins.insight_type||'health_dashboard';
      if(!activeFilters.has(itype)) continue;
      items.push({ins:ins,prog:progs[pi]});
    }
    if(items.length>0) groups.push({ds:d2,srcId:srcId,items:items});
  }
  var total=0; for(var gi=0;gi<groups.length;gi++) total+=groups[gi].items.length;
  var filterBarHtml = renderFilterBar(ac);
  var bar='<div class="total-bar">';
  bar+='<div><div class="t-num">'+total+'</div><div class="t-lbl">Matching Insights</div></div>';
  bar+='<div class="t-sep"></div><div><div class="t-num">'+activeSources.size+'</div><div class="t-lbl">Data Sources</div></div>';
  if(cart.length>0) bar+='<div class="t-sep"></div><div><div class="t-num" style="color:#c03030">'+cart.length+'</div><div class="t-lbl">In Cart</div></div>';
  bar+='</div>';
  var blocks='';
  for(var gi=0;gi<groups.length;gi++){
    var g=groups[gi],bg=srcBg(g.srcId),cards='';
    var ac_cur=program?program.color:g.items[0]?g.items[0].prog.color:'#1452d4';
    cards=renderSubcatGrouped(g.items, ac_cur, !program);
    var srcDisplayName = g.srcId === 'recommendation' ? 'Recommendation Engine' : (g.ds?g.ds.name:g.srcId);
  var srcDisplayIco  = g.srcId === 'recommendation' ? '💡' : (g.ds?g.ds.ico:'');
  var srcBgColor     = g.srcId === 'recommendation' ? '#166534' : bg;
  blocks+='<div class="src-block"><div class="src-hdr" style="background:'+srcBgColor+'">';
    blocks+='<span class="src-hdr-ico">'+srcDisplayIco+'</span>';
    blocks+='<span class="src-hdr-name">'+hesc(srcDisplayName)+'</span>';
    blocks+='<span class="src-hdr-count">'+g.items.length+' insight'+(g.items.length!==1?'s':'')+'</span></div>';
    blocks+='<div class="ins-grid">'+cards+'</div></div>';
  }
  var epH=''; srcArrFull.forEach(function(srcId){
    if(srcId==='recommendation'){
      epH+='<div class="api-ep"><span class="api-method post">POST</span><span class="api-path">/api/v1/recommendations/{userId}</span></div>';
      return;
    }
    var d3=ds(srcId); if(!d3) return;
    epH+='<div class="api-ep"><span class="api-method '+d3.method.toLowerCase()+'">'+d3.method+'</span><span class="api-path">'+hesc(d3.ep)+'</span></div>';
  });
  var api='<div class="api-block"><div class="api-title">&#128299; API Endpoints for This Configuration</div><div class="api-eps">'+epH+'</div><div class="api-note">Full OpenAPI spec: developers.lifenome.com &bull; Auth: Bearer Token (RFC6750)</div></div>';
  return filterBarHtml+bar+blocks+api;
}

/* ── EVENT BINDING ────────────────────────────────────────────────────── */
function bindDS(){
  var rows=document.querySelectorAll('.ds-row');
  for(var i=0;i<rows.length;i++)(function(row){
    row.onclick=function(){
      var item=row.parentElement,src=item.getAttribute('data-src');
      if(activeSources.has(src)) activeSources.delete(src); else activeSources.add(src);
      refresh();
    };
  })(rows[i]);
  var tiers=document.querySelectorAll('.bt');
  for(var i=0;i<tiers.length;i++)(function(tier){
    tier.onclick=function(e){
      e.stopPropagation(); bloodTier=tier.getAttribute('data-tier');
      if(!activeSources.has('blood')) activeSources.add('blood'); refresh();
    };
  })(tiers[i]);
  var cards=document.querySelectorAll('.ins-card');
  for(var i=0;i<cards.length;i++)(function(card){
    var chk=card.querySelector('.ic-cart');
    if(chk) chk.onclick=function(e){
      e.stopPropagation();
      cartToggle(card.getAttribute('data-key'),card.getAttribute('data-prog'),
        card.getAttribute('data-name'),card.getAttribute('data-src'),
        card.getAttribute('data-unit')||'',card.getAttribute('data-range')||'');
    };
  })(cards[i]);
}
function refresh(){
  var insCol=document.getElementById('ins-col'),dsCol=document.getElementById('ds-col');
  var ac=program?program.color:'#1452d4';
  if(insCol) insCol.innerHTML=renderInsights();
  if(dsCol){dsCol.innerHTML=renderDsPanel(ac);dsCol.style.setProperty('--ac',ac);}
  bindDS(); updateCartBtn(); updateFilterUI();
}

/* ── CART ─────────────────────────────────────────────────────────────── */
function cartToggle(key,progId,insName,srcId,unit,range){
  var found=-1; for(var i=0;i<cart.length;i++) if(cart[i].key===key){found=i;break;}
  if(found>=0){ cart.splice(found,1); }
  else{
    var prog=null; for(var i=0;i<PROGRAMS.length;i++) if(PROGRAMS[i].id===progId){prog=PROGRAMS[i];break;}
    var markers=[]; if(prog) for(var i=0;i<prog.insights.length;i++) if(prog.insights[i].name===insName){markers=prog.insights[i].markers||[];break;}
    cart.push({key:key,progId:progId,progName:prog?prog.name:progId,progColor:prog?prog.color:'#1452d4',insName:insName,srcId:srcId,unit:unit,range:range,markers:markers});
  }
  var safeKey=key.replace(/'/g,"\\'");
  var card=document.querySelector('[data-key="'+safeKey+'"]');
  if(card) card.classList.toggle('carted',found<0);
  updateCartBtn(); refreshBar();
  if(document.getElementById('cart-overlay').classList.contains('open')) renderCartPanel();
}
function refreshBar(){
  var bar=document.querySelector('.total-bar'); if(!bar) return;
  var progs=program?[program]:PROGRAMS,total=0;
  activeSources.forEach(function(srcId){
    for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++){
      var ins=progs[pi].insights[ii]; if(ins.src===srcId&&insActive(ins)) total++;
    }
  });
  bar.innerHTML='<div><div class="t-num">'+total+'</div><div class="t-lbl">Insights Available</div></div>'+
    '<div class="t-sep"></div><div><div class="t-num">'+activeSources.size+'</div><div class="t-lbl">Data Sources</div></div>'+
    (cart.length>0?'<div class="t-sep"></div><div><div class="t-num" style="color:#c03030">'+cart.length+'</div><div class="t-lbl">In Cart</div></div>':'');
}
function updateCartBtn(){
  var btn=document.getElementById('hdr-cart-btn'),cnt=document.getElementById('hdr-cart-count');
  if(cnt) cnt.textContent=cart.length;
  if(btn){if(cart.length>0) btn.classList.add('has-items'); else btn.classList.remove('has-items');}
}
function openCart(){ document.getElementById('cart-overlay').classList.add('open'); renderCartPanel(); }
function closeCart(){ document.getElementById('cart-overlay').classList.remove('open'); }

/* ── CART PANEL ───────────────────────────────────────────────────────── */
function renderCartPanel(){
  var body=document.getElementById('cart-body'),footer=document.getElementById('cart-footer');
  if(cart.length===0){
    body.innerHTML='<div class="cart-empty"><div style="font-size:32px;margin-bottom:12px">&#128722;</div><p style="font-size:13px;color:var(--ink3)">Your API Cart is empty.<br>Check insights to add them here.</p></div>';
    footer.innerHTML=''; return;
  }
  var srcMarkers={};
  for(var ci=0;ci<cart.length;ci++){
    var c=cart[ci];
    if(!srcMarkers[c.srcId]) srcMarkers[c.srcId]=new Set();
    (c.markers||[]).forEach(function(m){srcMarkers[c.srcId].add(m);});
  }
  var usedSrcs=[]; for(var ci=0;ci<cart.length;ci++) if(usedSrcs.indexOf(cart[ci].srcId)<0) usedSrcs.push(cart[ci].srcId);
  var modH='<div style="margin-bottom:18px"><div class="cart-sec-title">Required Testing Modalities & Biomarkers</div>';
  for(var di=0;di<DATA_SOURCES.length;di++){
    var d2=DATA_SOURCES[di]; if(usedSrcs.indexOf(d2.id)<0) continue;
    var cnt2=0; for(var ci=0;ci<cart.length;ci++) if(cart[ci].srcId===d2.id) cnt2++;
    var bms=srcMarkers[d2.id]?[...srcMarkers[d2.id]]:[];
    if(d2.hasBlood) BLOOD_TIERS[bloodTier].items.forEach(function(bm){bms.indexOf(bm)<0&&bms.push(bm);});
    var bmHtml=''; for(var bi=0;bi<bms.length;bi++) bmHtml+='<span class="mod-bm">'+hesc(bms[bi])+'</span>';
    modH+='<div class="modality-block"><div class="modality-hdr" style="background:'+srcBg(d2.id)+'">';
    modH+='<span class="mod-ico">'+d2.ico+'</span>';
    modH+='<span class="mod-hdr-name">'+hesc(d2.name)+(d2.hasBlood?' — '+BLOOD_TIERS[bloodTier].name:'')+'</span>';
    modH+='<span class="mod-hdr-count">'+cnt2+' insight'+(cnt2!==1?'s':'')+'</span></div>';
    modH+='<div class="modality-biomarkers"><div class="mod-bm-lbl">Biomarkers &amp; Inputs Required</div>';
    modH+='<div class="mod-bm-list">'+bmHtml+'</div></div></div>';
  }
  modH+='</div>';
  var byProg={};
  for(var ci=0;ci<cart.length;ci++){var c2=cart[ci]; if(!byProg[c2.progId]) byProg[c2.progId]=[]; byProg[c2.progId].push(c2);}
  var insH='<div><div class="cart-sec-title">Selected Insights ('+cart.length+')</div>';
  var progIds=Object.keys(byProg);
  for(var pi2=0;pi2<progIds.length;pi2++){
    var pid=progIds[pi2],items=byProg[pid],pc=items[0].progColor;
    insH+='<div class="cart-ins-prog"><div class="cart-prog-hdr" style="color:'+pc+'"><span class="cart-dot" style="background:'+pc+'"></span>'+hesc(items[0].progName)+'</div>';
    for(var ii2=0;ii2<items.length;ii2++){
      var item2=items[ii2],dsName=item2.srcId;
      for(var di2=0;di2<DATA_SOURCES.length;di2++) if(DATA_SOURCES[di2].id===item2.srcId){dsName=DATA_SOURCES[di2].name;break;}
      insH+='<div class="cart-item" data-key="'+hesc(item2.key)+'">';
      insH+='<div class="cart-dot" style="background:'+pc+';margin-top:4px"></div>';
      insH+='<div class="cart-item-info"><span class="cart-item-name">'+hesc(item2.insName)+'</span>';
      insH+='<span class="cart-item-meta">'+hesc(dsName)+(item2.unit?' &bull; '+hesc(item2.unit):'')+'</span>';
      if(item2.range) insH+='<span class="cart-item-range">'+hesc(item2.range)+'</span>';
      insH+='</div>';
      insH+='<button class="cart-rm" data-key="'+hesc(item2.key)+'" data-prog="'+hesc(item2.progId)+'" data-name="'+hesc(item2.insName)+'" data-src="'+hesc(item2.srcId)+'" data-unit="'+hesc(item2.unit||'')+'" data-range="'+hesc(item2.range||'')+'">&#10005;</button>';
      insH+='</div>';
    }
    insH+='</div>';
  }
  insH+='</div>';
  var epH='<div class="api-block"><div class="api-title">&#128299; Your Solution API Endpoints</div><div class="api-eps">';
  for(var si=0;si<usedSrcs.length;si++){
    var d3=ds(usedSrcs[si]); if(!d3) continue;
    epH+='<div class="api-ep"><span class="api-method '+d3.method.toLowerCase()+'">'+d3.method+'</span><span class="api-path">'+hesc(d3.ep)+'</span></div>';
  }
  epH+='</div><div class="api-note">Contact partnerships@lifenome.com for API key and pricing proposal.</div></div>';
  body.innerHTML=modH+insH+epH;
  var rmBtns=body.querySelectorAll('.cart-rm');
  for(var ri=0;ri<rmBtns.length;ri++)(function(btn){
    btn.onclick=function(){
      cartToggle(btn.getAttribute('data-key'),btn.getAttribute('data-prog'),btn.getAttribute('data-name'),
        btn.getAttribute('data-src'),btn.getAttribute('data-unit')||'',btn.getAttribute('data-range')||'');
    };
  })(rmBtns[ri]);
  footer.innerHTML=
    '<button class="send-btn" onclick="sendEmail()">&#9993;&nbsp; Send API Selection to Lifenome Partnership Team</button>'+
    '<button class="export-btn" onclick="exportCart()">&#128229; Download Solution Spec <span style="font-family:DM Mono,monospace;font-size:10px;background:rgba(0,0,0,.07);padding:1px 7px;border-radius:4px">'+cart.length+' insights</span></button>';
}

/* ── EMAIL & EXPORT ─────────────────────────────────────────────────── */
function buildEmailBody(){
  var lines=[];
  lines.push('Organization: '+orgName);
  lines.push('Email: '+orgEmail);
  if(orgUrl) lines.push('Website: '+orgUrl);
  lines.push('');
  var typeLabels=[];
  for(var i=0;i<orgTypes.length;i++) for(var j=0;j<CLIENT_TYPES.length;j++) if(CLIENT_TYPES[j].id===orgTypes[i]) typeLabels.push(CLIENT_TYPES[j].label);
  lines.push('Organization Type(s): '+typeLabels.join(', '));
  lines.push('');
  lines.push('\u2500'.repeat(50));
  lines.push('API CART SELECTION ('+cart.length+' insights)');
  lines.push('\u2500'.repeat(50));
  lines.push('');
  var usedSrcs=[]; for(var ci=0;ci<cart.length;ci++) if(usedSrcs.indexOf(cart[ci].srcId)<0) usedSrcs.push(cart[ci].srcId);
  lines.push('REQUIRED TESTING MODALITIES:');
  lines.push('');
  var srcMarkers2={};
  for(var ci=0;ci<cart.length;ci++){
    var c=cart[ci]; if(!srcMarkers2[c.srcId]) srcMarkers2[c.srcId]=new Set();
    (c.markers||[]).forEach(function(m){srcMarkers2[c.srcId].add(m);});
  }
  for(var si=0;si<usedSrcs.length;si++){
    var d4=ds(usedSrcs[si]);
    var cnt3=0; for(var ci=0;ci<cart.length;ci++) if(cart[ci].srcId===usedSrcs[si]) cnt3++;
    lines.push((d4?d4.name:usedSrcs[si])+(d4&&d4.hasBlood?' ['+BLOOD_TIERS[bloodTier].name+']':'')+'  ('+cnt3+' insights)');
    lines.push('  API Endpoint: '+(d4?d4.ep:''));
    var bms=srcMarkers2[usedSrcs[si]]?[...srcMarkers2[usedSrcs[si]]]:[];
    if(d4&&d4.hasBlood) BLOOD_TIERS[bloodTier].items.forEach(function(bm){bms.indexOf(bm)<0&&bms.push(bm);});
    if(bms.length>0) lines.push('  Biomarkers / Inputs: '+bms.join(' | '));
    lines.push('');
  }
  lines.push('\u2500'.repeat(50));
  lines.push('SELECTED INSIGHTS BY PROGRAM:');
  lines.push('');
  var byProg2={};
  for(var ci=0;ci<cart.length;ci++){var c3=cart[ci]; if(!byProg2[c3.progId]) byProg2[c3.progId]=[]; byProg2[c3.progId].push(c3);}
  Object.keys(byProg2).forEach(function(pid){
    var items=byProg2[pid];
    lines.push('[ '+items[0].progName+' ]');
    items.forEach(function(c4){
      lines.push('  * '+c4.insName);
      if(c4.unit) lines.push('    Unit: '+c4.unit);
      if(c4.range) lines.push('    Reference: '+c4.range);
    });
    lines.push('');
  });
  return lines.join('\n');
}
function sendEmail(){
  var subject=encodeURIComponent('API and Testing Selection \u2014 '+orgName);
  var body=encodeURIComponent(buildEmailBody());
  window.location.href='mailto:ali@lifenome.com?subject='+subject+'&body='+body;
}
function exportCart(){
  var blob=new Blob([buildEmailBody()],{type:'text/plain'});
  var a=document.createElement('a');a.href=URL.createObjectURL(blob);
  a.download='lifenome-api-selection-'+(orgName||'org').replace(/\s+/g,'-').toLowerCase()+'.txt';
  a.click();
}

const SUBCAT_ICONS = {"Chronic Disease Management & Prevention": "\ud83c\udfe5", "Cancer Genetics & Risk": "\ud83c\udf97\ufe0f", "Pharmacogenomics": "\ud83d\udc8a", "Neurological & Psychiatric Disease Risk": "\ud83e\udde0", "Women's Health Genomics": "\ud83c\udf38", "Digestive & Gastrointestinal Genomics": "\ud83e\udda0", "Immune, Autoimmune & Allergy Genomics": "\ud83d\udee1\ufe0f", "Respiratory & Pulmonary Genomics": "\ud83e\udec1", "Cardiogenomics & Structural Heart Disease": "\u2764\ufe0f", "Metabolic & Endocrine Rare Disease": "\u2697\ufe0f", "Renal, Ophthalmology & ENT Genomics": "\ud83d\udc41\ufe0f", "Nutrition Genomics & Precision Supplementation": "\ud83e\udd57", "Addiction & Behavioral Genomics": "\ud83e\uddec", "Dermatology & Skin Disease Genomics": "\ud83d\udd2c", "Hematology & Blood Disorders": "\ud83e\ude78", "Developmental & Congenital Disorders": "\ud83e\udde9", "Oral Health Genomics": "\ud83e\uddb7", "Epigenetic Disease Risk": "\ud83d\udd2d"};

function renderSubcatGrouped(items, ac, showProgChip) {
  // Group items by subcategory
  var groups = {}, order = [];
  for (var i = 0; i < items.length; i++) {
    var sc = items[i].ins.subcategory || '';
    if (!groups[sc]) { groups[sc] = []; order.push(sc); }
    groups[sc].push(items[i]);
  }
  var html = '';
  for (var gi = 0; gi < order.length; gi++) {
    var sc = order[gi], sc_items = groups[sc];
    if (sc) {
      var ico = SUBCAT_ICONS[sc] || '▸';
      html += '<div class="subcat-hdr"><span class="subcat-hdr-ico">' + ico + '</span>';
      html += '<span class="subcat-hdr-name">' + hesc(sc) + '</span>';
      html += '<span class="subcat-hdr-count">' + sc_items.length + ' insight' + (sc_items.length !== 1 ? 's' : '') + '</span></div>';
    }
    for (var ci = 0; ci < sc_items.length; ci++) {
      html += renderInsCard(sc_items[ci], ac, showProgChip);
    }
  }
  return html;
}

function renderInsCard(item, ac, showProgChip) {
  var ins = item.ins, p = item.prog;
  var key = cartKey(p.id, ins.name);
  var inCart = false;
  for (var ki = 0; ki < cart.length; ki++) if (cart[ki].key === key) { inCart = true; break; }
  var cardAc = ac;
  var tierLbl = (ins.src === 'blood' && ins.tier) ? ' &middot; ' + BLOOD_TIERS[ins.tier].name : '';
  var catChip = showProgChip ? ('<span class="ic-cat" style="background:color-mix(in srgb,' + p.color + ' 10%,white);color:' + p.color + ';border:1px solid color-mix(in srgb,' + p.color + ' 18%,transparent)">' + hesc(p.name) + '</span><br>') : '';
  var compSource = COMPETITOR_INSIGHTS[ins.name];
  var compBadge = compSource ? '<span class="comp-badge">&#128270; ' + hesc(compSource) + '</span>' : '';
  var scBadge = ins.subcategory ? '<div class="ic-subcat">' + hesc(ins.subcategory) + '</div>' : '';
  var mArr = ins.markers || [], mkrs = '';
  for (var mi = 0; mi < Math.min(mArr.length, 6); mi++) mkrs += '<span class="ic-m">' + hesc(mArr[mi]) + '</span>';
  if (mArr.length > 6) mkrs += '<span class="ic-m">+' + (mArr.length - 6) + ' more</span>';
  return '<div class="ins-card' + (inCart ? ' carted' : '') + '" data-key="' + hesc(key) + '" data-prog="' + hesc(p.id) + '" data-name="' + hesc(ins.name) + '" data-src="' + hesc(ins.src) + '" data-unit="' + hesc(ins.unit || '') + '" data-range="' + hesc(ins.range || '') + '" style="--ac:' + cardAc + '">' +
    '<div class="ic-cart" title="Add to API Cart">&#10003;</div>' +
    catChip + scBadge +
    '<div class="ic-src" style="background:color-mix(in srgb,' + cardAc + ' 9%,white);color:' + cardAc + ';border:1px solid color-mix(in srgb,' + cardAc + ' 14%,transparent)">' + hesc((function(){for(var i=0;i<DATA_SOURCES.length;i++) if(DATA_SOURCES[i].id===ins.src) return DATA_SOURCES[i].name; return ins.src;})()) + tierLbl + '</div>' +
    '<div class="ic-name">' + hesc(ins.name) + compBadge + '</div>' +
    '<div class="ic-desc">' + hesc(ins.desc) + '</div>' +
    (ins.unit ? '<div><span class="ic-unit">' + hesc(ins.unit) + '</span></div>' : '') +
    (ins.range ? '<div class="ic-range">' + hesc(ins.range) + '</div>' : '') +
    '<div class="ic-markers">' + mkrs + '</div></div>';
}

var COMPETITOR_INSIGHTS = {"InnerAge Biological Age Score": "InsideTracker InnerAge 2.0", "Blood-Based Biological Age": "InsideTracker InnerAge 2.0", "Endurance Healthspan Category Score": "InsideTracker", "Recovery & Muscle Damage Index": "InsideTracker", "Metabolism Healthspan Score": "InsideTracker", "Gut-Brain Axis Health Score": "InsideTracker", "Advanced Cardiovascular Risk Score": "Function Health + InsideTracker", "Insulin Resistance & Pre-Diabetes Index": "InsideTracker metabolism", "Organ Function Surveillance Panel": "Function Health", "Heavy Metal & Toxin Burden Index": "Function Health", "Autoimmune Surveillance Index": "Function Health", "Brain Aging & Alzheimer's Risk Score": "Function Health", "Omega-3 Index & Essential Fatty Acid Profile": "Function Health", "Electrolyte & Mineral Optimization Panel": "InsideTracker Ultimate", "Mood-Nutrient Deficiency Panel": "Function Health", "Thyroid-Mood Connection Score": "Function Health", "Neuroinflammation Index": "Function Health + InsideTracker"};

// ─── INSIGHT TYPE FILTER STATE ──────────────────────────────────────
var activeFilters = new Set(['biomarker_assessment','health_dashboard','recommendation']);

function toggleFilter(type) {
  if (activeFilters.has(type)) {
    // don't allow all off
    if (activeFilters.size > 1) activeFilters.delete(type);
  } else {
    activeFilters.add(type);
  }
  updateFilterUI();
  refresh();
}

function updateFilterUI() {
  var chips = document.querySelectorAll('.filter-chip');
  for (var i = 0; i < chips.length; i++) {
    var chip = chips[i];
    var ft = chip.getAttribute('data-filter');
    if (ft === 'all') {
      chip.classList.toggle('active', activeFilters.size === 3);
    } else {
      chip.classList.toggle('active', activeFilters.has(ft));
    }
  }
  // Update counts
  updateFilterCounts();
}

function toggleAllFilters() {
  if (activeFilters.size === 3) {
    // all on → keep all on (don't allow turning all off this way)
    return;
  }
  activeFilters = new Set(['biomarker_assessment','health_dashboard','recommendation']);
  updateFilterUI();
  refresh();
}

function updateFilterCounts() {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (!activeSources.has(ins.src) && ins.src !== 'recommendation') continue;
      if (ins.src === 'recommendation' && !activeFilters.has('recommendation')) continue;
      var t = ins.insight_type || 'health_dashboard';
      if (counts[t] !== undefined) counts[t]++;
    }
  }
  ['biomarker_assessment','health_dashboard','recommendation'].forEach(function(ft) {
    var chip = document.querySelector('.filter-chip[data-filter="'+ft+'"]');
    if (chip) {
      var cnt = chip.querySelector('.filter-chip-cnt');
      if (cnt) cnt.textContent = counts[ft];
    }
  });
}

// Filter bar HTML
function renderFilterBar(ac) {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (ins.src !== 'recommendation' && !activeSources.has(ins.src)) continue;
      if (ins.src !== 'blood' || !ins.tier || tierIdx(ins.tier) <= tierIdx(bloodTier)) {
        var t = ins.insight_type || 'health_dashboard';
        if (counts[t] !== undefined) counts[t]++;
      }
    }
  }
  var allActive = activeFilters.size === 3;
  var h = '<div class="filter-bar">';
  h += '<span class="filter-bar-lbl">Show</span>';
  h += '<div class="filter-chip'+(allActive?' active':'')+'" data-filter="all" style="--chip-color:'+ac+'" onclick="toggleAllFilters()">';
  h += '<span class="filter-chip-ico">⚡</span> All Insights';
  h += '</div>';
  h += '<div class="filter-sep"></div>';
  h += '<div class="filter-chip'+(activeFilters.has('biomarker_assessment')?' active':'')+'" data-filter="biomarker_assessment" style="--chip-color:#0077cc" onclick="toggleFilter(\'biomarker_assessment\')">';
  h += '<span class="filter-chip-ico">🔬</span> Biomarker Assessments';
  h += '<span class="filter-chip-cnt">'+counts.biomarker_assessment+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('health_dashboard')?' active':'')+'" data-filter="health_dashboard" style="--chip-color:'+ac+'" onclick="toggleFilter(\'health_dashboard\')">';
  h += '<span class="filter-chip-ico">📊</span> Health Indices';
  h += '<span class="filter-chip-cnt">'+counts.health_dashboard+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('recommendation')?' active':'')+'" data-filter="recommendation" style="--chip-color:#16a34a" onclick="toggleFilter(\'recommendation\')">';
  h += '<span class="filter-chip-ico">💡</span> Recommendations';
  h += '<span class="filter-chip-cnt">'+counts.recommendation+'</span></div>';
  h += '</div>';
  return h;
}

function renderSubcatGrouped(items, ac, showProgChip) {
  var groups = {}, order = [];
  for (var i = 0; i < items.length; i++) {
    var sc = items[i].ins.subcategory || '';
    if (!groups[sc]) { groups[sc] = []; order.push(sc); }
    groups[sc].push(items[i]);
  }
  var html = '';
  for (var gi = 0; gi < order.length; gi++) {
    var sc = order[gi], sc_items = groups[sc];
    if (sc) {
      var ico = SUBCAT_ICONS[sc] || '▸';
      html += '<div class="subcat-hdr"><span class="subcat-hdr-ico">'+ico+'</span>';
      html += '<span class="subcat-hdr-name">'+hesc(sc)+'</span>';
      html += '<span class="subcat-hdr-count">'+sc_items.length+' insight'+(sc_items.length!==1?'s':'')+'</span></div>';
    }
    for (var ci = 0; ci < sc_items.length; ci++) {
      html += renderInsCard(sc_items[ci], ac, showProgChip);
    }
  }
  if (html === '') {
    html = '<div class="filter-empty"><div class="filter-empty-ico">🔍</div><div class="filter-empty-p">No insights match this filter.<br>Try selecting a different insight type above.</div></div>';
  }
  return html;
}

function renderInsCard(item, ac, showProgChip) {
  var ins = item.ins, p = item.prog;
  var key = cartKey(p.id, ins.name);
  var inCart = false;
  for (var ki = 0; ki < cart.length; ki++) if (cart[ki].key === key) { inCart = true; break; }
  var tierLbl = (ins.src === 'blood' && ins.tier) ? ' &middot; ' + BLOOD_TIERS[ins.tier].name : '';
  var catChip = showProgChip ? ('<span class="ic-cat" style="background:color-mix(in srgb,'+p.color+' 10%,white);color:'+p.color+';border:1px solid color-mix(in srgb,'+p.color+' 18%,transparent)">'+hesc(p.name)+'</span><br>') : '';
  var compSource = COMPETITOR_INSIGHTS[ins.name];
  var compBadge = compSource ? '<span class="comp-badge">&#128270; '+hesc(compSource)+'</span>' : '';
  var scBadge = ins.subcategory ? '<div class="ic-subcat">'+hesc(ins.subcategory)+'</div>' : '';
  var itype = ins.insight_type || 'health_dashboard';
  
  // Type badge
  var typeBadge = '';
  if (itype === 'recommendation') {
    var rtLabel = ins.rec_type === 'product' ? '🛍️ Product Recs' : '📋 Personalized Plans';
    typeBadge = '<div class="rec-badge">💡 Recommendation <span class="rec-type-badge '+(ins.rec_type||'program')+'">'+rtLabel+'</span></div>';
  } else if (itype === 'biomarker_assessment') {
    typeBadge = '<div class="assess-badge">🔬 Biomarker Assessment</div>';
  }
  // For health_dashboard no extra badge (the card style implies it)
  
  var srcName = ins.src;
  for (var di = 0; di < DATA_SOURCES.length; di++) if (DATA_SOURCES[di].id === ins.src) { srcName = DATA_SOURCES[di].name; break; }
  if (ins.src === 'recommendation') srcName = 'Recommendation Engine';
  
  var mArr = ins.markers || [], mkrs = '';
  var mkrLabel = itype === 'recommendation' ? 'Personalized by:' : '';
  for (var mi = 0; mi < Math.min(mArr.length, 6); mi++) mkrs += '<span class="ic-m">'+hesc(mArr[mi])+'</span>';
  if (mArr.length > 6) mkrs += '<span class="ic-m">+'+(mArr.length-6)+' more</span>';

  return '<div class="ins-card'+(inCart?' carted':'')+'" data-key="'+hesc(key)+'" data-prog="'+hesc(p.id)+'" data-name="'+hesc(ins.name)+'" data-src="'+hesc(ins.src)+'" data-unit="'+hesc(ins.unit||'')+'" data-range="'+hesc(ins.range||'')+'" data-itype="'+hesc(itype)+'" style="--ac:'+ac+'">' +
    '<div class="ic-cart" title="Add to API Cart">&#10003;</div>' +
    catChip + typeBadge + scBadge +
    '<div class="ic-src" style="background:color-mix(in srgb,'+(itype==='recommendation'?'#16a34a':ac)+' 9%,white);color:'+(itype==='recommendation'?'#16a34a':ac)+';border:1px solid color-mix(in srgb,'+(itype==='recommendation'?'#16a34a':ac)+' 14%,transparent)">'+hesc(srcName)+tierLbl+'</div>' +
    '<div class="ic-name">'+hesc(ins.name)+compBadge+'</div>' +
    '<div class="ic-desc">'+hesc(ins.desc)+'</div>' +
    (ins.unit ? '<div><span class="ic-unit">'+hesc(ins.unit)+'</span></div>' : '') +
    (ins.range ? '<div class="ic-range">'+hesc(ins.range)+'</div>' : '') +
    (mkrLabel ? '<div style="font-size:9px;font-weight:600;color:var(--ink3);margin:4px 0 2px;text-transform:uppercase;letter-spacing:.06em">'+mkrLabel+'</div>' : '') +
    '<div class="ic-markers">'+mkrs+'</div></div>';
}

const PROGRAMS = [
  {
    "id": "longevity",
    "name": "Longevity",
    "sub": "Lifespan Optimization",
    "color": "#1452d4",
    "lt": "#e8effe",
    "img": "https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=320&q=75",
    "desc": "Multi-omic lifespan optimization combining biological age, inflammaging, metabolic vitality, and epigenetic clocks into actionable longevity protocols.",
    "tags": [
      "biological age",
      "lifespan",
      "inflammaging",
      "epigenetic clock",
      "PGS"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Lifestyle Longevity Risk Score",
        "desc": "Composite modifiable risk index from smoking, sleep duration, exercise frequency, stress load, and alcohol patterns.",
        "markers": [
          "sleep hrs",
          "exercise freq",
          "smoking status",
          "alcohol units/wk",
          "stress score"
        ],
        "unit": "Score 0\u2013100",
        "range": "Low risk: >70 | High risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Healthspan Trajectory Projection",
        "desc": "Lifestyle-adjusted projection of remaining healthy life years, calibrated to population norms.",
        "markers": [
          "diet quality",
          "activity level",
          "social connection",
          "BMI",
          "sleep regularity"
        ],
        "unit": "Projected healthy years",
        "range": "Reference: chronological age \u2212 10 yr",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "HRV Aging Biomarker",
        "desc": "30-day RMSSD trend as real-time autonomic aging marker. Declining HRV correlates with accelerated biological aging.",
        "markers": [
          "HRV RMSSD ms",
          "resting HR bpm",
          "recovery score %"
        ],
        "unit": "RMSSD in ms",
        "range": "Optimal: >55 ms | Concern: <30 ms",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "VO2 Max Biological Age Proxy",
        "desc": "Cardiorespiratory fitness-based biological age estimation. VO2 max is one of the strongest predictors of longevity.",
        "markers": [
          "VO2 max mL/kg/min",
          "zone 2 weekly hrs",
          "training load AU"
        ],
        "unit": "mL/kg/min",
        "range": "Excellent 40s M: >46 | Poor: <35",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture Score",
        "desc": "Deep/REM ratio and circadian alignment score reflecting cellular repair quality and immune regulation.",
        "markers": [
          "deep sleep %",
          "REM %",
          "sleep efficiency %",
          "circadian alignment hr"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: deep >20%, REM >20%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Resting Heart Rate Trend",
        "desc": "Long-term resting HR trajectory as cardiometabolic aging signal. Upward drift indicates declining fitness age.",
        "markers": [
          "resting HR bpm 30-day",
          "7-day HR variability",
          "nocturnal HR"
        ],
        "unit": "bpm",
        "range": "Optimal: 50\u201365 bpm | Concern: >75 bpm",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Facial Biological Age",
        "desc": "Lifenome patented smartphone camera-based facial biological age estimate informed by methylation clock correlates.",
        "markers": [
          "periorbital aging score",
          "skin texture index",
          "facial symmetry",
          "wrinkle depth proxy"
        ],
        "unit": "Estimated biological age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Age Index",
        "desc": "Smartphone-derived body fat %, visceral fat proxy, and muscle mass index combined into a morphological age score.",
        "markers": [
          "body fat %",
          "visceral fat proxy",
          "muscle mass index",
          "waist-hip ratio"
        ],
        "unit": "Morphological age score",
        "range": "Optimal: body fat M<20%, F<28%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Grip Strength Proxy",
        "desc": "Camera-based hand posture analysis as proxy for grip strength \u2014 a validated all-cause mortality predictor.",
        "markers": [
          "hand posture analysis",
          "forearm volume proxy"
        ],
        "unit": "Estimated kg force",
        "range": "Optimal M: >40 kg | F: >25 kg",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Metabolic Vitality Score",
        "desc": "Fasting glucose, HbA1c, and lipid panel combined into a foundational metabolic age signal.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "LDL mg/dL",
          "HDL mg/dL",
          "TG mg/dL",
          "TSH mIU/L"
        ],
        "unit": "Composite score 0\u2013100",
        "range": "Optimal glucose: 70\u2013100 | HbA1c: <5.7%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Inflammaging Index",
        "desc": "Chronic low-grade inflammation composite: hs-CRP, homocysteine, ferritin as the biological age accelerator panel.",
        "markers": [
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "ferritin ng/mL",
          "vitamin D ng/mL"
        ],
        "unit": "Composite risk score",
        "range": "hs-CRP optimal: <1.0 mg/L | Hcy: <10 \u00b5mol/L",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Hormonal Vitality Score",
        "desc": "IGF-1, DHEA-S, testosterone, and cortisol AM balance as validated longevity endocrine markers.",
        "markers": [
          "IGF-1 ng/mL",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "testosterone ng/dL",
          "SHBG nmol/L"
        ],
        "unit": "Composite hormonal age",
        "range": "IGF-1 optimal 40\u201360s: 100\u2013200 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "ApoB / Lp(a) Cardiovascular Age",
        "desc": "Most predictive lipid markers for arterial aging \u2014 ApoB and Lp(a) supersede standard LDL for longevity risk.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "oxidized LDL U/L",
          "LDL-P nmol/L"
        ],
        "unit": "ApoB mg/dL + Lp(a) nmol/L",
        "range": "ApoB optimal: <80 mg/dL | Lp(a): <75 nmol/L",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Kidney Biological Age (eGFR)",
        "desc": "eGFR and cystatin-C based kidney age \u2014 renal function declines predictably with biological aging.",
        "markers": [
          "eGFR mL/min/1.73m2",
          "cystatin-C mg/L",
          "creatinine mg/dL",
          "BUN mg/dL"
        ],
        "unit": "eGFR mL/min/1.73m\u00b2",
        "range": "Optimal: >90 | Mild decline: 60\u201389",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "NAD+ / Mitochondrial Panel",
        "desc": "NAD+, CoQ10, and glutathione as direct cellular energy and antioxidant capacity longevity biomarkers.",
        "markers": [
          "NAD+ \u00b5mol/L",
          "CoQ10 \u00b5g/mL",
          "GSH \u00b5mol/L",
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL"
        ],
        "unit": "NAD+ \u00b5mol/L",
        "range": "Optimal NAD+: >40 \u00b5mol/L | Decline: <25",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Telomere-Associated Blood Panel",
        "desc": "IL-6, TNF-\u03b1, and lymphocyte/neutrophil ratio as blood-based correlates of telomere length.",
        "markers": [
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL",
          "neutrophil:lymphocyte ratio",
          "WBC x10\u00b3/\u00b5L"
        ],
        "unit": "NLR ratio",
        "range": "NLR optimal: 1.0\u20132.5 | Concern: >3.5",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Polygenic Longevity Score",
        "desc": "Lifenome 184-trait wellbeing PGS spanning fitness, nutrition, personality, and biological resilience genetics.",
        "markers": [
          "APOE status",
          "MTHFR C677T/A1298C",
          "telomere-length SNPs",
          "184 wellbeing PGS"
        ],
        "unit": "Percentile vs population",
        "range": "Top quartile: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Medical Disease PGS Panel",
        "desc": "213-condition medical PGS covering all major disease categories as all-cause mortality and morbidity modifiers.",
        "markers": [
          "circulatory PGS",
          "metabolic PGS",
          "cancer PGS",
          "neurological PGS",
          "213 medical traits"
        ],
        "unit": "Per-disease risk percentile",
        "range": "Elevated: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Pharmacogenomics Longevity Panel",
        "desc": "193-trait PGx covering supplement absorption, drug metabolism, and statin response for longevity protocols.",
        "markers": [
          "CYP2D6/2C19/3A4 status",
          "SLCO1B1 statin",
          "VDR vitamin D",
          "193 PGx traits"
        ],
        "unit": "Metabolizer phenotype",
        "range": "Normal / Poor / Rapid / Ultrarapid",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Circadian Rhythm Chronotype PGS",
        "desc": "Genetic chronotype (morning/evening) and sleep architecture predisposition \u2014 affects biological aging rate.",
        "markers": [
          "CLOCK gene",
          "PER3 SNPs",
          "BMAL1 variants",
          "chronotype PGS"
        ],
        "unit": "Chronotype score",
        "range": "Intermediate optimal; extreme owl/lark = risk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Rare Variant Longevity Risk",
        "desc": "Pathogenic and likely-pathogenic variants in longevity-associated genes across 230 Exome+ clinical panels.",
        "markers": [
          "PCSK9 gain-of-function",
          "LMNA variants",
          "TP53 germline",
          "MEN1",
          "TERT",
          "16,600+ panel traits"
        ],
        "unit": "Pathogenicity classification",
        "range": "ACMG P/LP = actionable",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_exome",
        "name": "Mitochondrial DNA Variants",
        "desc": "mtDNA variants affecting oxidative phosphorylation efficiency \u2014 haplogroup and pathogenic variant analysis.",
        "markers": [
          "mtDNA copy number",
          "OXPHOS variants",
          "mitochondrial haplogroup"
        ],
        "unit": "mtDNA copy number",
        "range": "Optimal: >100 copies/cell",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_wgs",
        "name": "Full Genome Longevity Scan",
        "desc": "WGS improves PRS accuracy by 25\u201335% and discovers ultra-rare structural variants missed by arrays and exome.",
        "markers": [
          "All array PGS enhanced",
          "structural variants",
          "copy number variants",
          "rare INDELs"
        ],
        "unit": "Enhanced PRS score",
        "range": "WGS PRS \u00b11.5 SD from mean",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Microbiome Diversity Longevity Index",
        "desc": "Alpha and beta diversity as independent aging predictors \u2014 centenarians show distinct microbiome signatures.",
        "markers": [
          "Shannon diversity index",
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia % abundance",
          "Bifidobacterium %"
        ],
        "unit": "Shannon index (H)",
        "range": "Optimal H: >3.0 | Concern: <2.0",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Leaky Gut & Systemic Inflammation",
        "desc": "Intestinal permeability markers measured via microbiome composition correlates affecting inflammaging.",
        "markers": [
          "zonulin-correlated species",
          "LPS-producing bacteria %",
          "mucosal barrier species"
        ],
        "unit": "Dysbiosis score 0\u201310",
        "range": "Optimal: <3 | High risk: >7",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Functional Longevity Metabolomics",
        "desc": "Butyrate producers, SCFA synthesis capacity, and tryptophan metabolism from shotgun functional analysis.",
        "markers": [
          "butyrate pathway gene count",
          "SCFA producers %",
          "tryptophan metabolism genes",
          "serotonin pathway capacity"
        ],
        "unit": "Functional gene abundance (RPKM)",
        "range": "Butyrate genes: optimal >1.5 RPKM",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Epigenetic Biological Age (DNAmAge)",
        "desc": "Horvath, GrimAge, DunedinPACE, and PhenoAge clocks \u2014 gold-standard multi-algorithm biological age battery.",
        "markers": [
          "Horvath age (yr)",
          "GrimAge (yr)",
          "DunedinPACE (yr/yr)",
          "PhenoAge (yr)"
        ],
        "unit": "Biological age in years",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Epigenetic Age Acceleration",
        "desc": "Age gap vs. chronological age \u2014 the most actionable longevity intervention target available.",
        "markers": [
          "AgeAccelGrim (yr)",
          "AgeAccelHorvath (yr)",
          "DunedinPACE pace value",
          "methylation clock consensus"
        ],
        "unit": "Age acceleration in years",
        "range": "Optimal: \u22640 yr | High: >5 yr acceleration",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Methylation-Based Disease Risk Scores",
        "desc": "DNAm-derived risk scores for cardiovascular disease, T2DM, and cancer independent of genetic risk.",
        "markers": [
          "DNAm CVD risk score",
          "DNAm T2DM score",
          "CpG cancer methylation loci",
          "epigenetic immune age"
        ],
        "unit": "Percentile vs population",
        "range": "Elevated: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Heavy Metal & Toxin Burden Index",
        "desc": "Function Health includes mercury and lead in standard membership. Chronic heavy metal accumulation accelerates aging, impairs cognition, and drives cardiovascular and kidney disease. Lead, mercury, arsenic, and cadmium panel.",
        "markers": [
          "blood lead (Pb)",
          "blood mercury (Hg)",
          "blood arsenic (As)",
          "urine cadmium (Cd)",
          "urine aluminum (Al)",
          "serum thallium"
        ],
        "unit": "\u03bcg/L per metal",
        "range": "Mercury: <5 \u03bcg/L | Lead: <3.5 \u03bcg/dL | Arsenic: <20 \u03bcg/L",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Autoimmune Surveillance Index",
        "desc": "Function Health data shows 23% of members have elevated autoimmune antibodies \u2014 most entirely asymptomatic. ANA screen, anti-dsDNA, TPO, TgAb, and anti-CCP provide early autoimmune detection before clinical symptoms emerge.",
        "markers": [
          "ANA screen",
          "ANA pattern (IF)",
          "anti-dsDNA",
          "TPO antibodies",
          "TgAb",
          "anti-CCP",
          "RF (rheumatoid factor)",
          "complement C3/C4"
        ],
        "unit": "Antibody titer / IU/mL",
        "range": "ANA negative | TPO Ab: <35 IU/mL | Anti-dsDNA: <30 IU/mL",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration"
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Longevity Exercise Protocol",
        "desc": "Individualized exercise prescription balancing aerobic (VO\u2082max optimization), resistance (lean mass preservation), and flexibility training. Intensity zones set by HRV-derived lactate threshold, adjusted weekly by recovery readiness score and biological age gap.",
        "markers": [
          "VO\u2082max",
          "HRV (RMSSD)",
          "biological age gap",
          "testosterone",
          "IGF-1",
          "cortisol AM",
          "CRP",
          "muscle damage index"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Precision Longevity Nutrition Plan",
        "desc": "Personalized macronutrient ratios and meal timing based on metabolic type (carb/fat response genetics), insulin sensitivity, circadian chronotype, and microbiome composition. Includes intermittent fasting protocol if metabolic markers support it.",
        "markers": [
          "HOMA-IR",
          "chronotype PGS",
          "Firmicutes:Bacteroidetes ratio",
          "HbA1c",
          "omega-3 index",
          "tryptophan:LNAA",
          "diet PGS"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Stress Resilience & Mind-Body Program",
        "desc": "Structured program combining breathwork (HRV biofeedback), mindfulness meditation, and sleep hygiene protocols. Protocol intensity matched to cortisol burden score, HRV baseline, and stress resilience genetics (FKBP5, COMT).",
        "markers": [
          "cortisol AM",
          "DHEA-S",
          "HRV",
          "FKBP5 genotype",
          "COMT genotype",
          "PSS-10 score",
          "sleep efficiency"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Longevity Supplement Stack",
        "desc": "Personalized longevity supplement protocol selected from client product catalog. Matched to identified deficiencies and genetic predispositions: NAD+ precursors (NMN/NR) if mitochondrial markers low, omega-3 if index <6%, vitamin D if <40 ng/mL, magnesium if RBC Mg low, CoQ10 if statin use or mitochondrial panel.",
        "markers": [
          "NAD+ proxy (NMN need)",
          "omega-3 index",
          "25-OH Vit D",
          "magnesium RBC",
          "CoQ10",
          "glutathione",
          "folate",
          "B12",
          "MTHFR genotype",
          "heavy metals"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Biological Age Reversal Program",
        "desc": "12-month structured lifestyle intervention program targeting GrimAge deceleration. Protocol includes caloric restriction mimetics support, time-restricted eating windows, cold exposure, and sauna protocols personalized by epigenetic clock acceleration and physiological age gap.",
        "markers": [
          "GrimAge acceleration",
          "DunedinPACE",
          "blood biological age",
          "actuarial age",
          "physiological age",
          "NLR",
          "CRP",
          "telomere-associated markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "fertility",
    "name": "Fertility & Pregnancy",
    "sub": "Reproductive Health",
    "color": "#b82050",
    "lt": "#fcedf3",
    "img": "https://images.unsplash.com/photo-1559757175-0eb30cd8c063?w=320&q=75",
    "desc": "Science-backed reproductive health intelligence \u2014 ovarian reserve, hormonal cycle mapping, prenatal risk assessment, and IVF preparation insights.",
    "tags": [
      "ovarian reserve",
      "PCOS",
      "IVF prep",
      "prenatal",
      "endometriosis"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Fertility Lifestyle Risk Score",
        "desc": "Modifiable fertility risk composite from BMI, alcohol, smoking, stress, exercise patterns, and environmental exposures.",
        "markers": [
          "BMI kg/m\u00b2",
          "smoking pack-years",
          "alcohol units/wk",
          "exercise freq",
          "stress score",
          "environmental toxin exposure"
        ],
        "unit": "Fertility risk score 0\u2013100",
        "range": "Low risk: >70 | High risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Nutritional Fertility Readiness",
        "desc": "Dietary gap analysis for conception readiness: folate, iron, zinc, and anti-inflammatory diet quality.",
        "markers": [
          "dietary folate mcg/day",
          "iron intake mg/day",
          "omega-3 intake",
          "anti-inflammatory diet score"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Optimal: >75 | Deficient: <50",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Ovulation Cycle Detection",
        "desc": "Basal body temperature + HRV + resting HR pattern analysis for fertile window precision prediction.",
        "markers": [
          "basal HR nadir (\u00b0C)",
          "HRV LH-surge pattern",
          "cycle day 1 detection",
          "fertile window days"
        ],
        "unit": "Fertile window days predicted",
        "range": "\u00b11 day accuracy vs LH test",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Luteal Phase Quality Index",
        "desc": "Post-ovulation HRV and temperature elevation duration as luteal phase adequacy proxy.",
        "markers": [
          "post-ovulation temp elevation (\u00b0C)",
          "luteal HRV pattern",
          "luteal phase length (days)"
        ],
        "unit": "Luteal phase days",
        "range": "Optimal: 12\u201316 days | Short: <10 days",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Cycle Length & Regularity",
        "desc": "Smartphone-based AI-assisted cycle tracking with ovulation prediction and irregularity detection.",
        "markers": [
          "cycle length (days)",
          "cycle variability (CV%)",
          "cycle pattern classification"
        ],
        "unit": "Cycle length in days",
        "range": "Normal: 24\u201338 days | Variation: \u22649 days",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "AMH Correlation Index",
        "desc": "Body composition and lifestyle-based AMH estimation proxy from camera and SAQ data.",
        "markers": [
          "BMI",
          "waist circumference",
          "lifestyle AMH correlates"
        ],
        "unit": "Estimated AMH proxy score",
        "range": "Confirm with blood test",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Thyroid-Fertility Panel",
        "desc": "TSH, free T3, free T4 \u2014 subclinical thyroid dysfunction is the #1 reversible treatable fertility cause.",
        "markers": [
          "TSH mIU/L",
          "free T4 ng/dL",
          "free T3 pg/mL",
          "anti-TPO Ab IU/mL"
        ],
        "unit": "TSH mIU/L",
        "range": "Optimal fertility TSH: 0.5\u20132.5 mIU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Ovarian Reserve Assessment",
        "desc": "AMH + basal FSH + estradiol day 3 \u2014 complete ovarian reserve evaluation panel.",
        "markers": [
          "AMH ng/mL",
          "basal FSH IU/L",
          "estradiol day 3 pg/mL",
          "inhibin B pg/mL",
          "vitamin D ng/mL"
        ],
        "unit": "AMH ng/mL",
        "range": "Good reserve: >1.5 ng/mL | Low: <0.5 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Full Reproductive Hormone Panel",
        "desc": "Complete cycle hormone mapping: E2, LH, progesterone, prolactin, SHBG, testosterone, DHEA-S.",
        "markers": [
          "LH IU/L",
          "FSH IU/L",
          "E2 pg/mL",
          "progesterone ng/mL",
          "prolactin ng/mL",
          "SHBG nmol/L",
          "testosterone ng/dL"
        ],
        "unit": "Progesterone ng/mL (mid-luteal)",
        "range": "Adequate ovulation: >5 ng/mL | Optimal: >10",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "PCOS Diagnostic Panel",
        "desc": "Androgen excess, LH:FSH ratio, and insulin resistance markers for PCOS risk stratification.",
        "markers": [
          "LH:FSH ratio",
          "free testosterone pg/mL",
          "DHEA-S \u00b5g/dL",
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR"
        ],
        "unit": "LH:FSH ratio",
        "range": "Normal: \u22642:1 | PCOS risk: >3:1",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Prenatal Micronutrient Optimization",
        "desc": "Complete nutritional readiness panel for conception and early pregnancy fetal development.",
        "markers": [
          "folate ng/mL",
          "B12 pg/mL",
          "ferritin ng/mL",
          "zinc \u00b5g/dL",
          "omega-3 index %",
          "iodine \u00b5g/L",
          "choline mg/dL",
          "CoQ10 \u00b5g/mL"
        ],
        "unit": "Folate ng/mL",
        "range": "Optimal: >10 ng/mL | Deficient: <4 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Immunological Implantation Panel",
        "desc": "NK cell activity, antiphospholipid antibodies, and immune markers affecting implantation success.",
        "markers": [
          "NK cell % CD56+",
          "antiphospholipid Ab",
          "anti-beta2-glycoprotein Ab",
          "ANA titer",
          "complement C3/C4"
        ],
        "unit": "NK cell %",
        "range": "Elevated: NK >18% may impair implantation",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Reproductive PGS Panel",
        "desc": "Lifenome 19-trait female reproductive genetics: PCOS, endometriosis, AMH variants, implantation PGS.",
        "markers": [
          "PCOS risk SNPs (LHCGR, FSHR)",
          "endometriosis PGS",
          "AMH genetic variants",
          "implantation PGS",
          "miscarriage risk PGS"
        ],
        "unit": "Per-trait percentile",
        "range": "Elevated risk: >80th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Gestational Complication PGS",
        "desc": "Gestational diabetes (GDM), preeclampsia, gestational hypertension polygenic risk scores.",
        "markers": [
          "GDM PGS (TCF7L2, MTNR1B)",
          "preeclampsia PGS (FLT1, ENG)",
          "gestational hypertension PGS",
          "preterm birth PGS"
        ],
        "unit": "OR vs population",
        "range": "High risk: OR >2.0 vs reference",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "MTHFR & Methylation Fertility",
        "desc": "Methylation cycle genetics affecting folate metabolism, homocysteine, and neural tube defect risk.",
        "markers": [
          "MTHFR C677T genotype",
          "MTHFR A1298C genotype",
          "MTR A2756G",
          "MTRR A66G"
        ],
        "unit": "Genotype",
        "range": "TT homozygous: highest risk \u2014 methyl-folate required",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Reproductive Disorder Panel",
        "desc": "Rare variants: Turner syndrome, BRCA1/2, Lynch syndrome \u2014 hereditary reproductive risk genes.",
        "markers": [
          "BRCA1/BRCA2 variants",
          "Lynch syndrome genes (MLH1/MSH2)",
          "FMR1 premutation",
          "POI-associated genes"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = actionable variant",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_wgs",
        "name": "Complete Carrier Screening",
        "desc": "Comprehensive recessive disease carrier status across the full genome \u2014 all 300+ carrier conditions.",
        "markers": [
          "SMA (SMN1)",
          "CF (CFTR)",
          "Fragile X (FMR1)",
          "spinal muscular atrophy",
          "300+ recessive conditions"
        ],
        "unit": "Carrier status (Y/N per gene)",
        "range": "Relevant if partner also carrier",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Vaginal & Gut Microbiome Fertility Index",
        "desc": "Lactobacillus dominance vs. dysbiosis impact on implantation rates and cervical environment.",
        "markers": [
          "Lactobacillus % dominance",
          "Gardnerella vaginalis %",
          "BV-associated anaerobes",
          "Shannon diversity H"
        ],
        "unit": "Lactobacillus %",
        "range": "Optimal: >80% Lactobacillus dominance",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Reproductive Microbiome Function",
        "desc": "Functional analysis of cytokine-modulating species and immune tolerance pathways affecting implantation.",
        "markers": [
          "endometrial flora gene pathways",
          "cytokine-modulating species",
          "immune tolerance functional genes"
        ],
        "unit": "Functional gene abundance (RPKM)",
        "range": "Pro-inflammatory pathway: flag if elevated",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Reproductive Epigenetic Age",
        "desc": "Ovarian epigenetic age \u2014 independent predictor of IVF success rates and ovarian response to stimulation.",
        "markers": [
          "ovarian age acceleration (yr)",
          "methylation fertility loci",
          "reproductive CpG signature"
        ],
        "unit": "Ovarian biological age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Fertility Nutrition & Supplement Plan",
        "desc": "Evidence-based fertility nutrition protocol and targeted supplementation matched to identified deficiencies: folate (MTHFR-aware dosing), CoQ10 for oocyte quality, vitamin D, omega-3, iron (if ferritin low), inositol (if PCOS markers present), and prenatal formulation from client catalog.",
        "markers": [
          "folate (RBC)",
          "MTHFR C677T",
          "CoQ10",
          "25-OH Vit D",
          "ferritin",
          "omega-3 index",
          "PCOS markers",
          "homocysteine"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Cycle Optimization & Conception Timing Program",
        "desc": "Personalized ovulation tracking and conception timing program using wearable cycle data, LH surge monitoring, and luteal phase quality scoring. Lifestyle interventions timed to cycle phase.",
        "markers": [
          "LH",
          "FSH",
          "AMH",
          "estradiol (E2)",
          "progesterone",
          "cycle length regularity",
          "HRV luteal phase"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Preconception Health Program",
        "desc": "3\u20136 month preconception preparation program addressing identified fertility blockers: thyroid optimization, BMI/body composition, stress management, sleep protocol, and environmental toxin reduction plan.",
        "markers": [
          "TSH",
          "TPO Ab",
          "BMI",
          "cortisol",
          "sleep efficiency",
          "heavy metals",
          "BPA proxy",
          "AMH",
          "SHBG"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "menopause",
    "name": "Menopause Management",
    "sub": "Perimenopause & Post-Menopause",
    "color": "#d96c1a",
    "lt": "#fdf2e6",
    "img": "https://images.unsplash.com/photo-1506126613408-eca07ce68773?w=320&q=75",
    "desc": "Holistic transition management \u2014 vasomotor symptom tracking, HRT personalization, bone protection, estrobolome insight, and post-menopausal cardiovascular risk monitoring.",
    "tags": [
      "perimenopause",
      "HRT optimization",
      "vasomotor symptoms",
      "bone density",
      "CVD risk"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Menopausal Symptom Burden Score",
        "desc": "Validated lifestyle-correlated composite of vasomotor, mood, sleep, libido, and cognitive symptom severity.",
        "markers": [
          "hot flash freq/day",
          "sleep disruption score",
          "mood/anxiety score",
          "libido index",
          "cognitive complaints score"
        ],
        "unit": "Greene Climacteric Scale proxy",
        "range": "Mild: <15 | Moderate: 15\u201330 | Severe: >30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Cardiometabolic Transition Risk",
        "desc": "Post-menopausal CVD and metabolic syndrome risk from lifestyle modifiers \u2014 estrogen loss amplifies.",
        "markers": [
          "physical activity MET-hr/wk",
          "dietary pattern score",
          "smoking status",
          "BMI trajectory",
          "waist circumference"
        ],
        "unit": "10-year CVD risk %",
        "range": "Low: <10% | Intermediate: 10\u201320% | High: >20%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Vasomotor Episode Quantification",
        "desc": "Automated hot flash and night sweat detection via skin temperature sensor + nocturnal HRV spikes.",
        "markers": [
          "skin temp spike freq/night",
          "nocturnal HRV disruptions/hr",
          "sleep fragmentation index",
          "core temp elevation \u00b0C"
        ],
        "unit": "Episodes per 24 hours",
        "range": "Mild: <7/day | Severe: >14/day",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Cardiovascular Transition Monitor",
        "desc": "Estrogen withdrawal accelerates CVD risk \u2014 continuous wearable cardiac markers tracking.",
        "markers": [
          "HRV 30-day trend (ms)",
          "resting HR elevation bpm",
          "SpO2 %",
          "activity minutes/day"
        ],
        "unit": "HRV RMSSD ms",
        "range": "Optimal: >50 ms | Post-meno concern: <30 ms",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture Disruption Index",
        "desc": "Menopause-specific sleep staging changes: reduced deep sleep and increased wakefulness quantification.",
        "markers": [
          "deep sleep %",
          "wakefulness %",
          "sleep efficiency %",
          "REM latency min",
          "WASO min"
        ],
        "unit": "WASO minutes per night",
        "range": "Optimal: <30 min WASO | Concern: >60 min",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Menopausal Shift",
        "desc": "Smartphone-derived visceral fat redistribution from gluteo-femoral to central \u2014 characteristic of menopause.",
        "markers": [
          "waist-hip ratio",
          "visceral fat proxy score",
          "body fat %",
          "muscle mass trend"
        ],
        "unit": "Waist-hip ratio",
        "range": "Optimal F: <0.85 | Concern: >0.90",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Menopausal Staging Panel",
        "desc": "E2, FSH, progesterone \u2014 serum-based staging of perimenopause, menopause, and post-menopause.",
        "markers": [
          "E2 pg/mL",
          "FSH IU/L",
          "progesterone ng/mL",
          "TSH mIU/L",
          "vitamin D ng/mL"
        ],
        "unit": "FSH IU/L",
        "range": "Perimenopausal: FSH 10\u201340 | Menopausal: >40 IU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "HRT Personalization Baseline",
        "desc": "Full hormonal baseline required for bioidentical HRT dosing personalization and safety monitoring.",
        "markers": [
          "E2 pg/mL",
          "testosterone (total/free) ng/dL",
          "SHBG nmol/L",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "IGF-1 ng/mL",
          "prolactin ng/mL"
        ],
        "unit": "E2 pg/mL",
        "range": "HRT target range: E2 50\u2013150 pg/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Post-Menopausal CVD Risk Panel",
        "desc": "ApoB, Lp(a), hs-CRP, homocysteine \u2014 estrogen loss unmasks previously protected cardiovascular risk.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "lipid panel",
          "hsTroponin I ng/L"
        ],
        "unit": "ApoB mg/dL",
        "range": "Optimal: <80 mg/dL | Concern post-meno: >100",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Bone Turnover Markers",
        "desc": "CTX (resorption) and P1NP (formation) for real-time bone loss velocity measurement beyond DXA.",
        "markers": [
          "CTX pg/mL",
          "P1NP ng/mL",
          "calcium mg/dL",
          "phosphorus mg/dL",
          "vitamin D ng/mL",
          "PTH pg/mL",
          "osteocalcin ng/mL"
        ],
        "unit": "CTX pg/mL",
        "range": "Pre-meno: <300 | Accelerated resorption: >600",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Metabolic Syndrome Menopause Panel",
        "desc": "Insulin resistance, uric acid, and liver function as metabolic syndrome risk after estrogen withdrawal.",
        "markers": [
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "uric acid mg/dL",
          "ALT IU/L",
          "GGT IU/L",
          "adiponectin \u00b5g/mL"
        ],
        "unit": "HOMA-IR",
        "range": "Optimal: <2.0 | Insulin resistant: >3.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Menopause Timing & HRT Response PGS",
        "desc": "Early-menopause PGS + ESR1, PGR, VDR variants predicting HRT response and bone protection.",
        "markers": [
          "menopause timing SNPs (BRSK1, TERT)",
          "ESR1 (estrogen receptor alpha)",
          "PGR (progesterone receptor)",
          "VDR (bone response)",
          "CYP1B1 (estrogen metabolism)"
        ],
        "unit": "Menopause age prediction",
        "range": "Early meno PGS: >75th percentile = action",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Osteoporosis Genetic Risk Score",
        "desc": "Fracture risk PGS (RANK/RANKL pathway, VDR, COL1A1) for bone-protective intervention prioritization.",
        "markers": [
          "RANK/RANKL variants",
          "VDR FokI/BsmI/TaqI",
          "COL1A1 Sp1 SNP",
          "LRP5 variants",
          "SOST variants",
          "osteoporosis PGS"
        ],
        "unit": "Fracture risk OR",
        "range": "High risk: OR >2.0 vs population",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Cardiovascular Menopause PGS",
        "desc": "Post-menopausal CVD PGS \u2014 genetic risk amplified by estrogen loss timeline.",
        "markers": [
          "CAD PGS (ChrHRIS)",
          "atrial fibrillation PGS",
          "hypertension PGS",
          "stroke PGS"
        ],
        "unit": "Percentile",
        "range": "High risk: >80th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Breast/Ovarian Cancer Panel",
        "desc": "BRCA1/2, PALB2, ATM, CHEK2 \u2014 mandatory menopause-era hereditary cancer risk assessment.",
        "markers": [
          "BRCA1/BRCA2 variants",
          "PALB2",
          "ATM",
          "CHEK2",
          "RAD51C/D \u2014 hereditary cancer panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = immediate referral",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Estrobolome Diversity Index",
        "desc": "Gut bacteria metabolizing estrogen via beta-glucuronidase activity \u2014 directly impacts estrogen availability and hot flash severity.",
        "markers": [
          "beta-glucuronidase activity proxy",
          "Clostridiales diversity",
          "Ruminococcaceae %",
          "Lactobacillaceae % (if gut)"
        ],
        "unit": "Estrobolome diversity score",
        "range": "High beta-glucuronidase = elevated estrogen reactivation",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Bone-Gut Microbiome Axis",
        "desc": "Functional microbiome analysis of secondary bile acids and SCFA affecting osteoblast/osteoclast balance.",
        "markers": [
          "secondary bile acid synthesis genes",
          "butyrate producers %",
          "Akkermansia muciniphila %",
          "calcium absorption pathway genes"
        ],
        "unit": "Functional gene abundance RPKM",
        "range": "Butyrate genes optimal: >1.5 RPKM",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Menopausal Epigenetic Clock",
        "desc": "DNAm-based menopausal staging and post-menopausal biological age acceleration score.",
        "markers": [
          "menopause epigenetic score",
          "AgeAccelGrim (yr)",
          "CpG loci \u2014 menopausal transition",
          "immune epigenetic age"
        ],
        "unit": "Biological age (yr)",
        "range": "Post-meno age acceleration >3 yr = intervention",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Estrogen-Sensitive Methylation Panel",
        "desc": "ESR1 promoter methylation and estrogen-responsive gene methylation as HRT response biomarkers.",
        "markers": [
          "ESR1 promoter CpG methylation %",
          "breast cancer risk CpG loci",
          "bone-associated methylation marks"
        ],
        "unit": "% methylation at ESR1 promoter",
        "range": "Hypermethylated ESR1 = reduced HRT response",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "HRT / MHT Selection Guide",
        "desc": "Pharmacogenomics-informed hormone therapy recommendations based on COMT/CYP2D6/ESR1 genotype, breast cancer PGS, cardiovascular risk, and symptom burden score. Identifies optimal HRT type (bioidentical vs synthetic), route (oral vs transdermal), and dose from client formulary.",
        "markers": [
          "ESR1 genotype",
          "CYP2D6",
          "COMT Val158Met",
          "breast cancer PGS",
          "NT-proBNP",
          "ApoB",
          "symptom burden score",
          "menopausal staging"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Bone Health & Osteoporosis Prevention Program",
        "desc": "Personalized bone-protective exercise protocol (weight-bearing + resistance training prescriptions), calcium/vitamin D supplementation dosing based on blood levels and genetics, and dietary calcium adequacy scoring.",
        "markers": [
          "25-OH Vit D",
          "osteocalcin",
          "CTX-I",
          "P1NP",
          "calcium",
          "magnesium",
          "osteoporosis PGS",
          "testosterone"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Menopausal Symptom Relief Protocol",
        "desc": "Multimodal symptom management program: vasomotor symptom interventions (dietary phytoestrogens, paced respiration protocol), sleep hygiene for disrupted sleep architecture, libido support strategies, and mood stabilization through exercise and mind-body practices.",
        "markers": [
          "vasomotor episode count",
          "sleep architecture score",
          "SHBG",
          "estradiol",
          "serotonin precursor (Trp:LNAA)",
          "cortisol",
          "progesterone"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Menopausal Supplement & Botanical Protocol",
        "desc": "Evidence-based botanical and supplement recommendations from client catalog: black cohosh (if phytoestrogen responder genetics), magnesium glycinate, ashwagandha (cortisol support), omega-3, probiotics (estrobolome support), and collagen peptides.",
        "markers": [
          "estrobolome diversity",
          "cortisol AM",
          "omega-3 index",
          "magnesium RBC",
          "gut microbiome diversity",
          "estradiol"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "athlete",
    "name": "Elite Athlete Performance",
    "sub": "Peak Performance & Recovery",
    "color": "#0a7c6e",
    "lt": "#e5f4f2",
    "img": "https://images.unsplash.com/photo-1530549387789-4c1017266635?w=320&q=75",
    "desc": "Data-driven performance optimization integrating Lifenome 26-trait fitness PGS with real-time readiness, recovery, overtraining prevention, and genetic injury risk.",
    "tags": [
      "VO2max",
      "HRV readiness",
      "overtraining prevention",
      "injury genetics",
      "performance PGS"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Training Load & Recovery Balance",
        "desc": "Sleep, nutrition timing, training volume, stress load, and recovery practice quality composite score.",
        "markers": [
          "sleep hrs/night",
          "protein g/kg/day",
          "alcohol units/wk",
          "training hrs/wk",
          "recovery practice score"
        ],
        "unit": "Recovery quality score 0\u2013100",
        "range": "Optimal: >75 | Overreach risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Nutritional Performance Readiness",
        "desc": "Carbohydrate periodization, protein adequacy, and micronutrient sufficiency for performance.",
        "markers": [
          "carb intake g/kg",
          "protein timing",
          "iron dietary intake",
          "hydration L/day",
          "caffeine mg/day"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal protein: 1.6\u20132.2 g/kg/day",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Daily Recovery Readiness Score",
        "desc": "Go/no-go training decision signal from overnight HRV, sleep quality, and acute:chronic load balance.",
        "markers": [
          "HRV RMSSD ms",
          "deep sleep %",
          "resting HR bpm",
          "7-day training load AU",
          "acute:chronic load ratio"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Green: >70 | Yellow: 40\u201370 | Red: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "VO2 Max Trajectory",
        "desc": "Continuous VO2 max tracking, periodization response curve, and training zone calibration.",
        "markers": [
          "VO2 max mL/kg/min",
          "zone 2 weekly hrs",
          "lactate threshold HR bpm",
          "FTP watts or pace"
        ],
        "unit": "mL/kg/min",
        "range": "Elite M: >60 | Recreational: 40\u201355 | Sedentary: <35",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Overtraining Risk Index",
        "desc": "HRV 7-day decline + ACWR spike early warning \u2014 validated overtraining syndrome predictor.",
        "markers": [
          "7-day HRV trend % decline",
          "ACWR (acute:chronic workload ratio)",
          "nocturnal HR elevation bpm",
          "mood score (POMS proxy)"
        ],
        "unit": "ACWR ratio",
        "range": "Optimal: 0.8\u20131.3 | Overtraining risk: >1.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Lactate Threshold & Aerobic Base",
        "desc": "HR-derived lactate threshold (LT1/LT2) estimation for precision training zone assignment.",
        "markers": [
          "LT1 HR bpm",
          "LT2 HR bpm",
          "aerobic decoupling %",
          "cardiac drift %"
        ],
        "unit": "LT1 heart rate bpm",
        "range": "Well-trained LT2: 85\u201392% HRmax",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Sleep & Circadian Performance Impact",
        "desc": "Sleep architecture quality and circadian timing effect on same-day performance output.",
        "markers": [
          "total sleep hrs",
          "deep sleep %",
          "sleep regularity index",
          "circadian phase offset hr"
        ],
        "unit": "Sleep score 0\u2013100",
        "range": "Optimal athlete: 8\u20139 hrs | Deep: >20%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Movement Quality & Asymmetry",
        "desc": "Smartphone-based gait analysis, postural asymmetry detection, and compensatory movement pattern flagging.",
        "markers": [
          "gait symmetry index %",
          "postural alignment score",
          "ROM proxy score",
          "limb asymmetry %"
        ],
        "unit": "Symmetry index %",
        "range": "Optimal: >95% symmetry | Injury risk: <90%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Athletic Profile",
        "desc": "Smartphone lean mass, body fat %, and muscle distribution for sport-specific optimization.",
        "markers": [
          "body fat %",
          "muscle mass kg",
          "lean mass ratio",
          "sport-specific comp target"
        ],
        "unit": "Body fat %",
        "range": "Elite endurance M: 6\u201312% | Power: 10\u201315%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Iron & Oxygen Transport Panel",
        "desc": "Ferritin, transferrin, CBC \u2014 foundational endurance performance and altitude adaptation markers.",
        "markers": [
          "ferritin ng/mL",
          "serum iron \u00b5g/dL",
          "transferrin saturation %",
          "hemoglobin g/dL",
          "hematocrit %",
          "reticulocytes %"
        ],
        "unit": "Ferritin ng/mL",
        "range": "Optimal athlete: >50 ng/mL | Deficient: <20 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Vitamin D & Bone Health",
        "desc": "Vitamin D and bone remodeling markers for injury prevention and muscle function optimization.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "PTH pg/mL",
          "calcium mg/dL",
          "ALP IU/L"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal athlete: 50\u201380 ng/mL | Deficient: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Hormonal Performance Profile",
        "desc": "Testosterone:cortisol ratio \u2014 gold-standard overtraining biomarker and anabolic:catabolic balance.",
        "markers": [
          "testosterone total ng/dL",
          "testosterone free pg/mL",
          "cortisol AM \u00b5g/dL",
          "T:C ratio",
          "DHEA-S \u00b5g/dL",
          "IGF-1 ng/mL"
        ],
        "unit": "Testosterone:Cortisol ratio",
        "range": "Optimal: >0.035 | Overtrained: <0.015",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Muscle Damage & Recovery Panel",
        "desc": "CK, LDH, myoglobin as muscle stress markers for session intensity calibration and recovery timing.",
        "markers": [
          "CK IU/L",
          "LDH IU/L",
          "myoglobin \u00b5g/L",
          "hsCRP mg/L",
          "IL-6 pg/mL"
        ],
        "unit": "CK IU/L",
        "range": "Post-exercise normal: <500 | Concern: >1000 IU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Mitochondrial Performance Panel",
        "desc": "CoQ10, NAD+, amino acid panel, omega-3 index for cellular energy and anti-inflammatory optimization.",
        "markers": [
          "CoQ10 \u00b5g/mL",
          "NAD+ \u00b5mol/L",
          "amino acid panel",
          "omega-3 index %",
          "GSH \u00b5mol/L",
          "carnitine \u00b5mol/L"
        ],
        "unit": "CoQ10 \u00b5g/mL",
        "range": "Optimal: >0.8 \u00b5g/mL | Deficient: <0.5 \u00b5g/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Gut Health & Absorption Panel",
        "desc": "Gut permeability and nutrient absorption capacity \u2014 performance-limiting factor in elite athletes.",
        "markers": [
          "zonulin ng/mL",
          "calprotectin \u00b5g/g",
          "secretory IgA mg/dL",
          "lactulose:mannitol ratio"
        ],
        "unit": "Calprotectin \u00b5g/g stool",
        "range": "Normal: <50 \u00b5g/g | Elevated: >200 \u00b5g/g",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Athletic Performance PGS (26 Traits)",
        "desc": "Lifenome 26-trait fitness genetics: aerobic capacity, power, endurance, VO2 max trainability, elite endurance potential.",
        "markers": [
          "ACTN3 R577X (power)",
          "ACE I/D (endurance)",
          "PPARGC1A (mitochondria)",
          "HIF1A (hypoxia)",
          "ADRB2 (beta-2 adrenergic)",
          "26 fitness traits total"
        ],
        "unit": "Performance percentile",
        "range": "Top 10%: elite potential | Avg: 40\u201360th %ile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Injury Risk Genetic Profile",
        "desc": "ACL rupture, Achilles tendinopathy, stress fracture, and joint laxity polygenic risk scores.",
        "markers": [
          "ACL rupture PGS (COL5A1, MMP3)",
          "Achilles tendinopathy PGS",
          "stress fracture PGS",
          "joint laxity (COL1A1, COL3A1)",
          "muscle injury risk PGS"
        ],
        "unit": "Per-injury OR vs population",
        "range": "High risk: OR >2.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Recovery & Adaptation Genetics",
        "desc": "Muscle recovery speed, DOMS susceptibility, muscle-damage-risk, and sleep genetics affecting adaptation.",
        "markers": [
          "DOMS PGS (CK elevation genetics)",
          "muscle-repair speed PGS",
          "slow-muscle-recovery PGS",
          "MSTN (myostatin variants)",
          "sleep depth genetics"
        ],
        "unit": "Recovery percentile",
        "range": "Fast recovery: >70th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Caffeine & Stimulant Metabolism",
        "desc": "CYP1A2 caffeine metabolism status \u2014 determines ergogenic benefit vs. cardiovascular risk.",
        "markers": [
          "CYP1A2 *1F genotype",
          "ADORA2A (adenosine receptor)",
          "caffeine sensitivity variants"
        ],
        "unit": "Metabolizer phenotype",
        "range": "Fast metabolizer: ergogenic benefit confirmed",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Cardiac Genetic Screening (SCD Risk)",
        "desc": "HCM, ARVC, Brugada, long-QT syndrome \u2014 mandatory pre-participation cardiac clearance gene panel.",
        "markers": [
          "MYH7 (HCM)",
          "MYBPC3 (HCM)",
          "PKP2 (ARVC)",
          "SCN5A (Brugada/long-QT)",
          "KCNQ1/KCNH2 (LQTS)",
          "cardiology exome panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = disqualify pending cardiology review",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_exome",
        "name": "Rare Metabolic Performance Variants",
        "desc": "AMPD1, ACADVL, CPT1/2 \u2014 rare variants causing exertional myopathy and rhabdomyolysis.",
        "markers": [
          "AMPD1 Q12X (exercise fatigue)",
          "ACADVL (fatty acid oxidation)",
          "CPT2 (carnitine metabolism)",
          "GSD-related genes"
        ],
        "unit": "Variant classification",
        "range": "Pathogenic = modify training protocol",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_wgs",
        "name": "Full Athletic Genome Panel",
        "desc": "WGS-level resolution of all performance, injury, cardiac, and rare metabolic athletic variants.",
        "markers": [
          "All array PGS enhanced",
          "structural variants",
          "rare INDELs",
          "doping gene variants (EPOR, EPO)"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS improves PRS by ~30%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Athletic Gut Microbiome Profile",
        "desc": "Prevotella, Veillonella propionate pathway, and lactate metabolism \u2014 performance-enhancing species abundance.",
        "markers": [
          "Prevotella % (carb fermentation)",
          "Veillonella % (lactate-to-propionate)",
          "Shannon diversity H",
          "butyrate producers %",
          "Akkermansia %"
        ],
        "unit": "Shannon diversity index H",
        "range": "Athletic optimal H: >3.2 | Poor gut: <2.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Inflammatory Load & Gut Integrity",
        "desc": "Gut permeability and systemic inflammation markers via microbiome composition as performance limiter.",
        "markers": [
          "LPS-producing bacteria %",
          "mucosal barrier species",
          "Faecalibacterium prausnitzii %",
          "zonulin-correlated species"
        ],
        "unit": "Dysbiosis score 0\u201310",
        "range": "Optimal: <3 | Performance-limiting: >6",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Performance Metabolomics (Functional)",
        "desc": "Propionate synthesis, NO precursor capacity, and BCAA metabolism from shotgun functional analysis.",
        "markers": [
          "propionate synthesis gene count",
          "nitric oxide precursor genes",
          "BCAA catabolism pathway",
          "secondary bile acid genes"
        ],
        "unit": "Functional gene RPKM",
        "range": "Propionate genes optimal: >1.8 RPKM",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Training Adaptability & Aging Clock",
        "desc": "Epigenetic age acceleration as cumulative training stress marker and adaptation capacity predictor.",
        "markers": [
          "GrimAge acceleration (yr)",
          "DunedinPACE",
          "muscle-tissue methylation CpGs",
          "mTOR pathway methylation"
        ],
        "unit": "DunedinPACE (yr/yr)",
        "range": "Optimal athlete: <1.0 yr/yr | Overtrained: >1.15",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Endurance Healthspan Category Score",
        "desc": "InsideTracker's endurance category: ferritin (3\u00d7 more impactful than serum iron), hemoglobin, hematocrit, vitamin B12, folate, and transferrin saturation \u2014 the complete oxygen-transport and energy-substrate picture for aerobic performance.",
        "markers": [
          "ferritin",
          "hemoglobin",
          "hematocrit",
          "serum iron",
          "transferrin saturation",
          "TIBC",
          "vitamin B12",
          "folate",
          "reticulocyte count"
        ],
        "unit": "Score 0\u2013100",
        "range": "Ferritin optimal (athletes): men >50 ng/mL | women >30 ng/mL",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Recovery & Muscle Damage Index",
        "desc": "InsideTracker's recovery healthspan category: ALT, AST, CK, magnesium RBC (gold standard), and LDH. RBC magnesium is the most sensitive marker for true magnesium status \u2014 critical for muscle recovery, nerve function, and 300+ enzymatic reactions.",
        "markers": [
          "CK (creatine kinase)",
          "ALT",
          "AST",
          "LDH",
          "magnesium RBC",
          "magnesium serum",
          "myoglobin",
          "uric acid"
        ],
        "unit": "CK IU/L + composite",
        "range": "CK resting: <200 IU/L | Overtrained: >500 | Mg RBC: 4.2\u20136.8 mg/dL",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Periodized Training Program",
        "desc": "Science-backed periodized training plan generated from VO\u2082max trajectory, overtraining risk index, injury genetics, and recovery readiness score. Prescribes volume, intensity, frequency, and modality (power vs endurance ratio) matched to genetic profile (power:endurance PGS).",
        "markers": [
          "VO\u2082max",
          "HRV recovery score",
          "overtraining risk index",
          "power:endurance PGS",
          "CK (muscle damage)",
          "cortisol AM",
          "injury genetics",
          "sleep architecture"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Performance Supplement Protocol",
        "desc": "Evidence-rated performance supplements from client catalog personalized by blood status and genetic response: creatine monohydrate (responder genetics), beta-alanine, caffeine (CYP1A2 metabolizer status), iron (if ferritin <30 ng/mL athletes), magnesium, vitamin D, omega-3, and electrolyte profile.",
        "markers": [
          "ferritin",
          "CYP1A2 caffeine genotype",
          "creatine response genetics",
          "magnesium RBC",
          "vitamin D",
          "omega-3 index",
          "sodium sweat loss proxy"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Sport Nutrition & Fueling Plan",
        "desc": "Periodized sport nutrition protocol: carbohydrate loading timing matched to glycogen depletion signals and race schedule, protein distribution for muscle protein synthesis (1.6\u20132.2g/kg/day), pre/during/post-exercise fueling matched to sweat rate and GI tolerance genetics.",
        "markers": [
          "ferritin",
          "HbA1c",
          "blood glucose trend",
          "GI tolerance genetics",
          "lean body mass",
          "VO\u2082max",
          "daily energy expenditure (wearable)"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Injury Prevention Protocol",
        "desc": "Targeted injury prevention program based on genetic injury risk (ACL, tendon, stress fracture PGS): proprioception training for high ACL-risk individuals, collagen synthesis protocol (Vitamin C + gelatin timing), load management schedule, and movement quality intervention.",
        "markers": [
          "ACL risk PGS",
          "tendinopathy PGS",
          "stress fracture PGS",
          "vitamin D",
          "collagen stability genotype",
          "CK baseline",
          "asymmetry score"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "prevention",
    "name": "Chronic Disease Prevention",
    "sub": "Primary Prevention",
    "color": "#5730b8",
    "lt": "#f0ecff",
    "img": "https://images.unsplash.com/photo-1576671081837-49000212a370?w=320&q=75",
    "desc": "Proactive population-scale health \u2014 detecting cardiometabolic, oncological, and neurological risk years before clinical onset using Lifenome full 213-trait medical PGS.",
    "tags": [
      "CVD prevention",
      "T2DM prevention",
      "hereditary cancer",
      "dementia risk",
      "ASCVD"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "10-Year Multi-Disease Risk Index",
        "desc": "Modifiable risk factor composite for CVD, T2DM, cancer, and dementia onset in the next decade.",
        "markers": [
          "diet quality score",
          "physical activity MET-hr/wk",
          "smoking pack-years",
          "sleep hrs",
          "BMI",
          "alcohol units/wk"
        ],
        "unit": "10-year composite risk %",
        "range": "Low: <5% | Intermediate: 5\u201315% | High: >15%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Framingham-Adjusted Lifestyle Score",
        "desc": "Lifestyle modifier applied to genetic CVD risk \u2014 quantifies how much behavior attenuates or amplifies PGS risk.",
        "markers": [
          "DASH diet compliance",
          "Mediterranean diet score",
          "exercise min/wk",
          "smoking status",
          "BP category"
        ],
        "unit": "Lifestyle risk adjustment factor",
        "range": "Protective: <1.0 | Harmful: >1.0 multiplier",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Resting HR Cardiometabolic Signal",
        "desc": "Long-term resting HR elevation as early cardiometabolic deterioration marker.",
        "markers": [
          "resting HR bpm 30-day avg",
          "7-day HR trend",
          "nocturnal HR dip %",
          "activity mins/day"
        ],
        "unit": "Resting HR bpm",
        "range": "Optimal: 50\u201365 bpm | Cardiometabolic concern: >75",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Activity & Sedentary Behavior Index",
        "desc": "Sitting hours, activity breaks, and moderate intensity minutes as cancer and metabolic disease modifiers.",
        "markers": [
          "sedentary hours/day",
          "MVPA min/week",
          "step count",
          "standing breaks/hr"
        ],
        "unit": "MVPA min/week",
        "range": "WHO target: \u2265150 min/wk | Cancer risk: <75 min/wk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Duration & Quality Index",
        "desc": "Sleep duration and quality as T2DM, CVD, and cancer risk modifiers \u2014 U-shaped relationship.",
        "markers": [
          "sleep duration hrs",
          "sleep efficiency %",
          "HRV overnight",
          "sleep regularity index"
        ],
        "unit": "Sleep duration hrs",
        "range": "Optimal: 7\u20139 hrs | Risk zones: <6 or >9 hrs",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "BMI & Adiposity Risk Classification",
        "desc": "Smartphone-derived body composition risk stratification with visceral adiposity index.",
        "markers": [
          "BMI kg/m\u00b2",
          "waist circumference cm",
          "visceral fat index",
          "waist:height ratio"
        ],
        "unit": "Waist:height ratio",
        "range": "Optimal: <0.5 | High risk: >0.6",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Cardiometabolic Screening Panel",
        "desc": "Foundational 6-marker CVD and diabetes risk panel \u2014 recommended annually for all adults >35.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "total cholesterol mg/dL",
          "LDL mg/dL",
          "HDL mg/dL",
          "TG mg/dL",
          "TSH mIU/L"
        ],
        "unit": "10-year ASCVD risk %",
        "range": "Low: <7.5% | Intermediate: 7.5\u201320% | High: >20%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Enhanced CVD Risk Panel",
        "desc": "hs-CRP and homocysteine-enhanced ASCVD risk calculation beyond standard lipid panel.",
        "markers": [
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "vitamin D ng/mL",
          "ferritin ng/mL",
          "B12 pg/mL"
        ],
        "unit": "hs-CRP mg/L",
        "range": "Optimal: <1.0 | Elevated risk: 1.0\u20133.0 | High: >3.0 mg/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Advanced Lipid & Insulin Resistance",
        "desc": "ApoB, Lp(a), HOMA-IR \u2014 the three most underused but predictive metabolic disease biomarkers.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "oxidized LDL U/L",
          "uric acid mg/dL"
        ],
        "unit": "ApoB mg/dL",
        "range": "Optimal: <80 mg/dL | Statin indication: >100",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Organ Function Longevity Panel",
        "desc": "Liver, kidney, and cardiovascular organ-specific function as disease burden and aging markers.",
        "markers": [
          "ALT IU/L",
          "AST IU/L",
          "GGT IU/L",
          "eGFR mL/min",
          "cystatin-C mg/L",
          "albumin g/dL",
          "bilirubin mg/dL"
        ],
        "unit": "eGFR mL/min/1.73m\u00b2",
        "range": "Optimal eGFR: >90 | Mild CKD: 60\u201389",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Cancer & Immune Surveillance Panel",
        "desc": "IL-6, TNF-\u03b1, BDNF, and early cancer immune signature markers for proactive oncology screening.",
        "markers": [
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL",
          "BDNF ng/mL",
          "hsTroponin I ng/L",
          "CEA ng/mL",
          "PSA ng/mL (M)",
          "CA-125 IU/mL (F)"
        ],
        "unit": "IL-6 pg/mL",
        "range": "Optimal IL-6: <3.0 pg/mL | Elevated: >5.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Micronutrient Prevention Panel",
        "desc": "Vitamin D, omega-3 index, magnesium, selenium \u2014 deficiencies linked to cancer and CVD risk.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "omega-3 index %",
          "magnesium RBC mg/dL",
          "selenium \u00b5g/L",
          "zinc \u00b5g/dL",
          "folate ng/mL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal: 50\u201380 ng/mL | Deficient: <30 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Medical PGS \u2014 213 Conditions",
        "desc": "Full Lifenome medical PGS: 27 cancers, 24 circulatory, 16 endocrine, 22 digestive, 15 neurological, 18 mental-behavioural.",
        "markers": [
          "cancer PGS (27 conditions)",
          "CVD PGS (24 conditions)",
          "T2DM PGS",
          "neurological PGS (15)",
          "mental health PGS (18)",
          "213 medical traits total"
        ],
        "unit": "Per-disease percentile",
        "range": "Elevated risk: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "APOE & Neurodegeneration Risk",
        "desc": "APOE4 genotyping plus full nervous-system PGS for Alzheimer, Parkinson, and dementia stratification.",
        "markers": [
          "APOE E2/E3/E4 genotype",
          "Alzheimer PGS (CLU, BIN1, CR1)",
          "Parkinson PGS (SNCA, LRRK2)",
          "BDNF Val66Met",
          "15 neurological PGS traits"
        ],
        "unit": "APOE genotype + AD PGS percentile",
        "range": "APOE E4/E4: 8\u201312x risk vs E3/E3",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Hypertension & Stroke PGS",
        "desc": "Polygenic hypertension risk and ischemic/hemorrhagic stroke PGS \u2014 actionable early lifestyle intervention.",
        "markers": [
          "hypertension PGS (SBP/DBP loci)",
          "coronary artery disease PGS",
          "stroke PGS",
          "atrial fibrillation PGS",
          "CKD PGS"
        ],
        "unit": "Systolic BP genetic score",
        "range": "High PGS: +10\u201315 mmHg genetic SBP lift",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Cancer Panel (Tier 1)",
        "desc": "BRCA1/2, Lynch syndrome, PALB2, ATM \u2014 clinically actionable Tier 1 cancer predisposition variants.",
        "markers": [
          "BRCA1/BRCA2 (breast/ovarian)",
          "MLH1/MSH2/MSH6/PMS2 (Lynch)",
          "PALB2",
          "ATM",
          "APC (FAP)",
          "VHL",
          "hereditary-cancer exome panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = immediate genetic counseling referral",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_exome",
        "name": "Cardiovascular Rare Variants",
        "desc": "Familial hypercholesterolemia, HCM, Marfan syndrome \u2014 clinically actionable cardiac exome panel.",
        "markers": [
          "LDLR/APOB/PCSK9 (FH)",
          "MYH7/MYBPC3 (HCM)",
          "FBN1 (Marfan)",
          "SCN5A/KCNQ1 (arrhythmia)",
          "cardiology exome panel"
        ],
        "unit": "Variant classification",
        "range": "P/LP FH: LDL >190 + genetic = statin imperative",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_wgs",
        "name": "WGS Population Prevention Scan",
        "desc": "WGS enhances all PRS and discovers ultra-rare, population-frequency <0.01% pathogenic variants.",
        "markers": [
          "All array + exome enhanced",
          "structural variants",
          "ultra-rare coding variants",
          "pharmacogenomics refinement"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS adds ~15% sensitivity for rare disease",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Cancer-Protective Microbiome Score",
        "desc": "Butyrate producers and anti-inflammatory species linked to colorectal and systemic cancer prevention.",
        "markers": [
          "Faecalibacterium prausnitzii %",
          "Roseburia intestinalis %",
          "Akkermansia muciniphila %",
          "Shannon diversity H",
          "LPS-producing species %"
        ],
        "unit": "Protective species %",
        "range": "F. prausnitzii optimal: >5% | Concern: <2%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Metabolic Disease Microbiome Risk",
        "desc": "Firmicutes:Bacteroidetes ratio and Prevotella abundance as T2DM and obesity risk correlates.",
        "markers": [
          "Firmicutes:Bacteroidetes ratio",
          "Prevotella copri %",
          "Ruminococcus gnavus %",
          "total SCFA producers %"
        ],
        "unit": "F:B ratio",
        "range": "Optimal: F:B 1:1 to 2:1 | T2DM risk: >3:1",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Metabolic Pathway Disease Map",
        "desc": "Functional SCFA, bile acid, and glucose regulatory gene abundance as metabolic disease prevention markers.",
        "markers": [
          "SCFA synthesis gene count",
          "primary-to-secondary bile acid ratio",
          "GLP-1 stimulating gene pathways",
          "LPS biosynthesis genes"
        ],
        "unit": "Functional diversity score",
        "range": "LPS genes: optimal low | SCFA genes: high",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Multi-Disease Epigenetic Risk Clock",
        "desc": "PhenoAge and GrimAge \u2014 the most validated predictors of multi-disease onset and all-cause mortality.",
        "markers": [
          "PhenoAge (yr)",
          "GrimAge (yr)",
          "DNAmTL (kb) \u2014 telomere length",
          "AgeAccelGrim (yr)",
          "disease-specific CpG loci"
        ],
        "unit": "GrimAge biological age (yr)",
        "range": "GrimAge > chronological + 5 yr = high risk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Advanced Cardiovascular Risk Score",
        "desc": "Goes beyond standard lipid panel: ApoB, Lp(a), LDL particle number and size, and oxidized LDL \u2014 the biomarkers Function Health and InsideTracker both highlight as far superior to total cholesterol for predicting MI risk. ApoB has >2\u00d7 the predictive weight of total cholesterol (InsideTracker data).",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL particle number (LDL-P)",
          "small dense LDL",
          "oxidized LDL",
          "HDL-P",
          "lipoprotein particle size",
          "ApoA1"
        ],
        "unit": "ApoB mg/dL + nmol/L",
        "range": "ApoB optimal: <80 mg/dL | High risk: >100 | Lp(a): <75 nmol/L",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Insulin Resistance & Pre-Diabetes Index",
        "desc": "InsideTracker's metabolism category: fasting glucose, insulin, and HbA1c with HOMA-IR composite. Early insulin resistance is detectable 10\u201315 years before T2DM diagnosis. HOMA-IR is 3\u00d7 more sensitive than glucose alone.",
        "markers": [
          "fasting glucose",
          "fasting insulin",
          "HbA1c",
          "HOMA-IR",
          "1,5-anhydroglucitol (1,5-AG)",
          "triglycerides:HDL ratio",
          "c-peptide"
        ],
        "unit": "HOMA-IR score",
        "range": "Optimal: <1.5 | Pre-resistance: 1.5\u20132.5 | Resistant: >2.5",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Organ Function Surveillance Panel",
        "desc": "Function Health reports >80% of members have in-range liver and kidney results, >90% in-range pancreas \u2014 but outliers are caught only through regular testing. Comprehensive organ health panel including GGT, cystatin-C, and lipase.",
        "markers": [
          "ALT",
          "AST",
          "GGT",
          "alkaline phosphatase",
          "total bilirubin",
          "albumin",
          "creatinine",
          "cystatin-C",
          "eGFR",
          "BUN",
          "uric acid",
          "lipase"
        ],
        "unit": "Multi-organ score",
        "range": "GGT optimal: <25 U/L | Cystatin-C: <0.95 mg/L | eGFR: >90",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration"
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Personalized Prevention Supplement Stack",
        "desc": "Preventive supplements from client catalog matched to identified risk factors: omega-3 (CVD risk), vitamin D (cancer + immune risk), magnesium (metabolic + MSK), berberine/bergamot (lipid optimization), and CoQ10 if statin likely. Dosed against blood levels and genetic metabolizer status.",
        "markers": [
          "ApoB",
          "25-OH Vit D",
          "magnesium RBC",
          "omega-3 index",
          "homocysteine",
          "hs-CRP",
          "MTHFR",
          "CoQ10"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Prevention Lifestyle Program",
        "desc": "Comprehensive primary prevention program: Mediterranean diet implementation, progressive aerobic exercise ramp (target VO\u2082max improvement by 20%), stress reduction protocol, and 7\u20139 hour sleep optimization. All elements personalized to genetic risk profile.",
        "markers": [
          "10-year risk index",
          "biological age gap",
          "physical activity level",
          "diet quality score",
          "chronotype",
          "cortisol AM",
          "HRV"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "weightloss",
    "name": "Weight Loss",
    "sub": "Precision Nutrition & Metabolic Health",
    "color": "#1a6a8a",
    "lt": "#e5f2f8",
    "img": "https://images.unsplash.com/photo-1490645935967-10de6ba17061?w=320&q=75",
    "desc": "Metabolic phenotyping meets genomics \u2014 precision weight management using Lifenome 51-trait nutrition PGS, gut microbiome, CGM-guided optimization, and hormonal metabolic profiling.",
    "tags": [
      "metabolic phenotyping",
      "nutrition PGS",
      "low-carb vs low-fat",
      "satiety genetics",
      "CGM"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Dietary Habit & Adherence Profile",
        "desc": "Eating patterns, meal timing, snacking behavior, caloric awareness, and diet quality composite scoring.",
        "markers": [
          "meal timing regularity",
          "snacking freq/day",
          "alcohol cals/wk",
          "ultra-processed %",
          "diet quality score",
          "caloric awareness"
        ],
        "unit": "Diet adherence score 0\u2013100",
        "range": "Good adherence: >70 | Poor: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Caloric Balance Estimation",
        "desc": "TDEE estimation from lifestyle questionnaire with activity factor adjustment.",
        "markers": [
          "activity factor (1.2\u20131.9)",
          "dietary intake estimate kcal/day",
          "meal frequency",
          "eating window hrs"
        ],
        "unit": "Estimated TDEE kcal/day",
        "range": "Reference by gender/age/activity level",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Energy Expenditure & NEAT",
        "desc": "BMR estimation, TDEE, and non-exercise activity thermogenesis \u2014 the key variable in weight management.",
        "markers": [
          "TDEE kcal/day",
          "BMR kcal/day",
          "NEAT kcal/day estimate",
          "active calories",
          "step count"
        ],
        "unit": "TDEE kcal/day",
        "range": "NEAT: 200\u2013900 kcal/day range",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "CGM Metabolic Response Profile",
        "desc": "Time-in-range, glucose variability, and postprandial spike patterns for diet optimization.",
        "markers": [
          "TIR % (70\u2013140 mg/dL)",
          "glucose CV %",
          "postprandial peak mg/dL",
          "fasting glucose trend mg/dL",
          "dawn phenomenon"
        ],
        "unit": "TIR %",
        "range": "Optimal non-diabetic TIR: >90% | Concern: <70%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep-Weight Axis Monitor",
        "desc": "Short sleep duration and poor sleep quality correlation with weight gain and insulin resistance.",
        "markers": [
          "sleep hrs/night",
          "deep sleep %",
          "cortisol-HRV coupling",
          "sleep debt cumulative hrs"
        ],
        "unit": "Sleep debt hrs/week",
        "range": "Optimal: 0 hr debt | Weight risk: >5 hr debt/wk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Trajectory",
        "desc": "Smartphone-based longitudinal fat mass vs. lean mass tracking with visceral fat proxy.",
        "markers": [
          "body fat %",
          "muscle mass kg",
          "visceral fat proxy score",
          "waist circumference cm"
        ],
        "unit": "Body fat %",
        "range": "Healthy M: 8\u201319% | F: 21\u201333% | Obese M: >25%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Metabolic Health Baseline",
        "desc": "Glucose, HbA1c, lipids \u2014 foundational cardiometabolic weight-loss targets and starting point.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "lipid panel",
          "TSH mIU/L",
          "ALT IU/L"
        ],
        "unit": "HbA1c %",
        "range": "Normal: <5.7% | Prediabetes: 5.7\u20136.4% | T2DM: \u22656.5%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Insulin Resistance Panel",
        "desc": "Fasting insulin, HOMA-IR, and vitamin D \u2014 the top 3 metabolic weight-loss blockers.",
        "markers": [
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "vitamin D ng/mL",
          "TSH mIU/L",
          "adiponectin \u00b5g/mL"
        ],
        "unit": "HOMA-IR",
        "range": "Optimal: <1.5 | Insulin resistant: >2.9 | High: >4.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Full Metabolic & Hormonal Profile",
        "desc": "Cortisol, DHEA-S, testosterone, IGF-1, leptin \u2014 stress-driven and hormonal obesity drivers.",
        "markers": [
          "cortisol AM \u00b5g/dL",
          "DHEA-S \u00b5g/dL",
          "testosterone ng/dL",
          "IGF-1 ng/mL",
          "leptin ng/mL",
          "prolactin ng/mL"
        ],
        "unit": "Cortisol AM \u00b5g/dL",
        "range": "Optimal: 10\u201320 \u00b5g/dL | Elevated (stress): >25",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Thyroid Metabolic Panel",
        "desc": "Full thyroid panel including antibodies \u2014 subclinical hypothyroidism causes 15\u201320% BMR reduction.",
        "markers": [
          "TSH mIU/L",
          "free T3 pg/mL",
          "free T4 ng/dL",
          "reverse T3 ng/dL",
          "anti-TPO IU/mL",
          "anti-Tg IU/mL"
        ],
        "unit": "Free T3 pg/mL",
        "range": "Optimal T3: 3.2\u20134.2 pg/mL | Low: <2.8",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Micronutrient Weight-Loss Blockers",
        "desc": "All micronutrient deficiencies that directly block weight loss: magnesium, zinc, omega-3, B vitamins.",
        "markers": [
          "magnesium RBC mg/dL",
          "zinc \u00b5g/dL",
          "omega-3 index %",
          "B12 pg/mL",
          "folate ng/mL",
          "CoQ10 \u00b5g/mL",
          "chromium \u00b5g/L"
        ],
        "unit": "Magnesium RBC mg/dL",
        "range": "Optimal: 5.0\u20136.5 mg/dL | Deficient: <4.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Nutrition PGS \u2014 51 Traits",
        "desc": "Lifenome 51-trait nutrition genetics: carb/fat sensitivity, satiety, overweight potential, 16 vitamin PGS, 13 mineral PGS.",
        "markers": [
          "FTO rs9939609 (obesity risk)",
          "MC4R (satiety signal)",
          "TCF7L2 (carb metabolism)",
          "PPARG Pro12Ala (fat metabolism)",
          "16 vitamin PGS",
          "13 mineral PGS",
          "51 nutrition traits total"
        ],
        "unit": "Per-trait percentile",
        "range": "High overweight potential: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Diet Response Predictor",
        "desc": "Which diet works best for this individual: low-carb, low-fat, Mediterranean, protein-rich, fasting.",
        "markers": [
          "low-carb effectiveness PGS",
          "low-fat effectiveness PGS",
          "Mediterranean diet PGS",
          "protein sensitivity PGS",
          "intermittent fasting response"
        ],
        "unit": "Diet match score",
        "range": "High match: >80% concordance",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Satiety & Appetite Genetics",
        "desc": "FTO, MC4R, LEPR, NPY \u2014 genetic satiety signaling variants driving hunger and portion control.",
        "markers": [
          "FTO obesity risk allele",
          "MC4R satiety variants",
          "LEPR (leptin receptor)",
          "NPY (neuropeptide Y)",
          "CCK satiety PGS"
        ],
        "unit": "Satiety deficit score",
        "range": "High deficit: >75th percentile = structured meal planning",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "MTHFR & Metabolic Methylation",
        "desc": "Methylation genetics affecting homocysteine, B vitamin needs, and metabolic enzyme efficiency.",
        "markers": [
          "MTHFR C677T",
          "MTHFR A1298C",
          "COMT Val158Met",
          "CBS variants",
          "methylation efficiency score"
        ],
        "unit": "Methylation capacity score",
        "range": "TT homozygous C677T: highest need for methyl-B9/B12",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Rare Obesity Gene Discovery",
        "desc": "MC4R frameshift/truncating, LEP, LEPR, PCSK1 \u2014 monogenic obesity genes missed by array testing.",
        "markers": [
          "MC4R rare variants",
          "LEP/LEPR pathogenic variants",
          "PCSK1 variants",
          "SIM1 (hypothalamic obesity)",
          "rare obesity gene exome panel"
        ],
        "unit": "Variant classification",
        "range": "Monogenic obesity: rare (<1%) but fully penetrant",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_wgs",
        "name": "WGS Metabolic Risk Refinement",
        "desc": "WGS improves all metabolic PGS and discovers rare regulatory variants affecting energy metabolism.",
        "markers": [
          "Enhanced nutrition PGS (all 51)",
          "rare regulatory variants",
          "structural variants in metabolic genes",
          "CNV affecting energy genes"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS PRS improves prediction by ~20%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Caloric Extraction Microbiome",
        "desc": "Firmicutes:Bacteroidetes ratio and caloric extraction capacity \u2014 same calories, different absorption.",
        "markers": [
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia muciniphila %",
          "Prevotella vs Ruminococcus dominance",
          "Bifidobacterium %"
        ],
        "unit": "F:B ratio",
        "range": "High F:B (>3:1) = increased caloric extraction",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Satiety Hormone Microbiome Score",
        "desc": "GLP-1 and PYY-stimulating species abundance affecting post-meal satiety duration.",
        "markers": [
          "Bifidobacterium %",
          "GLP-1-stimulating Akkermansia %",
          "SCFA producers %",
          "serotonin pathway species"
        ],
        "unit": "GLP-1 stimulating species %",
        "range": "High GLP-1 stimulators: >15% = better satiety",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Metabolic Functional Capacity Map",
        "desc": "Functional gene pathways for fat storage, SCFA fermentation, and energy harvest from diet.",
        "markers": [
          "butyryl-CoA transferase gene count",
          "acetate/propionate balance",
          "secondary bile acid synthesis",
          "short-chain fatty acid gene diversity"
        ],
        "unit": "Functional metabolic score",
        "range": "High SCFA capacity: protective vs obesity",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Metabolic Epigenetic Age",
        "desc": "Epigenetic age acceleration in metabolic pathways \u2014 HbA1c-associated CpG sites as targets.",
        "markers": [
          "HbA1c-associated CpGs methylation",
          "adiposity methylation score",
          "lipid-associated CpG loci",
          "AgeAccelGrim metabolic component"
        ],
        "unit": "Metabolic epigenetic age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Metabolism Healthspan Score",
        "desc": "InsideTracker's metabolism category combining sugar biomarkers (glucose, HbA1c, fasting insulin) and lipid biomarkers (LDL, HDL, TG, ApoB) into a composite metabolism optimization score \u2014 predicts T2DM risk and weight trajectory.",
        "markers": [
          "fasting glucose",
          "HbA1c",
          "fasting insulin",
          "HOMA-IR",
          "LDL",
          "HDL",
          "triglycerides",
          "ApoB",
          "total cholesterol"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | At-risk metabolism: <45",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Genotype-Matched Diet Plan",
        "desc": "Personalized macronutrient prescription derived from dietary genetics: low-carb vs low-fat diet effectiveness genes, saturated fat sensitivity, trans-fat sensitivity, Mediterranean diet response, and monounsaturated fat benefit profile. Includes food lists, meal templates, and shopping guides.",
        "markers": [
          "low-carb diet effectiveness PGS",
          "low-fat diet effectiveness PGS",
          "saturated fat sensitivity",
          "Mediterranean diet PGS",
          "HOMA-IR",
          "HbA1c",
          "triglycerides"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Metabolic Optimization Exercise Plan",
        "desc": "Exercise prescription optimized for fat loss and metabolic health: HIIT vs steady-state ratio based on cardiovascular age, resistance training volume for lean mass preservation, NEAT enhancement strategies, and activity timing by chronotype.",
        "markers": [
          "resting metabolic rate PGS",
          "HOMA-IR",
          "cortisol AM",
          "chronotype PGS",
          "lean body mass",
          "VO\u2082max",
          "physical activity level"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Weight Loss Supplement Protocol",
        "desc": "Evidence-based supplements from client catalog matched to metabolic blockers: magnesium for insulin sensitivity, chromium for glucose regulation, berberine proxy biomarkers, omega-3 for triglyceride reduction, fiber/prebiotic for satiety microbiome, and protein formulation.",
        "markers": [
          "magnesium RBC",
          "triglycerides",
          "HOMA-IR",
          "omega-3 index",
          "Firmicutes:Bacteroidetes ratio",
          "vitamin D"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "glp1",
    "name": "GLP-1 Weight Loss",
    "sub": "Pharmacotherapy Monitoring & Optimization",
    "color": "#7a4090",
    "lt": "#f5eeff",
    "img": "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=320&q=75",
    "desc": "Precision monitoring for semaglutide and tirzepatide \u2014 responder prediction, lean mass protection, dose optimization, contraindication screening, and side-effect management.",
    "tags": [
      "semaglutide",
      "tirzepatide",
      "responder PGS",
      "lean mass protection",
      "PGx side effects"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "GLP-1 Candidacy Assessment",
        "desc": "Lifestyle baseline, BMI trajectory, comorbidity profile, and GLP-1 indication evaluation.",
        "markers": [
          "BMI kg/m\u00b2",
          "BMI trajectory (5-yr)",
          "T2DM/prediabetes status",
          "previous weight-loss attempts",
          "NAFLD risk"
        ],
        "unit": "Candidacy score (Yes/Conditional/No)",
        "range": "BMI \u226530 or \u226527 + comorbidity = FDA indication",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Adherence & Lifestyle Co-Intervention",
        "desc": "Readiness assessment for behavioral co-intervention required alongside GLP-1 therapy.",
        "markers": [
          "dietary change readiness",
          "physical activity readiness",
          "support system score",
          "adherence history",
          "health literacy"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Optimal co-intervention: >65",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Body Composition Response Monitor",
        "desc": "Continuous lean vs. fat mass loss tracking during GLP-1 therapy \u2014 muscle preservation alert.",
        "markers": [
          "weight kg (weekly)",
          "body fat % trend",
          "muscle mass trend",
          "visceral fat reduction proxy"
        ],
        "unit": "Fat mass lost vs lean mass lost ratio",
        "range": "Optimal: >80% fat loss | Alert: muscle loss >25%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Cardiovascular Improvement Tracking",
        "desc": "HR, HRV, and activity improvement \u2014 quantifying GLP-1 cardioprotective benefit.",
        "markers": [
          "resting HR change bpm",
          "HRV trend change ms",
          "systolic BP proxy change",
          "activity increase steps/day"
        ],
        "unit": "Resting HR reduction bpm",
        "range": "Expected: -5 to -10 bpm over 12 wks",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Nausea & Tolerability Biomarker",
        "desc": "HRV vagal tone as proxy for GI tolerability \u2014 low HF-HRV predicts higher nausea burden.",
        "markers": [
          "HF-HRV ms\u00b2",
          "nocturnal HRV",
          "heart rate variability frequency domain",
          "sleep disruption index"
        ],
        "unit": "HF-HRV ms\u00b2",
        "range": "High vagal tone: better GI tolerability predicted",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Visceral Fat Reduction Tracking",
        "desc": "Smartphone-estimated visceral fat change \u2014 primary GLP-1 target independent of total weight.",
        "markers": [
          "waist circumference cm",
          "visceral fat proxy score",
          "waist-height ratio",
          "abdominal protrusion index"
        ],
        "unit": "Waist circumference cm",
        "range": "Target: \u22655 cm reduction at 12 weeks",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "GLP-1 Pre-Treatment Baseline",
        "desc": "Metabolic benchmark panel before starting GLP-1 therapy for responder monitoring.",
        "markers": [
          "HbA1c %",
          "fasting glucose mg/dL",
          "weight kg",
          "BMI",
          "lipid panel",
          "liver panel (ALT/AST)"
        ],
        "unit": "HbA1c %",
        "range": "T2DM response target: HbA1c reduction \u22651.0%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "GLP-1 Safety Monitoring Panel",
        "desc": "Pancreatitis markers, thyroid, and kidney function \u2014 mandatory GLP-1 safety monitoring protocol.",
        "markers": [
          "amylase IU/L",
          "lipase IU/L",
          "TSH mIU/L",
          "calcitonin pg/mL",
          "creatinine mg/dL",
          "eGFR mL/min",
          "ALT IU/L"
        ],
        "unit": "Lipase IU/L",
        "range": "Pancreatitis concern: lipase >3x ULN (>180 IU/L)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Lean Mass Protection Panel",
        "desc": "IGF-1, albumin, testosterone, and amino acids \u2014 muscle preservation monitoring during rapid weight loss.",
        "markers": [
          "IGF-1 ng/mL",
          "albumin g/dL",
          "testosterone ng/dL",
          "SHBG nmol/L",
          "amino acid panel",
          "creatinine (muscle mass proxy) mg/dL"
        ],
        "unit": "IGF-1 ng/mL",
        "range": "Maintain IGF-1: >100 ng/mL during therapy",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Metabolic Improvement Velocity Panel",
        "desc": "ApoB, hs-CRP, liver panel \u2014 tracking comprehensive cardiometabolic benefit of GLP-1.",
        "markers": [
          "ApoB mg/dL",
          "hs-CRP mg/L",
          "ALT IU/L (NAFLD marker)",
          "uric acid mg/dL",
          "adiponectin \u00b5g/mL",
          "IL-6 pg/mL"
        ],
        "unit": "ApoB mg/dL change",
        "range": "Expected ApoB reduction: 15\u201325% at 6 months",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Bone Density Monitoring Panel",
        "desc": "Bone turnover markers \u2014 GLP-1 is associated with increased bone resorption at high doses.",
        "markers": [
          "CTX pg/mL",
          "P1NP ng/mL",
          "vitamin D ng/mL",
          "PTH pg/mL",
          "calcium mg/dL",
          "osteocalcin ng/mL"
        ],
        "unit": "CTX pg/mL",
        "range": "Monitor: CTX should not exceed 600 pg/mL during therapy",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "GLP-1 Responder PGS",
        "desc": "GLP1R and metabolic pathway variants predicting semaglutide/tirzepatide weight loss magnitude.",
        "markers": [
          "GLP1R Ala316Thr (rs3765467)",
          "TCF7L2 (glycemic response)",
          "MC4R (satiety enhancement)",
          "ADCY3 variants",
          "metabolic response PGS"
        ],
        "unit": "Predicted weight loss %",
        "range": "High PGS responder: >15% weight loss expected",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Lean Mass Preservation Genetics",
        "desc": "Lean-body-mass potential, myostatin variants, and muscle-strength-loss resistance PGS.",
        "markers": [
          "lean body mass PGS",
          "MSTN (myostatin)",
          "ACTN3 R577X",
          "muscle-strength PGS",
          "anabolic response PGS"
        ],
        "unit": "Muscle loss risk score",
        "range": "High risk: >75th percentile = resistance training imperative",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "GLP-1 Pharmacogenomics Panel",
        "desc": "193-trait PGx: CYP metabolism, GI tolerability genetics, nausea susceptibility, and side-effect risk.",
        "markers": [
          "CYP3A4/2D6 metabolizer status",
          "serotonin receptor (5-HT3) variants",
          "substance P (NK1R) nausea variants",
          "gastric emptying rate variants",
          "GI motility genetics"
        ],
        "unit": "Tolerability risk score",
        "range": "High nausea risk genotype: dose titration essential",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "GLP-1 Absolute Contraindication Screen",
        "desc": "MEN2A/B, medullary thyroid carcinoma risk \u2014 RET proto-oncogene variants are absolute contraindications.",
        "markers": [
          "RET proto-oncogene (MEN2A/B)",
          "PTEN (Cowden syndrome)",
          "VHL syndrome",
          "MEN1",
          "endocrine exome panel"
        ],
        "unit": "ACMG classification",
        "range": "Any P/LP RET variant = absolute contraindication",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "GLP-1 Microbiome Response Predictor",
        "desc": "Gut microbiome composition predicts GLP-1 weight loss magnitude \u2014 Akkermansia abundance is key predictor.",
        "markers": [
          "Akkermansia muciniphila %",
          "Bifidobacterium %",
          "Shannon diversity H",
          "Prevotella %",
          "Bacteroidetes % change"
        ],
        "unit": "Predicted response modifier",
        "range": "High Akkermansia (>1%): enhanced GLP-1 response",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "GI Side Effect Microbiome Risk",
        "desc": "Microbiome dysbiosis patterns predicting nausea, vomiting, and constipation on GLP-1 therapy.",
        "markers": [
          "Proteobacteria % (dysbiosis marker)",
          "Bacteroides fragilis %",
          "motility-associated species",
          "intestinal transit-associated species"
        ],
        "unit": "GI symptom risk score 0\u201310",
        "range": "High risk: >6 | Low risk: <3",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Functional GLP-1 Response Map",
        "desc": "GLP-1 secretion-stimulating functional gene abundance and gut hormone pathway capacity.",
        "markers": [
          "GLP-1 secretion-stimulating species genes",
          "PYY stimulating pathway",
          "CCK-releasing gene capacity",
          "enteroendocrine function score"
        ],
        "unit": "GLP-1 stimulating gene RPKM",
        "range": "High functional capacity: enhanced drug response",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Metabolic Reprogramming Biomarker",
        "desc": "GLP-1-induced methylation changes at metabolic loci as biomarkers of durable therapeutic benefit.",
        "markers": [
          "HbA1c-associated CpGs methylation",
          "adipogenesis pathway methylation",
          "pancreatic beta-cell methylation marks",
          "AgeAccelGrim metabolic component"
        ],
        "unit": "Epigenetic metabolic age change",
        "range": "Target: reduction in metabolic CpG methylation age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "GLP-1 Lean Mass Protection Program",
        "desc": "Structured resistance training and protein optimization protocol to minimize muscle loss during GLP-1 treatment. Resistance training 3\u00d7/week minimum, protein target 1.6\u20132.2g/kg lean mass, creatine supplementation if responder, and lean mass monitoring schedule.",
        "markers": [
          "lean mass (DEXA/impedance)",
          "testosterone",
          "IGF-1",
          "albumin",
          "creatine kinase",
          "protein intake (24h recall)",
          "resistance training volume"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "GLP-1 Nutritional Support Protocol",
        "desc": "Micronutrient supplementation protocol for GLP-1 users experiencing reduced food intake: vitamin B12 (absorption risk), iron, zinc, calcium, vitamin D, and omega-3. Products matched from client catalog, dosed against measured deficiency.",
        "markers": [
          "vitamin B12",
          "ferritin",
          "zinc",
          "25-OH Vit D",
          "omega-3 index",
          "calcium",
          "albumin"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "GLP-1 Side Effect Management Plan",
        "desc": "Personalized nausea/GI side effect mitigation: meal timing adjustment, food texture modification, ginger supplementation, probiotic selection based on microbiome composition, and hydration optimization during dose titration.",
        "markers": [
          "GI tolerance genetics",
          "nausea biomarker proxy",
          "microbiome composition",
          "Lactobacillus spp.",
          "gut permeability markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "supplements",
    "name": "Personalized Supplementation",
    "sub": "Evidence-Based Protocols",
    "color": "#1a6630",
    "lt": "#e8f5ec",
    "img": "data:image/jpeg;base64,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",
    "desc": "Biomarker and genomic-driven supplement protocols using Lifenome 51-trait nutrition PGS, MTHFR methylation genetics, and 193-trait PGx for absorption optimization and dosing.",
    "tags": [
      "vitamin deficiency PGS",
      "mineral PGS",
      "MTHFR",
      "absorption genetics",
      "longevity stacks"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Dietary Gap & Deficiency Risk",
        "desc": "SAQ-derived nutrient shortfalls from dietary patterns, cooking habits, sun exposure, and lifestyle.",
        "markers": [
          "dietary vitamin D intake IU/day",
          "animal protein intake g/day",
          "fruit/veg servings/day",
          "sun exposure hrs/day",
          "vegan/vegetarian status"
        ],
        "unit": "Deficiency risk score per nutrient",
        "range": "High deficiency probability: >70%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Supplement Interaction Risk Screen",
        "desc": "Current medication and supplement combinations flagged for potential interactions.",
        "markers": [
          "current medications list",
          "current supplements",
          "alcohol use",
          "smoking status",
          "renal/hepatic function proxy"
        ],
        "unit": "Interaction flag (Y/N per pair)",
        "range": "High-risk interactions: require physician review",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Recovery Micronutrient Demand",
        "desc": "Magnesium, zinc, and electrolyte needs estimated from training load, sweat rate, and recovery quality.",
        "markers": [
          "training load AU/week",
          "sleep quality score",
          "HRV 7-day trend",
          "exercise sweat rate proxy",
          "recovery score %"
        ],
        "unit": "Estimated demand (% increase over RDA)",
        "range": "Heavy training: +20\u201360% Mg/Zn demand above RDA",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Deficiency Symptom Biomarker Score",
        "desc": "Smartphone-assisted fatigue visual scale, hair/nail quality analysis, and cognitive performance proxy.",
        "markers": [
          "fatigue VAS score 0\u201310",
          "hair loss severity proxy",
          "nail quality score",
          "cognitive performance proxy"
        ],
        "unit": "Symptom burden score 0\u201330",
        "range": "High deficiency burden: >15",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Core Deficiency Panel",
        "desc": "Vitamin D, CBC (hemoglobin/MCV), TSH \u2014 three most common supplement-responsive deficiencies.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "hemoglobin g/dL",
          "MCV fL",
          "TSH mIU/L",
          "fasting glucose mg/dL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal: 50\u201380 ng/mL | Deficient: <20 ng/mL | Toxic: >150",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Comprehensive Micronutrient Panel",
        "desc": "B12, folate, iron, ferritin, zinc \u2014 essential micronutrient deficiency status battery.",
        "markers": [
          "B12 pg/mL",
          "folate ng/mL",
          "ferritin ng/mL",
          "serum iron \u00b5g/dL",
          "transferrin saturation %",
          "zinc \u00b5g/dL",
          "vitamin D ng/mL"
        ],
        "unit": "B12 pg/mL",
        "range": "Optimal B12: 400\u2013900 pg/mL | Deficient: <200 pg/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Advanced Nutrient Status Panel",
        "desc": "Magnesium RBC, selenium, CoQ10, omega-3 index \u2014 advanced depletion markers not in standard panel.",
        "markers": [
          "magnesium RBC mg/dL",
          "selenium \u00b5g/L",
          "CoQ10 \u00b5g/mL",
          "omega-3 index %",
          "GSH \u00b5mol/L",
          "alpha-tocopherol (vit E) mg/L"
        ],
        "unit": "Omega-3 index %",
        "range": "Optimal: 8\u201312% | Deficient: <4% | Cardiovascular risk: <6%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Longevity Stack Target Panel",
        "desc": "NAD+, BDNF, IGF-1, cortisol \u2014 anti-aging supplementation protocol optimization targets.",
        "markers": [
          "NAD+ \u00b5mol/L",
          "BDNF ng/mL",
          "IGF-1 ng/mL",
          "cortisol AM \u00b5g/dL",
          "IL-6 pg/mL",
          "sirtuin activity proxy"
        ],
        "unit": "NAD+ \u00b5mol/L",
        "range": "Optimal: >40 \u00b5mol/L | Decline: <25 \u00b5mol/L (>40 yrs)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Fat-Soluble Vitamin Panel",
        "desc": "Full fat-soluble vitamin status: A, D, E, K2 \u2014 often neglected but critical for bone, immune, and vascular health.",
        "markers": [
          "retinol \u00b5g/L (vit A)",
          "25-OH D3 ng/mL",
          "alpha-tocopherol mg/L (vit E)",
          "K2 (MK-7) ng/mL",
          "K1 ng/mL"
        ],
        "unit": "K2 (MK-7) ng/mL",
        "range": "Optimal K2: >0.5 ng/mL | Most adults deficient",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Nutrigenomics PGS \u2014 51 Traits",
        "desc": "All 16 vitamin deficiency PGS + 13 mineral deficiency PGS + 22 diet/metabolism traits \u2014 complete nutrition genome.",
        "markers": [
          "vitamin D PGS (GC, CYP2R1, DHCR7)",
          "B12 PGS (FUT2, CUBN)",
          "iron PGS (HFE, TMPRSS6)",
          "magnesium PGS (TRPM6)",
          "omega-3 PGS (FADS1/2)",
          "51 nutrition traits total"
        ],
        "unit": "Per-nutrient percentile",
        "range": "High deficiency genetics: >80th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "MTHFR Methylation Panel",
        "desc": "Complete methylation cycle genetics driving folate form requirements (methyl vs folic acid), B12 form, and betaine.",
        "markers": [
          "MTHFR C677T genotype",
          "MTHFR A1298C genotype",
          "MTR A2756G",
          "MTRR A66G",
          "BHMT variants",
          "CBS variants"
        ],
        "unit": "Methylation capacity category",
        "range": "TT + A1298C compound: severe methylation deficit",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "PGx Absorption & Toxicity Panel",
        "desc": "193-trait PGx: VDR (vitamin D absorption), BCMO1 (beta-carotene conversion), SLC19A1 (folate), CYP metabolism.",
        "markers": [
          "VDR FokI/BsmI (D absorption)",
          "BCMO1 (beta-carotene to A)",
          "SLC19A1 (folate transporter)",
          "SLCO1B1 (supplement transport)",
          "FMO3 (choline/TMAO)",
          "193 PGx traits"
        ],
        "unit": "Absorption phenotype",
        "range": "Poor converter: 2\u20134x higher supplement dose needed",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Rare Inborn Metabolic Deficiency",
        "desc": "Rare inborn errors of metabolism in vitamin/mineral pathways \u2014 exome panel for treatment-refractory deficiencies.",
        "markers": [
          "PCCA/PCCB (B12-responsive MMA)",
          "biotinidase deficiency",
          "G6PD (antioxidant risk)",
          "Wilson disease (ATP7B)",
          "metabolic disorders exome panel"
        ],
        "unit": "Variant classification",
        "range": "P/LP = specific medical supplementation protocol",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Microbiome Nutrient Synthesis",
        "desc": "B vitamin synthesis (B12, folate, K2, biotin), and mineral bioavailability from gut microbial communities.",
        "markers": [
          "B12-producing species (Propionibacterium)",
          "K2-synthesizing species (Bacteroides, Fusobacterium)",
          "folate-producing Bifidobacterium %",
          "biotin-synthesizing species",
          "Lactobacillus % (B vitamin producers)"
        ],
        "unit": "Synthesis capacity score",
        "range": "High synthesis: reduces supplement dose needs",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Nutrient Absorption Efficiency Map",
        "desc": "Functional genomics of nutrient transporter gene expression from gut microbiome.",
        "markers": [
          "folate transport gene count (folate operon)",
          "zinc transporter species (znuABC)",
          "cobalamin biosynthesis genes",
          "calcium absorption pathway (cbsT)"
        ],
        "unit": "Transporter gene RPKM",
        "range": "Low transporter genes: enhanced oral dosing required",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Methylation Cycle Epigenetic Status",
        "desc": "DNAm-based global methylation capacity assessment \u2014 directly drives B9/B12 supplementation protocol.",
        "markers": [
          "global DNA methylation index (% 5mC)",
          "LINE-1 methylation %",
          "SAM/SAH ratio proxy (CpG pattern)",
          "DNMT3A methylation marks"
        ],
        "unit": "Global methylation %",
        "range": "Hypomethylation (<70% LINE-1): methyl-donor deficiency",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Electrolyte & Mineral Optimization Panel",
        "desc": "InsideTracker's Ultimate test includes sodium and potassium as critical electrolyte biomarkers. Low sodium increases risk of irregular heartbeat, poor kidney function, and muscle spasms. High dietary sodium increases cardiovascular risk. Full electrolyte panel for precision supplementation.",
        "markers": [
          "sodium",
          "potassium",
          "chloride",
          "bicarbonate",
          "calcium",
          "phosphorus",
          "magnesium serum",
          "magnesium RBC"
        ],
        "unit": "mEq/L per electrolyte",
        "range": "Sodium: 136\u2013145 mEq/L | Potassium: 3.8\u20135.0 mEq/L | Mg RBC: 4.2\u20136.8",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "name": "Omega-3 Index & Essential Fatty Acid Profile",
        "desc": "Function Health and InsideTracker both highlight omega-3 as critical for brain, heart, and mood. Omega-3 index (EPA+DHA as % of RBC total fatty acids) below 8% doubles cardiovascular and depression risk.",
        "markers": [
          "omega-3 index (EPA+DHA %)",
          "EPA (eicosapentaenoic acid)",
          "DHA (docosahexaenoic acid)",
          "AA:EPA ratio",
          "omega-6 total",
          "trans fatty acids"
        ],
        "unit": "% of RBC fatty acids",
        "range": "Optimal: >8% | Deficient: <4% | Depression risk: <6%",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Precision Vitamin & Mineral Stack",
        "desc": "Personalized supplement stack from client product catalog addressing confirmed deficiencies (blood + genetic). Priority ranking: (1) D3+K2 if Vit D <30 ng/mL, (2) methylfolate vs folic acid based on MTHFR genotype, (3) methylcobalamin for B12 if low/MTHFR+, (4) magnesium glycinate if RBC Mg low, (5) zinc if deficient, (6) omega-3 if index <6%.",
        "markers": [
          "25-OH Vit D",
          "MTHFR C677T/A1298C",
          "vitamin B12",
          "folate RBC",
          "magnesium RBC",
          "zinc",
          "omega-3 index",
          "iron/ferritin"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Longevity & Performance Supplement Protocol",
        "desc": "Personalized longevity supplement protocol from catalog based on advanced biomarkers: CoQ10 (statin use or mitochondrial markers), NAD+ precursor (biologic age gap), glutathione (oxidative stress), berberine (insulin resistance), ashwagandha (cortisol), and adaptogens.",
        "markers": [
          "CoQ10 blood level",
          "NAD+ proxy",
          "glutathione (TAC)",
          "HOMA-IR",
          "cortisol AM",
          "GrimAge acceleration",
          "CRP"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Supplement Timing & Absorption Optimization Plan",
        "desc": "Personalized supplement timing protocol based on absorption genetics (MTHFR, VDR, FUT2, BCMO1), meal composition, and interaction screening. Identifies morning vs evening optimal dosing, fat-soluble vitamin timing with meals, and iron-calcium separation requirements.",
        "markers": [
          "MTHFR genotype",
          "VDR BsmI/FokI",
          "FUT2 (B12 absorption)",
          "BCMO1 (beta-carotene)",
          "iron + calcium interaction",
          "supplement interaction screen"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "skincare",
    "name": "Personalized Skin Care",
    "sub": "Precision Dermatology",
    "color": "#8a3060",
    "lt": "#fce8f0",
    "img": "https://images.unsplash.com/photo-1556228720-195a672e8a03?w=320&q=75",
    "desc": "Genomic and biomarker-driven skincare using Lifenome 20-trait skincare PGS covering collagen breakdown, glycation, photoaging, barrier sensitivity, rosacea, acne, and stretch marks.",
    "tags": [
      "collagen genetics",
      "photoaging PGS",
      "barrier function",
      "acne PGS",
      "rosacea",
      "sebum genetics"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Skin Aging Lifestyle Score",
        "desc": "UV exposure dose, sleep quality, smoking, alcohol, dietary antioxidants, and skin care habit composite.",
        "markers": [
          "UV exposure hrs/day (lifetime)",
          "sleep hrs/night",
          "smoking pack-years",
          "alcohol units/wk",
          "dietary antioxidant score"
        ],
        "unit": "Skin aging risk score 0\u2013100",
        "range": "High risk (accelerated aging): >65 | Optimal: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Dietary Skin Health Profile",
        "desc": "Anti-glycation, omega-3 intake, and collagen-supporting micronutrient dietary assessment.",
        "markers": [
          "glycemic load/day",
          "omega-3 intake g/day",
          "vitamin C dietary intake mg/day",
          "collagen precursor intake (glycine, proline)",
          "carotenoid intake"
        ],
        "unit": "Skin nutrition score 0\u2013100",
        "range": "Optimal: >70 | Skin-aging diet pattern: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep-Collagen Synthesis Index",
        "desc": "Deep sleep and overnight HRV as proxies for nocturnal collagen synthesis and skin barrier repair.",
        "markers": [
          "deep sleep % ",
          "sleep efficiency %",
          "overnight HRV RMSSD ms",
          "sleep duration hrs"
        ],
        "unit": "Collagen synthesis opportunity score",
        "range": "Optimal: deep sleep >20%, efficiency >85%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Facial Skin Biological Age",
        "desc": "Lifenome smartphone camera-based facial biological age with wrinkle depth, texture, and pigmentation analysis.",
        "markers": [
          "wrinkle depth score",
          "skin texture roughness index",
          "periorbital area aging",
          "hyperpigmentation map",
          "pore size proxy"
        ],
        "unit": "Facial skin age (yr)",
        "range": "Target: facial age \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Sebum Rate & Skin Hydration",
        "desc": "Smartphone camera sebum and TEWL proxy measurement for oiliness/barrier function classification.",
        "markers": [
          "sebum sheen index",
          "pore visibility score",
          "skin redness index (rosacea proxy)",
          "skin hydration proxy"
        ],
        "unit": "Sebum rate classification",
        "range": "Oily: high sheen | Dry: low sheen + barrier concern",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Pigmentation & Photo-Damage Map",
        "desc": "AI analysis of sun damage, melasma, solar lentigines, and UV-related hyperpigmentation.",
        "markers": [
          "UV spot count",
          "melasma distribution score",
          "skin tone evenness index",
          "solar lentigo proxy"
        ],
        "unit": "Photo-damage score 0\u201310",
        "range": "Minimal: 0\u20132 | Moderate: 3\u20135 | Severe: 6\u201310",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Skin Hormonal Foundation",
        "desc": "Vitamin D, thyroid, iron \u2014 the three foundational skin hormone and micronutrient drivers.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "TSH mIU/L",
          "ferritin ng/mL",
          "B12 pg/mL",
          "zinc \u00b5g/dL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal skin D: 50\u201380 ng/mL | Deficient: <30 = dull skin",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Collagen & Hormonal Skin Panel",
        "desc": "Estradiol, DHEA-S, DHT, testosterone, SHBG \u2014 hormonal drivers of collagen synthesis and sebum production.",
        "markers": [
          "estradiol pg/mL",
          "DHEA-S \u00b5g/dL",
          "testosterone total ng/dL",
          "DHT pg/mL",
          "SHBG nmol/L",
          "IGF-1 ng/mL"
        ],
        "unit": "DHT pg/mL",
        "range": "Acne-driving DHT: >300 pg/mL (F) | >850 pg/mL (M)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Glycation & Oxidative Stress Panel",
        "desc": "HbA1c, uric acid, and antioxidant capacity as skin glycation and oxidative stress biomarkers.",
        "markers": [
          "HbA1c % (glycation proxy)",
          "uric acid mg/dL",
          "8-OHdG (oxidative DNA damage)",
          "total antioxidant capacity",
          "malondialdehyde (MDA) \u00b5mol/L"
        ],
        "unit": "HbA1c % (glycation risk)",
        "range": "Skin glycation accelerates: HbA1c >5.5% | Visible: >6.0%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Skin Antioxidant & Collagen Panel",
        "desc": "GSH, CoQ10, vitamin C, selenium, and omega-3 \u2014 complete anti-aging skin antioxidant/collagen optimization.",
        "markers": [
          "GSH \u00b5mol/L",
          "CoQ10 \u00b5g/mL",
          "vitamin C mg/dL",
          "selenium \u00b5g/L",
          "omega-3 index %",
          "hydroxyproline (collagen turnover)"
        ],
        "unit": "Omega-3 index %",
        "range": "Optimal skin omega-3: >8% | Deficient: <4%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Skincare PGS \u2014 20 Traits",
        "desc": "Lifenome 20-trait skincare genetics: collagen-breakdown rate, glycation propensity, youthfulness, photoaging, barrier sensitivity, acne, rosacea, stretch marks.",
        "markers": [
          "COL1A1/COL3A1 (collagen structure)",
          "MMP1/MMP3 (collagen breakdown)",
          "GSTP1 (antioxidant capacity)",
          "MC1R (pigmentation/sun sensitivity)",
          "FLG (barrier function)",
          "20 skincare traits total"
        ],
        "unit": "Per-trait aging risk percentile",
        "range": "Accelerated collagen breakdown PGS: >80th %ile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Acne & Sebum Genetics",
        "desc": "DHT receptor sensitivity, IGF-1 pathway, and sebum overproduction genetic risk for acne.",
        "markers": [
          "androgen receptor (AR) CAG repeats",
          "SRD5A2 (5-alpha reductase)",
          "IGF-1 pathway variants",
          "CYP17A1 (androgen synthesis)",
          "sebum overproduction PGS"
        ],
        "unit": "Acne genetic risk score",
        "range": "High acne risk PGS: >80th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Rosacea & Vascular Reactivity PGS",
        "desc": "Rosacea genetic predisposition, skin vascular reactivity, and flush response PGS.",
        "markers": [
          "HLA variants (rosacea)",
          "KLK5/7 (stratum corneum serine proteases)",
          "vascular reactivity PGS",
          "flush response variants (ALDH2)"
        ],
        "unit": "Rosacea risk percentile",
        "range": "High genetic risk: >75th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Monogenic Skin Disorder Screen",
        "desc": "Rare variants: ichthyosis vulgaris (FLG), epidermolysis bullosa (KRT5/14), albinism \u2014 dermatology exome panel.",
        "markers": [
          "FLG loss-of-function (atopic dermatitis)",
          "KRT1/KRT5/KRT14 (ichthyosis/EB)",
          "ABCA4 (skin photosensitivity)",
          "SLC45A2 (pigmentation)",
          "dermatology exome panel"
        ],
        "unit": "Variant classification",
        "range": "FLG null allele carrier: 3\u20135x atopic dermatitis risk",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Gut-Skin Axis Inflammation Score",
        "desc": "Gut dysbiosis driving systemic inflammation manifesting as acne, rosacea, psoriasis, and atopic dermatitis.",
        "markers": [
          "gut Shannon diversity H",
          "Akkermansia muciniphila %",
          "Bifidobacterium %",
          "LPS-producing Proteobacteria %",
          "Clostridiales diversity"
        ],
        "unit": "Gut-skin inflammation score 0\u201310",
        "range": "High gut-skin axis: >6 = systemic inflammatory load",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "SCFA Skin Immunomodulation Score",
        "desc": "Butyrate and propionate-producing functional gene abundance affecting skin immune regulation.",
        "markers": [
          "butyrate synthesis gene count (but pathway)",
          "propionate producers RPKM",
          "acetate producers RPKM",
          "skin-immune modulating pathway genes"
        ],
        "unit": "Butyrate gene RPKM",
        "range": "Optimal: >1.5 RPKM | Low: <0.8 (inflammation risk)",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Skin-Specific Epigenetic Age",
        "desc": "Skin-specific methylation clock based on sun-damage-associated CpG sites \u2014 photoaging biological age.",
        "markers": [
          "skin epigenetic age (yr)",
          "UV-damage CpG loci methylation",
          "collagen gene promoter methylation",
          "skin barrier methylation marks"
        ],
        "unit": "Skin epigenetic age (yr)",
        "range": "Accelerated: skin age > chronological + 3 yr",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Personalized Skincare Product Selection",
        "desc": "AI-matched skincare product recommendations from client catalog based on genetic skin type (oily/dry/combination), sun sensitivity genetics, acne predisposition, rosacea risk, collagen synthesis capacity, and current glycation/oxidative stress markers. Products matched by active ingredient mechanism.",
        "markers": [
          "skin type PGS",
          "sebum rate",
          "collagen stability genotype",
          "acne PGS",
          "rosacea PGS",
          "glycation markers",
          "UV sensitivity genetics",
          "skin hydration score"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Anti-Aging Skin Protocol",
        "desc": "Personalized anti-aging skin health program: dietary collagen precursors (glycine, proline, vitamin C timing), blue light exposure reduction, sleep position optimization, targeted antioxidant supplementation (astaxanthin, coenzyme Q10 topical, retinol timing by CYP genotype).",
        "markers": [
          "collagen stability genotype",
          "retinoic acid metabolism (CYP26A1)",
          "glycation index",
          "Vit C status",
          "skin biological age",
          "oxidative stress markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Skin Supplement Stack",
        "desc": "Skin-targeted nutritional supplements from client catalog: marine collagen peptides (dosed by collagen synthesis genetics), biotin (if hair/nail markers suggest deficiency), vitamin E + selenium as antioxidants, hyaluronic acid precursors, and astaxanthin.",
        "markers": [
          "collagen stability genotype",
          "biotin deficiency risk",
          "glutathione (TAC)",
          "selenium",
          "vitamin E",
          "skin biological age"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "hairloss",
    "name": "Hair Loss Solutions",
    "sub": "Alopecia Diagnostics & Treatment",
    "color": "#b03020",
    "lt": "#fdeaea",
    "img": "https://images.unsplash.com/photo-1522337360788-8b13dee7a37e?w=320&q=75",
    "desc": "Multi-dimensional alopecia diagnostics \u2014 AGA genetics, DHT pathway, telogen effluvium triggers, scalp microbiome, and PGx for minoxidil/finasteride treatment response.",
    "tags": [
      "AGA PGS",
      "DHT genetics",
      "minoxidil PGx",
      "finasteride response",
      "telogen effluvium"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Hair Loss Trigger Risk Assessment",
        "desc": "Comprehensive modifiable trigger profile: nutritional deficits, stress, hormonal disruption, medications.",
        "markers": [
          "chronic stress score",
          "recent weight loss kg/month",
          "protein intake g/day",
          "recent illness/surgery",
          "scalp hygiene habits",
          "hair styling trauma index"
        ],
        "unit": "Trigger risk score 0\u201310",
        "range": "High trigger burden: >6 | Low: <3",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Scalp Health Lifestyle Score",
        "desc": "UV scalp exposure, product chemical load, hair washing frequency, and sebum management habits.",
        "markers": [
          "scalp UV exposure score",
          "chemical exposure (dyes/bleach freq)",
          "washing frequency/week",
          "physical tension (tight hairstyles)"
        ],
        "unit": "Scalp health score 0\u2013100",
        "range": "Optimal: >70 | Damaging: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Chronic Stress & Cortisol Proxy",
        "desc": "HRV-derived chronic stress index as telogen effluvium trigger quantification.",
        "markers": [
          "HRV RMSSD 30-day trend ms",
          "resting HR elevation bpm",
          "sleep disruption index",
          "nocturnal cortisol proxy",
          "recovery score trend"
        ],
        "unit": "Chronic stress score 0\u201310",
        "range": "Telogen effluvium trigger: sustained score >6",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Scalp Density & Miniaturization Analysis",
        "desc": "Smartphone AI trichoscopy proxy \u2014 hair density mapping, miniaturization detection, and scalp coverage score.",
        "markers": [
          "hair density estimate (hairs/cm\u00b2)",
          "follicular miniaturization %",
          "scalp coverage score",
          "hair shaft diameter proxy",
          "terminal:vellus ratio"
        ],
        "unit": "Hairs/cm\u00b2",
        "range": "Normal scalp: 180\u2013300 hairs/cm\u00b2 | AGA: declining",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Hair Shaft Quality Analysis",
        "desc": "Smartphone optical analysis of hair shaft diameter, breakage index, and luster score.",
        "markers": [
          "hair shaft diameter \u00b5m proxy",
          "breakage score",
          "luster/shine index",
          "porosity proxy",
          "texture uniformity"
        ],
        "unit": "Breakage score 0\u201310",
        "range": "High breakage (>6): nutritional or structural cause",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Primary Hair Loss Triage Panel",
        "desc": "Ferritin, TSH, CBC \u2014 the three most common reversible and treatable hair loss causes.",
        "markers": [
          "ferritin ng/mL",
          "TSH mIU/L",
          "hemoglobin g/dL",
          "MCV fL",
          "WBC x10\u00b3/\u00b5L"
        ],
        "unit": "Ferritin ng/mL",
        "range": "Optimal hair ferritin: >70 ng/mL | Critical: <12 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Nutritional Hair Growth Panel",
        "desc": "B12, zinc, vitamin D, folate, biotin \u2014 complete micronutrient hair growth foundation.",
        "markers": [
          "B12 pg/mL",
          "folate ng/mL",
          "25-OH vitamin D ng/mL",
          "zinc \u00b5g/dL",
          "selenium \u00b5g/L",
          "biotin pg/mL"
        ],
        "unit": "Zinc \u00b5g/dL",
        "range": "Optimal zinc: 70\u2013120 \u00b5g/dL | Hair loss: <60 \u00b5g/dL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Androgenic Alopecia Hormone Panel",
        "desc": "DHT, free testosterone, SHBG, DHEA-S \u2014 complete androgen-driven AGA diagnostic panel.",
        "markers": [
          "DHT pg/mL",
          "testosterone (free) pg/mL",
          "SHBG nmol/L",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "prolactin ng/mL"
        ],
        "unit": "DHT pg/mL",
        "range": "AGA-associated: DHT M >500 pg/mL | F >45 pg/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Thyroid & Autoimmune Hair Panel",
        "desc": "Full thyroid panel plus alopecia areata-associated autoimmune markers.",
        "markers": [
          "TSH mIU/L",
          "free T3/T4",
          "anti-TPO IU/mL",
          "anti-Tg IU/mL",
          "ANA titer",
          "anti-dsDNA",
          "complement C3/C4"
        ],
        "unit": "Anti-TPO IU/mL",
        "range": "Positive anti-TPO (>35 IU/mL) = thyroid autoimmunity",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Inflammatory & Scarring Alopecia Panel",
        "desc": "IL-6, hs-CRP, IL-17, autoimmune panel \u2014 lichen planopilaris and scarring alopecia immune markers.",
        "markers": [
          "IL-6 pg/mL",
          "hs-CRP mg/L",
          "IL-17 pg/mL",
          "TNF-\u03b1 pg/mL",
          "ANA/anti-dsDNA",
          "ANCA panel",
          "complement C3/C4"
        ],
        "unit": "IL-6 pg/mL",
        "range": "Scarring alopecia flag: IL-6 >5 pg/mL + ANA positive",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "AGA Polygenic Risk Score",
        "desc": "Lifenome androgenetic alopecia PGS: male pattern A/B/C stages, female pattern hair loss \u2014 strongest single predictor.",
        "markers": [
          "AR gene (X-linked primary)",
          "SRD5A2 (5-alpha reductase)",
          "PAX1 (frontal hairline)",
          "HDAC4",
          "WNT10A",
          "20+ AGA SNPs",
          "FPHL-specific PGS"
        ],
        "unit": "AGA risk percentile",
        "range": "High risk: >85th percentile (NW III+ predicted by 50)",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Treatment Response PGx",
        "desc": "Pharmacogenomics for minoxidil (SULT1A1/1A2), finasteride (SRD5A2), dutasteride, and PRP response.",
        "markers": [
          "SULT1A1 *2 allele (minoxidil sulfation)",
          "SULT1A2 variants",
          "SRD5A2 V89L (finasteride)",
          "CYP3A4 (dutasteride)",
          "androgen receptor sensitivity"
        ],
        "unit": "Treatment response prediction",
        "range": "SULT1A1 poor sulfater: minoxidil ~50% less effective",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Scalp & Hair Condition PGS",
        "desc": "Seborrheic dermatitis genetic risk, scalp irritability, sebum overproduction \u2014 scalp environment genetics.",
        "markers": [
          "seborrheic dermatitis PGS",
          "scalp-irritability PGS",
          "sebum overproduction genetics",
          "atopic dermatitis FLG variants",
          "inflammatory PGS"
        ],
        "unit": "Scalp condition risk score",
        "range": "High SD risk: >70th percentile = medical shampoo first",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Alopecia Gene Panel",
        "desc": "Rare alopecia universalis (HR gene), monilethrix (KRT81/83/86), and genodermatoses.",
        "markers": [
          "HR gene (alopecia universalis)",
          "KRT81/KRT83/KRT86 (monilethrix)",
          "LAMA3 (junctional EB)",
          "LIPH (LAH)",
          "FZD6 (nail/hair dystrophies)",
          "dermatology exome panel"
        ],
        "unit": "Variant classification",
        "range": "Alopecia universalis (HR LOF): no current cure",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "micro_16s",
        "name": "Scalp Microbiome Dysbiosis Profile",
        "desc": "Malassezia spp. vs. Cutibacterium balance \u2014 dandruff, seborrheic dermatitis, and folliculitis risk.",
        "markers": [
          "Malassezia globosa % ",
          "Malassezia restricta %",
          "Cutibacterium acnes %",
          "Staphylococcus % ",
          "commensal diversity score"
        ],
        "unit": "Malassezia % dominance",
        "range": "Dandruff-associated: Malassezia >50% | Healthy: <35%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Gut-Hair Axis Inflammation",
        "desc": "Systemic gut-derived inflammation affecting scalp immune environment \u2014 telogen effluvium driver.",
        "markers": [
          "gut Shannon diversity H",
          "LPS-producing Proteobacteria %",
          "Akkermansia %",
          "Bifidobacterium %",
          "butyrate producers %"
        ],
        "unit": "Gut inflammation score 0\u201310",
        "range": "Hair loss amplification: gut score >6",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Androgen-Microbiome Metabolism",
        "desc": "Gut bacterial androgen conversion and 5-alpha reductase activity \u2014 DHT modulation via enterolignans.",
        "markers": [
          "androgen-metabolizing bacterial genes",
          "5AR pathway functional genes",
          "enterolignin-processing gene count",
          "equol-producing capacity (Slackia isoflavoniconvertens)"
        ],
        "unit": "Androgen conversion functional score",
        "range": "High conversion: increases DHT availability",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Hair Follicle Epigenetic Age",
        "desc": "Follicular biological age and WNT pathway methylation \u2014 predicts miniaturization velocity and treatment window.",
        "markers": [
          "follicular methylation age (yr)",
          "androgen receptor promoter methylation %",
          "WNT pathway CpG methylation",
          "AgeAccelGrim scalp component"
        ],
        "unit": "Follicular biological age (yr)",
        "range": "Follicular age acceleration >5 yr: reduced treatment response",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Hair Loss Treatment Product Matching",
        "desc": "Evidence-based hair loss treatment recommendations from client catalog matched by genetic profile and biomarkers: minoxidil response genetics (SULT1A1), finasteride/dutasteride metabolism (SRD5A2, CYP3A4), spironolactone for female AGA (hormone markers), and topical peptides (copper peptides, GHK-Cu) for non-androgenic loss.",
        "markers": [
          "AGA PGS",
          "SULT1A1 (minoxidil response)",
          "SRD5A2 genotype",
          "DHT:testosterone ratio",
          "finasteride metabolism genotype",
          "scalp inflammation score",
          "thyroid panel"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Hair Nutrition & Supplement Protocol",
        "desc": "Targeted hair health supplement stack from client catalog: iron (critical threshold ferritin >70 ng/mL for hair), zinc, biotin (if deficient \u2014 note: biotin artifacts in thyroid testing), vitamin D, selenium, and marine collagen for hair matrix support.",
        "markers": [
          "ferritin",
          "zinc",
          "biotin deficiency genetics",
          "25-OH Vit D",
          "selenium",
          "thyroid panel",
          "protein intake estimate"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Scalp Health & Hair Growth Program",
        "desc": "Multimodal hair and scalp health intervention: stress management protocol (cortisol-linked telogen effluvium), scalp microbiome rebalancing (probiotic selection from microbiome dysbiosis profile), dietary protein optimization, and DHT-reducing dietary interventions.",
        "markers": [
          "cortisol AM",
          "scalp microbiome dysbiosis score",
          "protein intake",
          "DHT proxy",
          "Malassezia spp. abundance",
          "gut-hair axis inflammation"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "mental_health",
    "name": "Mental Health & Brain Wellness",
    "sub": "Mood \u00b7 Cognition \u00b7 Stress \u00b7 Neuroinflammation",
    "color": "#6b3fa0",
    "lt": "#f0eaff",
    "img": "https://images.unsplash.com/photo-1544367567-0f2fcb009e0b?w=300&q=75",
    "desc": "Comprehensive mental wellness intelligence combining blood biomarkers, DNA risk, wearable psychophysiology, lifestyle assessment, and epigenetics to produce actionable indices for mood, cognition, stress resilience, neuroinflammation, and sleep quality.",
    "tags": [
      "Mood & Depression Risk",
      "Cognitive Performance",
      "Stress & HPA Axis",
      "Neuroinflammation",
      "Sleep Architecture",
      "Brain Aging",
      "Anxiety Biomarkers",
      "Gut-Brain Axis"
    ],
    "insights": [
      {
        "src": "blood",
        "name": "Neuroinflammation Index",
        "desc": "Composite of hs-CRP, IL-6, TNF-\u03b1, and homocysteine to quantify systemic and central nervous system inflammatory burden linked to depression, cognitive decline, and anxiety disorders.",
        "markers": [
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "homocysteine",
          "WBC count",
          "neutrophil/lymphocyte ratio"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: <25 | Elevated: 25\u201360 | High burden: >60",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Cortisol Stress Burden Score",
        "desc": "Morning cortisol and DHEA-S ratio reflecting HPA-axis dysregulation, burnout risk, and chronic stress load. Chronically elevated cortisol is causal in anxiety, depression, memory impairment, and sleep disruption.",
        "markers": [
          "cortisol AM",
          "DHEA-S",
          "cortisol/DHEA-S ratio"
        ],
        "unit": "Ratio + Score",
        "range": "Healthy ratio: 5\u201310 | Burnout risk: >15 | Adrenal fatigue: <3",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Serotonin Precursor Availability",
        "desc": "Tryptophan and its ratio to competing large neutral amino acids (LNAAs) determines CNS serotonin synthesis capacity. Low ratio is a validated biological marker for depression vulnerability and carbohydrate craving.",
        "markers": [
          "tryptophan",
          "tyrosine",
          "phenylalanine",
          "leucine",
          "isoleucine",
          "valine",
          "tryptophan:LNAA ratio"
        ],
        "unit": "Ratio (Trp:LNAA)",
        "range": "Optimal: >0.12 | Depleted: <0.08",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Dopamine & Catecholamine Balance",
        "desc": "Tyrosine availability (dopamine precursor), phenylalanine, and plasma catecholamine proxies reflecting reward circuitry, motivation, focus, and ADHD-related pathways.",
        "markers": [
          "tyrosine",
          "phenylalanine",
          "Tyr:Phe ratio",
          "homovanillic acid (HVA)"
        ],
        "unit": "Tyr:Phe ratio",
        "range": "Optimal: >1.5 | Depleted: <1.0",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Mood-Nutrient Deficiency Panel",
        "desc": "Critical neuronutrients whose deficiency is causally linked to depression, anxiety, fatigue, and cognitive impairment. Inspired by Function Health's finding that 38% of users are deficient in \u22651 key brain nutrient.",
        "markers": [
          "25-OH Vitamin D",
          "Vitamin B12",
          "folate",
          "Omega-3 index (EPA+DHA)",
          "magnesium RBC",
          "zinc",
          "iron/ferritin"
        ],
        "unit": "Multi-marker panel",
        "range": "Vit D optimal: 40\u201380 ng/mL | B12: >400 pg/mL | Omega-3: >8%",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "name": "Thyroid-Mood Connection Score",
        "desc": "Subclinical hypothyroidism and thyroid autoimmunity are strongly associated with depression, brain fog, fatigue, and anxiety. Full thyroid panel including TPO antibodies (elevated in ~23% of population per Function Health data).",
        "markers": [
          "TSH",
          "Free T3",
          "Free T4",
          "TPO antibodies",
          "TgAb",
          "reverse T3"
        ],
        "unit": "Composite score",
        "range": "TSH optimal: 1.0\u20132.5 mIU/L | TPO Ab: <35 IU/mL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Brain Aging & Alzheimer's Risk Score",
        "desc": "Blood-based neurodegenerative biomarker panel including p-tau217 (AUC 0.93\u20130.96 for Alzheimer's per Nature Medicine 2025), GFAP, and NfL. Function Health reports 14% of members have elevated p-tau217. Integrated with APOE genotype from DNA.",
        "markers": [
          "p-tau217",
          "GFAP (glial fibrillary acidic protein)",
          "NfL (neurofilament light chain)",
          "A\u03b242/40 ratio",
          "p-tau181"
        ],
        "unit": "Risk score + pg/mL",
        "range": "p-tau217 low risk: <0.4 pg/mL | High risk: >1.0 pg/mL",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "HPA-Axis Resilience Index",
        "desc": "Combined cortisol, ACTH, and adrenal reserve markers reflecting hypothalamic-pituitary-adrenal function. Predicts stress resilience, post-traumatic recovery capacity, and treatment response in anxiety and depression.",
        "markers": [
          "cortisol AM",
          "ACTH (adrenocorticotropic hormone)",
          "DHEA-S",
          "aldosterone",
          "salivary cortisol awakening response"
        ],
        "unit": "Index 0\u2013100",
        "range": "Resilient: >65 | Vulnerable: 35\u201365 | Depleted: <35",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Gut-Brain Axis Health Score",
        "desc": "Validated blood proxies of gut microbiome health (InsideTracker methodology: hsCRP, cortisol, HDL, triglycerides, glucose, HbA1c) plus LPS and zonulin markers of intestinal permeability linked to mood disorders via vagus nerve signaling.",
        "markers": [
          "hs-CRP",
          "cortisol",
          "HDL cholesterol",
          "triglycerides",
          "fasting glucose",
          "HbA1c",
          "LPS (lipopolysaccharides)",
          "zonulin"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | Dysbiosis risk: <45",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Metabolic-Psychiatric Risk Index",
        "desc": "Insulin resistance, blood sugar dysregulation, and lipid imbalance are bidirectionally linked to depression, anxiety, and cognitive decline. Adapted from InsideTracker's metabolism + cognition cross-category scoring.",
        "markers": [
          "fasting insulin",
          "fasting glucose",
          "HbA1c",
          "HOMA-IR",
          "ApoB",
          "triglycerides",
          "HDL"
        ],
        "unit": "HOMA-IR + composite",
        "range": "HOMA-IR optimal: <1.5 | Insulin resistance: >2.5",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Oxidative Stress & Antioxidant Capacity",
        "desc": "Excessive reactive oxygen species (ROS) damage neuronal membranes and mitochondria, driving neuroinflammation, depression, and cognitive aging. Panel includes 8-OHdG, glutathione, and uric acid.",
        "markers": [
          "8-OHdG (8-hydroxy-2-deoxyguanosine)",
          "glutathione (GSH)",
          "uric acid",
          "total antioxidant capacity (TAC)",
          "superoxide dismutase (SOD)"
        ],
        "unit": "TAC \u03bcmol/L",
        "range": "Optimal: >1.1 mmol/L | Depleted: <0.8",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Sex Hormone-Mental Health Bridge",
        "desc": "Testosterone, estradiol, and progesterone fluctuations modulate serotonin, GABA, and dopamine systems. Critical for premenstrual dysphoric disorder (PMDD), postpartum depression, perimenopause mood, and male testosterone-related depression.",
        "markers": [
          "total testosterone",
          "free testosterone",
          "estradiol (E2)",
          "progesterone",
          "SHBG",
          "LH",
          "FSH"
        ],
        "unit": "Multi-hormone profile",
        "range": "E2 optimal (women): 30\u2013200 pg/mL | Testosterone (men): 400\u2013700 ng/dL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Sleep Quality Biomarker Score",
        "desc": "Blood markers correlated with deep sleep, REM quality, and sleep architecture. Inspired by InsideTracker's sleep healthspan category. Melatonin pathway markers, magnesium, and circadian cortisol profiling.",
        "markers": [
          "magnesium RBC",
          "cortisol PM (evening)",
          "melatonin (AM draw)",
          "vitamin D",
          "glucose",
          "TSH"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | Poor sleep biology: <45",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Polygenic Depression & Anxiety Risk",
        "desc": "Multi-locus genetic risk score aggregating 100+ validated SNPs across serotonin transporter (5-HTTLPR), BDNF Val66Met, COMT Val158Met, FKBP5, CRHR1, and other stress-response and neurotransmitter genes.",
        "markers": [
          "5-HTTLPR (SLC6A4)",
          "BDNF Val66Met",
          "COMT Val158Met",
          "FKBP5 rs1360780",
          "CRHR1 haplotype",
          "MAOA uVNTR",
          "TPH2 SNPs",
          "HTR2A rs6311"
        ],
        "unit": "PRS percentile",
        "range": "Low risk: <40th percentile | High risk: >80th percentile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Neurotransmitter Metabolism Genotype",
        "desc": "MTHFR, COMT, MAO-A/B, and CBS gene variants affecting methylation, serotonin/dopamine breakdown, and folate-homocysteine cycle \u2014 the genetic backbone of psychiatric vulnerability and psychotropic drug response.",
        "markers": [
          "MTHFR C677T",
          "MTHFR A1298C",
          "COMT rs4680",
          "MAO-A rs6323",
          "MAO-B rs1799836",
          "CBS rs234706",
          "BHMT rs3733890"
        ],
        "unit": "Genotype call",
        "range": "Risk: homozygous MTHFR TT or COMT met/met",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "APOE & Neurodegeneration Risk Score",
        "desc": "APOE \u03b54 genotyping combined with CLU, CR1, PICALM, and BIN1 polygenic risk for late-onset Alzheimer's. APOE \u03b54 carriers have 3\u201312\u00d7 elevated risk. Critical for proactive brain health planning.",
        "markers": [
          "APOE \u03b52/\u03b53/\u03b54",
          "CLU rs11136000",
          "CR1 rs3818361",
          "PICALM rs3851179",
          "BIN1 rs744373",
          "TOMM40 poly-T"
        ],
        "unit": "Risk tier (\u03b52/\u03b53/\u03b54)",
        "range": "\u03b53/\u03b53: average | \u03b53/\u03b54: 3\u00d7 | \u03b54/\u03b54: 8\u201312\u00d7",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Stress Resilience & PTSD Genetic Profile",
        "desc": "Genetic variants in glucocorticoid receptor (NR3C1), FKBP5, CRHR1, and neuropeptide Y pathways that determine individual variation in stress sensitivity, trauma recovery, and resilience to adverse childhood experiences.",
        "markers": [
          "NR3C1 BclI polymorphism",
          "FKBP5 rs1360780",
          "CRHR1 haplotype",
          "NPY rs16139",
          "PACAP rs2267735",
          "RORA rs4774388"
        ],
        "unit": "Resilience tier",
        "range": "High resilience | Average | Sensitized stress response",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Validated Mental Health Risk Assessment",
        "desc": "Standardized psychometric tools (PHQ-9, GAD-7, PSQI, PSS-10) combined with adverse life events, sleep diary, and substance use questionnaire producing clinical-grade mental health risk stratification.",
        "markers": [
          "PHQ-9 score",
          "GAD-7 score",
          "PSQI sleep quality score",
          "PSS-10 stress score",
          "adverse life events",
          "substance use",
          "social support index"
        ],
        "unit": "Multi-scale composite",
        "range": "PHQ-9: <5 minimal | 5\u201314 moderate | \u226515 severe",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Circadian Disruption & Sleep Chronotype",
        "desc": "Lifestyle questionnaire mapping sleep timing, circadian misalignment (social jetlag), light exposure, and shift work patterns \u2014 major modifiable drivers of mood disorders, metabolic dysfunction, and cognitive decline.",
        "markers": [
          "chronotype (MEQ score)",
          "sleep midpoint",
          "social jetlag hours",
          "light exposure score",
          "screen time evening",
          "caffeine timing"
        ],
        "unit": "Circadian score",
        "range": "Aligned: score >70 | Moderate misalignment | Severely misaligned: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "HRV-Based Stress & Recovery Index",
        "desc": "Heart rate variability (RMSSD, SDNN) and resting heart rate as objective psychophysiological markers of autonomic nervous system balance, stress burden, and mental recovery quality \u2014 validated against cortisol and burnout scales.",
        "markers": [
          "RMSSD (ms)",
          "SDNN (ms)",
          "resting HR",
          "HRV trend 30-day",
          "stress score",
          "recovery score"
        ],
        "unit": "RMSSD ms + Score",
        "range": "Optimal RMSSD: >60 ms | Stressed: <30 ms",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture & Restorative Sleep Score",
        "desc": "Deep sleep (N3) percentage, REM latency, sleep efficiency, and nocturnal HRV from wearable device correlated with cognitive performance, emotional regulation, and mood stability next-day.",
        "markers": [
          "deep sleep %",
          "REM %",
          "sleep efficiency",
          "sleep latency (min)",
          "nocturnal HRV",
          "awakenings/night"
        ],
        "unit": "Sleep score 0\u2013100",
        "range": "Optimal: >80 | Poor: <55 | Deep sleep: ideal >15%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Brain Epigenetic Age (DNAmAge)",
        "desc": "DNA methylation-based biological age clocks (Horvath, GrimAge, PhenoAge) applied to brain-relevant CpG sites. GrimAge is the strongest predictor of mortality and cognitive aging; acceleration >3 years indicates elevated risk.",
        "markers": [
          "Horvath clock age",
          "GrimAge",
          "PhenoAge",
          "DNAmPhenoAge acceleration",
          "GrimAge acceleration",
          "DunedinPACE aging rate"
        ],
        "unit": "Biological age (years)",
        "range": "Ideal: chronological age | Concern: >3 years accelerated",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Stress Epigenome & Trauma Methylation",
        "desc": "Methylation patterns at NR3C1 (glucocorticoid receptor), FKBP5, and BDNF promoters that are modified by chronic stress, early adversity, and trauma \u2014 providing an epigenetic readout of the lived stress history.",
        "markers": [
          "NR3C1 promoter methylation",
          "FKBP5 intron 7 methylation",
          "BDNF promoter methylation",
          "SLC6A4 methylation",
          "OXTR methylation"
        ],
        "unit": "Methylation %",
        "range": "NR3C1 hypermethylation \u2192 HPA hyper-reactivity",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_16s",
        "name": "Gut-Brain Microbiome Mental Health Index",
        "desc": "Microbiome diversity, Lactobacillus/Bifidobacterium abundance, and dysbiosis markers linked to the gut-brain axis. Low Firmicutes:Bacteroidetes ratio and reduced SCFA producers correlate with depression and anxiety in clinical studies.",
        "markers": [
          "Shannon diversity index",
          "Lactobacillus spp. abundance",
          "Bifidobacterium spp. abundance",
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia muciniphila %",
          "SCFA-producing bacteria %",
          "Prevotella spp."
        ],
        "unit": "Diversity + dysbiosis score",
        "range": "Shannon diversity optimal: >3.5 | Dysbiosis: <2.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "micro_wgs",
        "name": "Psychobiotic Functional Profile",
        "desc": "Metagenomics quantification of GABA-producing bacteria (Lactobacillus rhamnosus), serotonin-pathway microbes, and neurotransmitter precursor synthesis genes (aromatic amino acid decarboxylase pathways) in the gut.",
        "markers": [
          "GABA-producing taxa (L. rhamnosus, L. brevis)",
          "tryptophan-catabolizing taxa",
          "aromatic amino acid decarboxylase genes",
          "kynurenine pathway microbes",
          "LPS-producing bacteria (endotoxin burden)"
        ],
        "unit": "Functional gene count",
        "range": "High psychobiotic richness vs. pro-inflammatory profile",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Precision Psychiatry Supplement Protocol",
        "desc": "Evidence-based nutraceutical protocol for mental health from client catalog, personalized by neurotransmitter genetics and biomarkers: methylfolate (MTHFR carriers with depression), omega-3 EPA (neuroinflammation index), saffron extract (serotonin), ashwagandha (cortisol), magnesium glycinate (anxiety/sleep), and probiotics for gut-brain axis.",
        "markers": [
          "MTHFR genotype",
          "omega-3 index",
          "cortisol AM",
          "Trp:LNAA ratio",
          "magnesium RBC",
          "gut-brain axis score",
          "NLR",
          "hs-CRP"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Mental Wellness Program",
        "desc": "Structured lifestyle-based mental health intervention: exercise protocol (aerobic \u2192 BDNF upregulation, matched to depression PGS), sleep architecture optimization, circadian realignment program, stress resilience practices (HRV biofeedback intensity by autonomic baseline), and social prescribing guide.",
        "markers": [
          "PHQ-9 score",
          "HRV baseline",
          "sleep efficiency",
          "BDNF Val66Met",
          "circadian misalignment score",
          "cortisol AM",
          "FKBP5 genotype"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Gut-Brain Axis Restoration Protocol",
        "desc": "Targeted microbiome intervention to improve gut-brain signaling: psychobiotic selection (L. rhamnosus, B. longum \u2014 by gut microbiome profile), dietary fiber and prebiotic plan, elimination of gut permeability triggers identified by individual profile, and fermented food recommendations.",
        "markers": [
          "gut-brain microbiome score",
          "Lactobacillus spp.",
          "GABA-producing bacteria",
          "Shannon diversity",
          "zonulin",
          "LPS",
          "tryptophan-catabolizing taxa"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      }
    ]
  },
  {
    "id": "precision_medicine",
    "name": "Precision Medicine",
    "sub": "Disease Risk \u00b7 Pharmacogenomics \u00b7 Chronic Disease \u00b7 Exome Diagnostics",
    "color": "#0f4c8a",
    "lt": "#e8f0fb",
    "img": "https://images.unsplash.com/photo-1576671081837-49000212a370?w=320&q=75",
    "desc": "The most comprehensive genomic medicine vertical on the platform. Integrates polygenic disease risk across 17 clinical organ systems, full pharmacogenomics (192 drug-gene interactions), chronic disease management, and exome-level rare variant diagnostics \u2014 enabling truly individualized prevention, treatment selection, and drug dosing.",
    "tags": [
      "Disease Risk Scoring",
      "Pharmacogenomics",
      "Chronic Disease Management",
      "Cancer Genetics",
      "Cardiovascular Genomics",
      "Neurogenomics",
      "Rare Disease Exome",
      "Drug Efficacy & Toxicity",
      "Metabolic Disease",
      "Women's Health Genomics",
      "Autoimmune",
      "Musculoskeletal",
      "Respiratory",
      "Mental Health Genomics",
      "Exome+ Clinical Panels"
    ],
    "insights": [
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Cardiovascular Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores across 24 circulatory conditions including coronary atherosclerosis, heart attack, atrial fibrillation, hypertension, heart failure, stroke, deep vein thrombosis, and peripheral artery disease. Integrates ApoE, 9p21, LPA, and 300+ cardiovascular GWAS loci for lifetime risk stratification.",
        "markers": [
          "Acute Ischeamic Heart Disease",
          "Angina",
          "Atrial Fibrillation",
          "Cardiomyopathy",
          "Coronary Atherosclerosis",
          "Deep Vein Thrombosis",
          "Gestational Hypertension",
          "Heart Attack Myocardial Infarction",
          "Heart Beat Abnormalities",
          "Heart Cardiac Problem",
          "Heart Failure Pulmonary Odema",
          "Heart Valve Problem Heart Murmur",
          "Hemorrhoids",
          "Hypertension",
          "Leg Claudication",
          "Peripheral Artery Disease",
          "Preeclampsia",
          "Raynauds Disease",
          "Rheumatic Fever",
          "Stroke",
          "Subarachnoid Hemorrhage",
          "Supraventricular Tachycardia",
          "Varicose Veins",
          "Vasculitis"
        ],
        "unit": "PRS percentile (0\u2013100th)",
        "range": "Low: <20th | Average: 20\u201380th | High: >80th | Very High: >95th",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Metabolic & Endocrine Disease Risk Score",
        "desc": "Polygenic risk scores for 16 metabolic conditions: Type 1 & 2 diabetes, hypothyroidism, hyperthyroidism, thyroiditis, thyroid goiter, gestational diabetes, high cholesterol, hepatitis, adrenal insufficiency, diabetic neuropathy, and diabetic retinopathy. TCF7L2, KCNJ11, PPARG and 400+ T2DM loci.",
        "markers": [
          "Adrenal Insufficiency",
          "Diabetic Neuropathy",
          "Diabetic Retinopathy",
          "Gestational Diabetes",
          "Gestational Diabetes Only During Pregnancy",
          "Hepatitis",
          "Hepatitis A",
          "High Cholesterol",
          "Hyperthyroidism",
          "Hypopituitarism",
          "Hypothyroidism",
          "Pituitary Tumor",
          "Thyroid Goiter",
          "Thyroiditis",
          "Type 1 Diabetes",
          "Type 2 Diabetes"
        ],
        "unit": "PRS percentile per condition",
        "range": "Type 2 diabetes PRS: <30th protective | >80th elevated | >95th high",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Musculoskeletal & Connective Tissue Disease Risk",
        "desc": "Polygenic risk scores for 20 MSK conditions: rheumatoid arthritis, osteoporosis, gout, ankylosing spondylitis, osteoarthritis, psoriatic arthritis, scoliosis, back pain, herniated disk, and connective tissue disorders. HLA-DRB1, PTPN22, TNFAIP3, and 200+ loci.",
        "markers": [
          "Ankylosing Spondylitis",
          "Arthritis",
          "Back Pain",
          "Bursitis",
          "Carpal Tunnel Syndrome",
          "Cervical Spondylosis",
          "Gout",
          "Herniated Disk",
          "Hip Fracture",
          "Mixed Connective Tissue Disease",
          "Osteoarthritis",
          "Osteomyelitis",
          "Osteoporosis",
          "Plantar Fasciitis",
          "Polymyalgia Rheumatica",
          "Rheumatoid Arthritis",
          "Sciatica",
          "Scoliosis",
          "Spinal Stenosis",
          "Tendinitis"
        ],
        "unit": "PRS percentile per condition",
        "range": "RA: >80th elevated | Osteoporosis: FRAX integration",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Chronic Disease Multimorbidity Index",
        "desc": "Composite genomic risk index quantifying probability of developing \u22652 chronic conditions simultaneously (multimorbidity). Combines PRS from cardiovascular, metabolic, musculoskeletal, respiratory, and neurological domains. High multimorbidity index triggers precision lifestyle and pharmacological prevention protocols.",
        "markers": [
          "Cardiovascular PRS",
          "Metabolic PRS",
          "Musculoskeletal PRS",
          "Respiratory PRS",
          "Neurological PRS",
          "Inflammatory load index",
          "HLA haplotype risk",
          "Clonal hematopoiesis variants"
        ],
        "unit": "Multimorbidity Score 0\u2013100",
        "range": "Low: <30 | Moderate: 30\u201360 | High: >60 | Extreme: >80",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "blood",
        "name": "Chronic Disease Biomarker Surveillance Panel",
        "desc": "Longitudinal blood monitoring panel for established chronic disease patients: glycemic control, lipid management, inflammatory burden, renal function, hepatic status, and thyroid tracking. Pairs with PRS for genotype-informed target ranges and medication adjustment triggers.",
        "markers": [
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "ApoB",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "creatinine",
          "eGFR",
          "cystatin-C",
          "uric acid",
          "ALT",
          "AST",
          "GGT",
          "TSH",
          "Free T4",
          "NT-proBNP",
          "fibrinogen"
        ],
        "unit": "Multi-organ composite",
        "range": "HbA1c: <5.7% optimal | ApoB: <80 mg/dL | hs-CRP: <1.0 mg/L",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "lifestyle",
        "name": "Gene-Environment Interaction Risk Assessment",
        "desc": "Integrates validated lifestyle factors (diet quality score, physical activity, smoking, alcohol, sleep quality, BMI, stress) with polygenic disease risk to compute modifiable vs. non-modifiable risk fractions. Identifies highest-leverage behavioral interventions per individual genetic profile.",
        "markers": [
          "Diet quality score (HEI/MeDi)",
          "Physical activity (MET-hours/week)",
          "Smoking status & pack-years",
          "Alcohol units/week",
          "Sleep duration & quality",
          "BMI & waist circumference",
          "Psychosocial stress score",
          "Environmental exposures"
        ],
        "unit": "Modifiable risk fraction %",
        "range": "High modifiable: >60% | Primarily genetic: <30%",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "dna_array",
        "name": "Multi-Cancer Polygenic Risk Score Panel",
        "desc": "Polygenic risk scores for 27 cancer types: breast, prostate, colorectal, lung, melanoma, ovarian, thyroid, endometrial, kidney, stomach, testicular, cervical, bladder, and hematologic malignancies. Integrates BRCA1/2-adjacent polygenic background, HER2 loci, and tissue-specific GWAS signals.",
        "markers": [
          "Basal Cell Carcinoma",
          "Bladder Cancer",
          "Bone Cancer",
          "Breast Cancer",
          "Cervical Cancer",
          "Chronic Lymphocytic Leukemia",
          "Colon Cancer",
          "Endometrial Cancer",
          "Esophageal Cancer",
          "Hodgkins Lymphoma",
          "Kidney Cancer",
          "Leukemia",
          "Lung Cancer",
          "Melanoma",
          "Multiple Myeloma",
          "Non Hodgkins Lymphoma",
          "Nonmelanoma Skin Cancer",
          "Ovarian Cancer",
          "Prostate Cancer",
          "Rectal Cancer",
          "Sarcoma",
          "Skin Cancer",
          "Squamous Cell Carcinoma",
          "Stomach Cancer",
          "Testicular Cancer",
          "Throat Cancer",
          "Thyroid Cancer"
        ],
        "unit": "PRS percentile per cancer type",
        "range": "High risk: >90th percentile | Very high: >95th | Actionable: BRCA-equivalent risk",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "dna_exome",
        "name": "Hereditary Cancer Syndrome Exome Panel",
        "desc": "Clinical-grade exome analysis of 0+ pathogenic variants across BRCA1, BRCA2, PALB2, CHEK2, ATM, MLH1, MSH2, MSH6, PMS2 (Lynch syndrome), APC, PTEN, TP53, RET, VHL, MEN1, CDKN2A, and 70+ hereditary cancer genes. ACMG Tier I reportable.",
        "markers": [
          "BRCA1 pathogenic variants",
          "BRCA2 pathogenic variants",
          "PALB2",
          "CHEK2 c.1100delC",
          "ATM",
          "MLH1 (Lynch)",
          "MSH2 (Lynch)",
          "MSH6 (Lynch)",
          "PMS2 (Lynch)",
          "APC (FAP)",
          "PTEN (Cowden)",
          "TP53 (Li-Fraumeni)",
          "RET (MEN2)",
          "VHL",
          "MEN1",
          "CDKN2A",
          "STK11",
          "SMAD4"
        ],
        "unit": "Pathogenic/Likely Pathogenic variant call",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "blood",
        "name": "Cancer Risk & Early Detection Biomarker Panel",
        "desc": "Blood-based cancer risk and surveillance markers: PSA for prostate, CA-125 for ovarian, CEA for colorectal, AFP for liver, CA 19-9 for pancreatic, and ctDNA methylation markers for multi-cancer early detection (MCED). Complements genomic risk scoring with phenotypic surveillance.",
        "markers": [
          "PSA (prostate-specific antigen)",
          "CEA (carcinoembryonic antigen)",
          "CA-125",
          "AFP (alpha-fetoprotein)",
          "CA 19-9",
          "LDH",
          "beta-hCG",
          "CA 15-3",
          "calcitonin",
          "ctDNA methylation (MCED)",
          "NfL (neuroblastoma proxy)"
        ],
        "unit": "ng/mL per marker",
        "range": "PSA: <4.0 ng/mL | CEA: <2.5 ng/mL | CA-125: <35 U/mL",
        "tier": "comprehensive",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Cardiovascular Drugs",
        "desc": "Pharmacogenomic guidance for 34 drug interactions in cardiovascular drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Candesartan, Atenolol, Rosuvastatin, Irbesartan, Chlorthalidone, Hydrochlorothiazide. Genes: CYP2C9, VKORC1, CYP2C19, SLCO1B1, ABCB1 and more.",
        "markers": [
          "CYP2C9",
          "VKORC1",
          "CYP2C19",
          "SLCO1B1",
          "ABCB1",
          "ACE I/D",
          "AGT M235T",
          "ADD1 460W",
          "CYP3A5",
          "Ace Inhibitors Efficacy",
          "Ace Inhibitors Toxicity",
          "Amiodarone Toxicity",
          "Amlodipine Efficacy",
          "Aspirin Efficacy",
          "Aspirin Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Oncology Drugs",
        "desc": "Pharmacogenomic guidance for 47 drug interactions in oncology drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Gemcitabine, Cetuximab, Carboplatin, Doxorubicin, Sorafenib, Cytarabine. Genes: DPYD (fluorouracil), UGT1A1 (irinotecan), CYP2D6 (tamoxifen), ERCC1, GSTP1 and more.",
        "markers": [
          "DPYD (fluorouracil)",
          "UGT1A1 (irinotecan)",
          "CYP2D6 (tamoxifen)",
          "ERCC1",
          "GSTP1",
          "TP53",
          "KRAS",
          "BRAF V600E",
          "HER2/ERBB2",
          "MLH1 (capecitabine)",
          "TPMT (mercaptopurine)",
          "Anastrozole Toxicity",
          "Bevacizumab Efficacy",
          "Bevacizumab Toxicity",
          "Bleomycin Toxicity",
          "Capecitabine Efficacy",
          "Capecitabine Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Psychiatric & Neuro Drugs",
        "desc": "Pharmacogenomic guidance for 36 drug interactions in psychiatric & neuro drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Aripiprazole, Clozapine, Venlafaxine, Haloperidol, Amitriptyline, Phenytoin. Genes: CYP2D6, CYP2C19, CYP3A4, SLC6A4 (SSRI response), HTR2A and more.",
        "markers": [
          "CYP2D6",
          "CYP2C19",
          "CYP3A4",
          "SLC6A4 (SSRI response)",
          "HTR2A",
          "COMT Val158Met",
          "ABCB1",
          "HLA-A*31:01 (carbamazepine)",
          "HLA-B*15:02",
          "Amitriptyline Efficacy",
          "Aripiprazole Efficacy",
          "Aripiprazole Toxicity",
          "Bupropion Efficacy",
          "Bupropion Toxicity",
          "Carbamazepine Dosage"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Pain & Opioids",
        "desc": "Pharmacogenomic guidance for 16 drug interactions in pain & opioids. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Oxycodone, Acetaminophen, Buprenorphine, Tramadol, Morphine, Methadone. Genes: CYP2D6 (codeine/tramadol), OPRM1 A118G, COMT Val158Met, CYP3A4, UGT2B7 and more.",
        "markers": [
          "CYP2D6 (codeine/tramadol)",
          "OPRM1 A118G",
          "COMT Val158Met",
          "CYP3A4",
          "UGT2B7",
          "ABCB1",
          "Acetaminophen Efficacy",
          "Acetaminophen Toxicity",
          "Buprenorphine Efficacy",
          "Buprenorphine Toxicity",
          "Fentanyl Dosage",
          "Fentanyl Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Immunosuppressants",
        "desc": "Pharmacogenomic guidance for 15 drug interactions in immunosuppressants. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Corticosteroids, Rituximab, Tocilizumab, Tumor Necrosis Factor Alpha Inhibitors, Tacrolimus, Dexamethasone. Genes: CYP3A5 *1/*3, ABCB1, TPMT, NUDT15, UGT1A9 and more.",
        "markers": [
          "CYP3A5 *1/*3",
          "ABCB1",
          "TPMT",
          "NUDT15",
          "UGT1A9",
          "HLA-DRB1",
          "Adalimumab Efficacy",
          "Corticosteroids Efficacy",
          "Cyclosporine Dosage",
          "Cyclosporine Efficacy",
          "Cyclosporine Toxicity",
          "Dexamethasone Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Diabetes Drugs",
        "desc": "Pharmacogenomic guidance for 2 drug interactions in diabetes drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Metformin, Repaglinide. Genes: SLC22A1 (metformin), KCNJ11, TCF7L2, PPARG and more.",
        "markers": [
          "SLC22A1 (metformin)",
          "KCNJ11",
          "TCF7L2",
          "PPARG",
          "Metformin Efficacy",
          "Repaglinide Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Antiviral & Antibiotic",
        "desc": "Pharmacogenomic guidance for 8 drug interactions in antiviral & antibiotic. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Ribavirin. Genes: HLA-B*57:01 (abacavir), CYP2B6 (efavirenz), UGT1A1 (atazanavir), NAT2 (rifampin), HLA-B*35:01 and more.",
        "markers": [
          "HLA-B*57:01 (abacavir)",
          "CYP2B6 (efavirenz)",
          "UGT1A1 (atazanavir)",
          "NAT2 (rifampin)",
          "HLA-B*35:01",
          "Atazanavir Toxicity",
          "Efavirenz Toxicity",
          "Ethambutol Toxicity",
          "Nevirapine Toxicity",
          "Ribavirin Efficacy",
          "Ribavirin Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Hair & Dermatology Drugs",
        "desc": "Pharmacogenomic guidance for 13 drug interactions in hair & dermatology drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: . Genes: SRD5A2 (finasteride), CYP3A4, PTGDR2, IGF1R, FGF5 and more.",
        "markers": [
          "SRD5A2 (finasteride)",
          "CYP3A4",
          "PTGDR2",
          "IGF1R",
          "FGF5",
          "Biotin Deficiency",
          "Collagen Stability",
          "Dutasteride Effectiveness",
          "Dutasteride Metabolism",
          "Estradiol Effectiveness",
          "Finasteride Effectiveness"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Respiratory Drugs",
        "desc": "Pharmacogenomic guidance for 3 drug interactions in respiratory drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Montelukast, Salbutamol. Genes: ADRB2 (salbutamol), CYP2C8 (montelukast), LTC4S and more.",
        "markers": [
          "ADRB2 (salbutamol)",
          "CYP2C8 (montelukast)",
          "LTC4S",
          "Montelukast Efficacy",
          "Salbutamol Efficacy",
          "Cetirizine Effectiveness"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Anticoagulants",
        "desc": "Pharmacogenomic guidance for 7 drug interactions in anticoagulants. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Prasugrel, Clopidogrel, Warfarin, Acenocoumarol. Genes: CYP2C9 *2/*3, VKORC1 -1639G>A, CYP4F2 V433M, GGCX and more.",
        "markers": [
          "CYP2C9 *2/*3",
          "VKORC1 -1639G>A",
          "CYP4F2 V433M",
          "GGCX",
          "Acenocoumarol Dosage",
          "Clopidogrel Efficacy",
          "Clopidogrel Toxicity",
          "Prasugrel Efficacy",
          "Warfarin Dosage",
          "Warfarin Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "Pharmacogenomics Master Profile (192 Drugs)",
        "desc": "Complete pharmacogenomics report covering all 192 drug-gene interactions in the Lifenome database across 10 drug classes. Generates a prescribing guidance table for clinicians showing predicted metabolizer phenotype, recommended dose adjustments, contraindications, and alternative drug suggestions. Powered by CPIC, PharmGKB, and FDA PGx guidelines.",
        "markers": [
          "CYP2D6 genotype & phenotype",
          "CYP2C9 *1\u2013*8",
          "CYP2C19 *1\u2013*17",
          "CYP3A4/3A5",
          "VKORC1 -1639G>A",
          "DPYD *2A/*13",
          "TPMT *2/*3C",
          "UGT1A1 *28/*6",
          "SLCO1B1 *5",
          "HLA-B*57:01",
          "HLA-B*15:02",
          "HLA-A*31:01",
          "OPRM1 A118G",
          "SLC22A1",
          "ABCB1 C3435T"
        ],
        "unit": "Clinical action score (CPIC) + phenotype",
        "range": "No action | Prescribing alert | Contraindicated | Dose adjust required",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_array",
        "name": "Neurological Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 15 neurological conditions: Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, essential tremor, myasthenia gravis, peripheral neuropathy, brain aneurysm, and Guillain-Barr\u00e9 syndrome. APOE \u03b54, LRRK2, SNCA, C9orf72, and 500+ GWAS loci.",
        "markers": [
          "Alzheimers Disease",
          "Bells Palsy",
          "Benign Peripheral Nerve Tumor",
          "Brain Aneurysm",
          "Cerebral Palsy",
          "Encephalitis",
          "Epilepsy",
          "Essential Tremor Benign",
          "Guillain Barre Syndrome",
          "Intracranial Hematoma",
          "Migraine",
          "Multiple Sclerosis",
          "Myasthenia Gravis",
          "Parkinsons Disease",
          "Peripheral Neuropathy"
        ],
        "unit": "PRS percentile per condition",
        "range": "Alzheimer's APOE \u03b54/\u03b54: 8\u201312\u00d7 risk | Parkinson's LRRK2 G2019S carrier",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_array",
        "name": "Psychiatric Disease Genomic Risk Panel",
        "desc": "Polygenic risk scores for 11 psychiatric and behavioral conditions: depression, bipolar disorder, schizophrenia, PTSD, panic disorder, postpartum depression, eating disorders, fibromyalgia, chronic fatigue, insomnia, and sleep apnea. SCN1A, CACNA1C, TCF4, DISC1, and 200+ psychiatric GWAS loci.",
        "markers": [
          "Bipolar Disorder",
          "Chronic Fatigue Syndrome",
          "Depression",
          "Eating Disorders",
          "Fibromyalgia",
          "Insomnia",
          "Panic Attacks Disorder",
          "Post Traumatic Stress Disorder",
          "Postpartum Depression",
          "Schizophrenia",
          "Sleep Apnea"
        ],
        "unit": "PRS percentile per condition",
        "range": "Schizophrenia PRS >90th: 3\u00d7 population risk | Bipolar >85th: elevated",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_wgs",
        "name": "Neurological Exome \u2014 Rare Variant Diagnostics",
        "desc": "Clinical exome analysis of 48+ rare pathogenic variants across 27 neurological panels: spinal muscular atrophy, ALS, Charcot-Marie-Tooth, epileptic encephalopathy, neuromuscular disorders, hereditary spastic paraplegia, mitochondrial disease, and 27 rare neurological panel categories.",
        "markers": [
          "SMN1/SMN2 (SMA)",
          "SOD1/TDP-43/FUS (ALS)",
          "C9orf72 repeat expansion",
          "LRRK2/SNCA (Parkinson's)",
          "SCN1A (Dravet syndrome)",
          "KCNQ2/3 (epilepsy)",
          "PMP22/MPZ (CMT)",
          "MAPT/GRN (FTD)",
          "HTT CAG repeat (Huntington)",
          "PSEN1/PSEN2/APP (early AD)",
          "MECP2 (Rett syndrome)",
          "FMR1 (Fragile X)",
          "DMPK (myotonic dystrophy)"
        ],
        "unit": "Pathogenic variant call (ACMG 5-tier)",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "dna_array",
        "name": "Female Reproductive & Breast Health Genetic Risk",
        "desc": "Polygenic risk scores for 19 female health conditions: endometriosis, polycystic ovary syndrome (PCOS), premature/early menopause, female infertility, uterine fibroids, breast conditions, ovarian dysfunction, miscarriage risk, gestational hypertension, and preeclampsia. BRCA-context PRS, FSHR, ESR1, and WNT4 loci.",
        "markers": [
          "Breast Cysts",
          "Breast Fibroadenoma",
          "Breast Lumps",
          "Cervical Polyps",
          "Dysmenorrhea",
          "Early Menopause",
          "Ectopic Pregnancy",
          "Endometriosis",
          "Female Infertility",
          "Fibrocystic Breasts",
          "Menorrhagia",
          "Miscarriage",
          "Ovarian Dysfunction",
          "Polycystic Ovary Syndrome",
          "Postmenopausal Osteoporosis",
          "Premature Menopause",
          "Uterine Fibroids",
          "Uterine Polyps",
          "Uterine Prolapse"
        ],
        "unit": "PRS percentile per condition",
        "range": "PCOS: >80th elevated | Endometriosis: >85th elevated | Early menopause: FOXL2",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "dna_array",
        "name": "Menstrual & Hormonal Cycle Genomic Profile",
        "desc": "Genetic determinants of menstrual cycle regulation, hormone sensitivity, and cycle-related symptoms. SHBG, ESR1, PGR, and FSHR variants predicting estrogen dominance, progesterone resistance, premenstrual dysphoria (PMDD), pain sensitivity (COMT), and response to hormonal therapy.",
        "markers": [
          "SHBG (rs727428)",
          "ESR1 (rs2234693)",
          "PGR PROGINS allele",
          "FSHR (rs6166)",
          "COMT Val158Met (pain)",
          "OPRM1 A118G",
          "CYP19A1 (aromatase)",
          "MAOA uVNTR",
          "FKBP5 rs1360780"
        ],
        "unit": "Risk tier per phenotype",
        "range": "Estrogen dominance risk | PMDD risk | Hormone therapy benefit score",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "blood",
        "name": "Hormonal & Reproductive Biomarker Panel",
        "desc": "Comprehensive hormonal blood panel for reproductive health monitoring: fertility hormones, thyroid function, adrenal status, and metabolic markers that modulate female hormone balance. Designed to pair with PRS for personalized reproductive health planning.",
        "markers": [
          "FSH",
          "LH",
          "AMH (anti-M\u00fcllerian hormone)",
          "estradiol (E2)",
          "progesterone",
          "total testosterone",
          "free testosterone",
          "SHBG",
          "prolactin",
          "TSH",
          "Free T4",
          "DHEA-S",
          "cortisol AM",
          "fasting insulin",
          "25-OH Vitamin D",
          "hs-CRP"
        ],
        "unit": "Hormone panel (mIU/mL, pg/mL, ng/mL)",
        "range": "AMH: >1.0 ng/mL good reserve | FSH day 3: <10 mIU/mL | E2: 25\u201375 pg/mL",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "dna_array",
        "name": "Gastrointestinal Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 22 GI conditions: Crohn's disease, ulcerative colitis, celiac disease, IBS, GERD, pancreatitis, H. pylori susceptibility, peptic ulcer, diverticulosis, and hepatic diseases. NOD2, IL23R, HLA-DQ2/DQ8, ATG16L1, and 300+ IBD GWAS loci.",
        "markers": [
          "Acute Liver Failure",
          "Anal Fissure",
          "Appendicitis",
          "Celiac Disease",
          "Cholecystitis",
          "Constipation",
          "Crohns Disease",
          "Functional Dyspepsia",
          "Gastritis",
          "Gastroesophageal Reflux Disease",
          "Gastrointestinal Bleeding",
          "Helicobacter Pylori Infection",
          "Hiatal Hernia",
          "Inguinal Hernia",
          "Intestinal Obstruction",
          "Irritable Bowel Syndrome",
          "Pancreatitis",
          "Peptic Ulcer",
          "Peritonitis",
          "Rectal Prolapse",
          "Ulcerative Colitis",
          "Umbilical Hernia"
        ],
        "unit": "PRS percentile per condition",
        "range": "IBD (Crohn's/UC): >85th elevated | Celiac: HLA-DQ2/DQ8 required",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "micro_16s",
        "name": "Gut Microbiome Disease Association Panel",
        "desc": "16S microbiome analysis linking dysbiosis patterns to GI disease risk: reduced Faecalibacterium prausnitzii in IBD, Helicobacter pylori detection, SIBO-associated taxa, and reduced diversity markers in IBS and colorectal cancer risk. Generates targeted probiotic and dietary intervention plan.",
        "markers": [
          "Faecalibacterium prausnitzii %",
          "Helicobacter pylori detection",
          "Fusobacterium nucleatum (CRC marker)",
          "Ruminococcus gnavus (IBD)",
          "Bacteroides fragilis",
          "Prevotella copri (RA association)",
          "Shannon diversity index",
          "Butyrate producer abundance",
          "Firmicutes:Bacteroidetes ratio"
        ],
        "unit": "Relative abundance % + diversity score",
        "range": "F. prausnitzii: optimal >5% | H. pylori: negative | Shannon: >3.5",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "blood",
        "name": "Gut Inflammation & Permeability Biomarkers",
        "desc": "Blood markers of intestinal inflammation, permeability, and hepatic stress: calprotectin pathway proteins, zonulin, LPS/endotoxemia markers, liver enzymes, and celiac antibodies. Enables monitoring of IBD activity, leaky gut, and NAFLD progression.",
        "markers": [
          "calprotectin (fecal proxy \u2014 serum IL-6)",
          "zonulin",
          "LPS-binding protein (LBP)",
          "anti-tissue transglutaminase IgA (tTG-IgA)",
          "anti-endomysial antibody",
          "hs-CRP",
          "ALT",
          "AST",
          "GGT",
          "total bilirubin",
          "albumin",
          "alkaline phosphatase",
          "fecal lactoferrin (proxy \u2014 fecal test add-on)"
        ],
        "unit": "IU/mL, mg/L",
        "range": "tTG-IgA: <4 U/mL normal | Zonulin: <22 ng/mL | LBP: <5 \u03bcg/mL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "dna_array",
        "name": "Autoimmune & Allergy Polygenic Risk Panel",
        "desc": "Polygenic risk scores for 12 immune conditions: lupus, Sj\u00f6gren's syndrome, anaphylaxis, hay fever/allergic rhinitis, house dust mite allergy, sarcoidosis, thrombocytopenia, iron deficiency anemia, and pernicious anemia. Plus 23 sensitivity traits: food allergies (nuts, dairy, shellfish), indoor/outdoor allergies, physiological sensitivities, and chemical sensitivities. HLA-DRB1, PTPN22, STAT4, IRF5 loci.",
        "markers": [
          "Allergy Anaphylactic Reaction Drug",
          "Allergy Anaphylactic Reaction Food",
          "Allergy House Dust Mite",
          "Allergy Hypersensitivity Anaphylaxis",
          "Hayfever Allergic Rhinitis",
          "Lupus",
          "Sjogrens Sicca Syndrome",
          "Anemia",
          "Iron Deficiency Anemia",
          "Pernicious Anemia",
          "Sarcoidosis",
          "Thrombocytopenia",
          "Allergy Eggs",
          "Allergy Milk",
          "Allergy Peanuts",
          "General Food Sensitivities",
          "Gluten Sensitivity",
          "Lactose Intolerance",
          "Allergy Cockroaches",
          "Allergy Dust Mites"
        ],
        "unit": "PRS percentile + allergy risk tier",
        "range": "Lupus: >85th elevated | Anaphylaxis risk: actionable at >90th",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "blood",
        "name": "Comprehensive Autoimmune & Immune Panel",
        "desc": "Full blood panel for autoimmune surveillance and immune function: ANA screen, specific autoantibodies, immunoglobulin levels, complement proteins, and complete blood count with differential. Function Health data shows 23% of individuals have elevated autoimmune antibodies with no symptoms.",
        "markers": [
          "ANA screen (IIF)",
          "ANA pattern",
          "anti-dsDNA (lupus)",
          "anti-Sm",
          "anti-SSA/SSB (Sj\u00f6gren's)",
          "anti-CCP (RA)",
          "RF (rheumatoid factor)",
          "anti-TPO",
          "anti-TgAb",
          "C3 complement",
          "C4 complement",
          "IgA",
          "IgG",
          "IgM",
          "IgE (total)",
          "CBC with differential",
          "eosinophil count",
          "basophil count"
        ],
        "unit": "Titer / IU/mL per antibody",
        "range": "ANA: negative | anti-dsDNA: <30 IU/mL | IgE total: <100 IU/mL",
        "tier": "comprehensive",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "dna_wgs",
        "name": "Immunological Rare Variant Panel (Exome+)",
        "desc": "Clinical exome analysis across immunological conditions: severe-combined-immunodeficiency, primary-immunodeficiency-(pid)-and-primary-ciliary-dyskinesia-(pcd), complement-system-disorder panels covering 218 rare immune conditions including primary immunodeficiencies, autoinflammatory syndromes, and complement deficiencies.",
        "markers": [
          "RAG1/RAG2 (SCID)",
          "MEFV (familial Mediterranean fever)",
          "NLRP3 (CAPS)",
          "ADA (adenosine deaminase)",
          "BTK (X-linked agammaglobulinemia)",
          "AIRE (APECED)",
          "DOCK8",
          "PIK3CD/PIK3R1",
          "LRBA",
          "CTLA4"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "dna_array",
        "name": "Respiratory Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 12 respiratory conditions: asthma, COPD, emphysema, interstitial lung disease, pulmonary embolism, bronchitis, sinusitis, nasal polyps, and pleurisy. ORMDL3, IL13, GSDMB (asthma), SERPINA1 (COPD/alpha-1-antitrypsin), and 150+ respiratory GWAS loci.",
        "markers": [
          "Asthma",
          "Bronchitis",
          "Chronic Obstructive Pulmonary Disease",
          "Chronic Sinusitis",
          "Emphysema",
          "Interstitial Lung Disease",
          "Nasal Polyps",
          "Pleurisy",
          "Pneumonia",
          "Pulmonary Embolism",
          "Respiratory Infection Unspecified Acute Lower",
          "Whooping Cough"
        ],
        "unit": "PRS percentile per condition",
        "range": "Asthma: >80th elevated | COPD: SERPINA1 ZZ-genotype critical",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "dna_wgs",
        "name": "Pulmonary Rare Disease Exome Panel",
        "desc": "Clinical exome analysis across 3 pulmonary panels covering 12 rare lung conditions. Includes cystic fibrosis (CFTR), primary ciliary dyskinesia, alpha-1 antitrypsin deficiency, surfactant protein deficiencies, and hereditary pulmonary arterial hypertension (BMPR2).",
        "markers": [
          "CFTR (all 2,000+ variants)",
          "SERPINA1 *S/*Z alleles",
          "BMPR2/ACVRL1/ENG (PAH)",
          "SFTPB/SFTPC (surfactant)",
          "DNAI1/DNAI2/DNAH5 (PCD)",
          "SLC34A2 (pulmonary alveolar microlithiasis)"
        ],
        "unit": "Pathogenic variant call",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "wearable",
        "name": "Respiratory & Cardiopulmonary Function Monitoring",
        "desc": "Continuous wearable monitoring for respiratory health: SpO2 (blood oxygen saturation), respiratory rate variability, nocturnal breathing patterns, apnea-hypopnea events (sleep apnea screening), and VO2max as cardiopulmonary capacity marker.",
        "markers": [
          "SpO2 (% oxygen saturation)",
          "respiratory rate (breaths/min)",
          "respiratory rate variability",
          "apnea events/night (AHI proxy)",
          "VO2max estimate",
          "nocturnal SpO2 nadir",
          "exertional SpO2 drop"
        ],
        "unit": "SpO2 % + respiratory rate",
        "range": "SpO2 optimal: \u226597% | AHI proxy: <5/hr normal | VO2max: age/sex normalized",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Cardiogenomics & Structural Heart Disease",
        "src": "dna_exome",
        "name": "Hereditary Cardiovascular Exome Panel",
        "desc": "Clinical exome analysis across 11 cardiology panels: marfan-syndrome, cardiomyopathy, hyperlipidemia-core, congenital-structural-heart-disease, short-qt-syndrome-(sqts), and more. Covers 307 rare pathogenic variants for inherited cardiomyopathies, channelopathies, aortopathies, arrhythmias, and lipid disorders. ACMG Tier I reportable variants.",
        "markers": [
          "MYBPC3 (HCM)",
          "MYH7 (HCM/DCM)",
          "LDLR/APOB/PCSK9 (FH)",
          "SCN5A (Brugada/LQTS)",
          "KCNQ1/KCNH2 (LQTS)",
          "PKP2 (ARVC)",
          "FBN1/FBN2 (Marfan/aortopathy)",
          "TNNT2/TPM1 (cardiomyopathy)",
          "RYR2 (CPVT)",
          "LMNA (dilated CM)",
          "TTR (transthyretin amyloid)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Cardiogenomics & Structural Heart Disease",
        "src": "blood",
        "name": "Advanced Cardiometabolic Risk Biomarker Suite",
        "desc": "Extended cardiovascular risk assessment beyond standard lipids: Lp(a) for familial hypercholesterolemia context, NT-proBNP for subclinical heart failure, troponin for myocardial stress, ApoB/ApoA1 ratio, and homocysteine. Pairs with hereditary exome panel for genotype-informed risk thresholds.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "ApoA1",
          "ApoB:ApoA1 ratio",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "homocysteine",
          "hs-CRP",
          "fibrinogen",
          "D-dimer",
          "lipoprotein(a) particle number",
          "LDL-C",
          "HDL-C",
          "small dense LDL",
          "oxidized LDL"
        ],
        "unit": "ng/mL, mg/dL, pmol/L",
        "range": "Lp(a): <30 mg/dL low | >50 high risk | NT-proBNP: <125 pg/mL normal",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Metabolic & Endocrine Rare Disease",
        "src": "dna_exome",
        "name": "Hereditary Metabolic Disorders Exome Panel",
        "desc": "Clinical exome analysis across 16 metabolic panels covering 206 rare conditions: organic-acidemia-aciduria-&-cobalamin-deficiency, hyperammonemia-and-urea-cycle-disorder, monogenic-obesity, congenital-mono--and-disaccharide-disorders, hypomagnesemia, peroxisomal-disorders, and more. Amino acid, fatty acid oxidation, lysosomal storage, glycogen storage, and peroxisomal disorders.",
        "markers": [
          "PAH (PKU)",
          "GALT (galactosemia)",
          "FAH (tyrosinemia)",
          "GAA (Pompe disease)",
          "HEXA/HEXB (Tay-Sachs/Sandhoff)",
          "GBA (Gaucher)",
          "IDUA/IDS (MPS I/II)",
          "ABCD1 (adrenoleukodystrophy)",
          "ACADM (MCAD)",
          "HADHA (LCHAD)",
          "NPC1/NPC2",
          "PCCA/PCCB (propionic acidemia)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Metabolic & Endocrine Rare Disease",
        "src": "dna_exome",
        "name": "Hereditary Endocrine Disorders Exome Panel",
        "desc": "Clinical exome analysis across 8 endocrinology panels: glucocorticoid-deficiency, premature-ovarian-failure-with-fmr1-repeat-expansion, abnormal-genitalia--disorders-of-sex-development, hyperparathyroidism, hypothyroidism-and-resistance-to-thyroid-hormone, and more. Covers 106 rare endocrine conditions including hereditary thyroid disorders, adrenal syndromes, pituitary tumors, MEN syndromes, and growth hormone pathway variants.",
        "markers": [
          "MENIN/MEN1 (MEN1)",
          "RET (MEN2/MTC)",
          "VHL (pheochromocytoma)",
          "SDHB/SDHD (paraganglioma)",
          "CYP21A2 (CAH)",
          "TSHR (TSH resistance)",
          "PRKAR1A (Carney complex)",
          "GH1/GHR (growth hormone)",
          "PROP1/POU1F1 (panhypopituitarism)"
        ],
        "unit": "Pathogenic variant call",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_array",
        "name": "Renal & Urological Disease Genetic Risk",
        "desc": "Polygenic risk scores for 9 renal/urological conditions: polycystic kidney disease, end-stage renal disease, kidney stones, UTI susceptibility, erectile dysfunction, and urinary incontinence. PKD1/PKD2, UMOD, and GWAS loci for kidney function.",
        "markers": [
          "Cystitis",
          "End Stage Renal Disease",
          "Erectile Dysfunction",
          "Hydronephrosis",
          "Kidney Ureter Bladder Stone",
          "Polycystic Kidney Disease",
          "Undescended Testicle",
          "Urinary Incontinence",
          "Urinary Tract Infection"
        ],
        "unit": "PRS percentile per condition",
        "range": "ADPKD: PKD1/PKD2 variant carrier | ESRD: APOL1 G1/G2 alleles",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_array",
        "name": "Ophthalmological Disease Genetic Risk",
        "desc": "Polygenic risk scores for 6 eye conditions: glaucoma, macular degeneration, dry eyes, iritis, retinal detachment, and blepharitis. MYOC/OPTN (glaucoma), CFH/ARMS2 (AMD), and 150+ ophthalmic GWAS loci. Exome panels cover 199 rare ophthalmic conditions.",
        "markers": [
          "Blepharitis",
          "Dry Eyes",
          "Glaucoma",
          "Iritis",
          "Macular Degeneration",
          "Retinal Detachment",
          "MYOC/OPTN/TBK1 (glaucoma)",
          "CFH/ARMS2/HTRA1 (AMD)",
          "PRPF31/RHO (RP)",
          "RS1 (retinoschisis)",
          "ABCA4 (Stargardt)",
          "CRX/RPGR"
        ],
        "unit": "PRS percentile + variant call",
        "range": "AMD: >90th elevated | Glaucoma: MYOC pathogenic = monogenic",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_wgs",
        "name": "ENT & Hearing Loss Exome Panel",
        "desc": "Clinical exome analysis for 274 ENT and hearing conditions including non-syndromic hearing loss (GJB2/GJB6, most common monogenic condition worldwide), Meni\u00e8re's disease, tinnitus susceptibility, benign positional vertigo, and otosclerosis. Largest ENT rare disease panel on the platform.",
        "markers": [
          "GJB2 (Cx26 \u2014 non-syndromic HL)",
          "GJB6 (Cx30 \u2014 DFNB1)",
          "TMPRSS3",
          "SLC26A4 (Pendred)",
          "CDH23/PCDH15 (Usher)",
          "MYO7A/MYO15A",
          "TECTA",
          "COCH (DFNA9)",
          "WFS1 (Wolfram)",
          "KCNQ4 (DFNA2)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "dna_array",
        "name": "Diet Response & Metabolic Type Profile",
        "desc": "Genetic predispositions for 35 diet and metabolic traits: carbohydrate/fat/protein overconsumption tendencies, satiety impairment, low resting metabolic rate, sweet preference, starch metabolism, bitter taste sensitivity, and response to low-carb, low-fat, Mediterranean, and high-protein diets. Informs macronutrient ratios and meal timing strategy.",
        "markers": [
          "Bitter Taste Sensitivity",
          "Caffeine Metabolism Impairment",
          "Carb Overconsumption",
          "Difficulty Losing Weight",
          "Fat Overconsumption",
          "Fat Taste Perception",
          "Low Carb Diet Effectiveness",
          "Low Fat Diet Effectiveness",
          "Low Protein Intake Risk",
          "Low Resting Metabolic Rate",
          "Low Vegetable Intake",
          "Mediterranean Diet Effectiveness",
          "Monounsaturated Fats Increased Benefits",
          "Overweight Potential",
          "Polyunsaturated Fats Increased Benefits",
          "Risk Saturated Fats",
          "Satiety Impairment",
          "Snacking",
          "Starch Metabolism",
          "Sweet Snack Preference",
          "Sweet Tooth",
          "Trans Fats Sensitivity",
          "Calcium Deficiency",
          "Choline Deficiency",
          "Coenzymeq10 Deficiency",
          "Copper Deficiency",
          "Glutathione Deficiency",
          "Iron Deficiency",
          "Iron Overload",
          "Magnesium Deficiency",
          "Phosphorus Deficiency",
          "Phytosterols Imbalance",
          "Selenium Deficiency",
          "Sensitivity Salt",
          "Zinc Deficiency"
        ],
        "unit": "Risk tier per dietary trait",
        "range": "Low-carb responder | Fat-sensitive | Mediterranean optimal | Standard",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "dna_array",
        "name": "Vitamin & Micronutrient Genetic Deficiency Risk",
        "desc": "Genetic variants predisposing to deficiency of 16 vitamins and 13 minerals: all B vitamins (B1, B2, B3, B5, B6, B7, B9/folate, B12), Vitamins A, C, D, E, K, plus carotenoids (lutein/zeaxanthin, lycopene), calcium, iron, magnesium, zinc, copper, selenium, CoQ10, glutathione, and choline. Enables truly personalized supplement protocol.",
        "markers": [
          "Lutein Zeaxanthin Deficiency",
          "Lycopene Deficiency",
          "Vitamina Carotene Deficiency",
          "Vitamina Retinol Deficiency",
          "Vitaminb1 Deficiency",
          "Vitaminb12 Deficiency",
          "Vitaminb2 Deficiency",
          "Vitaminb3 Deficiency",
          "Vitaminb5 Deficiency",
          "Vitaminb6 Deficiency",
          "Vitaminb7 Deficiency",
          "Vitaminb9 Deficiency",
          "Vitaminc Deficiency",
          "Vitamind Deficiency",
          "Vitamine Deficiency",
          "Vitamink Deficiency",
          "Calcium Deficiency",
          "Choline Deficiency",
          "Coenzymeq10 Deficiency",
          "Copper Deficiency",
          "Glutathione Deficiency",
          "Iron Deficiency",
          "Iron Overload",
          "Magnesium Deficiency",
          "Phosphorus Deficiency",
          "Phytosterols Imbalance",
          "Selenium Deficiency",
          "Sensitivity Salt",
          "Zinc Deficiency"
        ],
        "unit": "Deficiency risk tier per nutrient",
        "range": "High risk = 2\u20134\u00d7 population prevalence | Low risk = below average",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "blood",
        "name": "Precision Micronutrient Status Blood Panel",
        "desc": "Confirmatory blood testing of genetically predicted nutrient deficiencies. Pairs genomic risk scores with measured levels for the highest-evidence actionable nutrients. Differentiates genetic vs. dietary/absorption etiology for targeted supplementation.",
        "markers": [
          "25-OH Vitamin D",
          "Vitamin B12",
          "methylmalonic acid (functional B12)",
          "folate (RBC)",
          "homocysteine (B9/B12 proxy)",
          "ferritin",
          "serum iron",
          "transferrin saturation",
          "magnesium RBC",
          "zinc",
          "selenium",
          "CoQ10",
          "glutathione",
          "Omega-3 index",
          "retinol (Vitamin A)",
          "tocopherol (Vitamin E)",
          "Vitamin K2 (MK-7)"
        ],
        "unit": "Per-nutrient units (ng/mL, nmol/L, mg/L)",
        "range": "Vitamin D: 40\u201380 ng/mL | B12: >400 pg/mL | Folate: >15 ng/mL",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "dna_array",
        "name": "Substance Use & Addiction Risk Genomic Profile",
        "desc": "Polygenic risk scores for 21 addiction and substance use traits: alcohol dependence (age-at-onset, co-dependence, weekly consumption), nicotine dependence (initiation, cessation, quantity), cannabis use and dependence, cocaine sensitivity, opioid sensitivity, and gambling disorder. Neurotransmitter gene variants (GABRA2, ADH1B, CYP2A6, OPRM1, DRD2/DRD4, COMT).",
        "markers": [
          "Alcohol And Nicotine Co Dependence",
          "Alcohol Consumption Drinks Per Week Mtag",
          "Alcohol Dependence",
          "Alcohol Dependence Age At Onset",
          "Alcoholic Chronic Pancreatitis",
          "Caffeine Consumption",
          "Coffee Consumption",
          "Coffee Consumption Cups Per Day",
          "Gambling",
          "Cannabis Dependence",
          "Cannabis Use Initiation",
          "Cocaine Dependence",
          "Methadone Dose In Opioid Dependence",
          "Opioid Sensitivity",
          "Nicotine Glucouronidation",
          "Nicotine Use",
          "Smoking Cessation In Chronic Obstructive Pulmonary Disease",
          "Smoking Cessation Mtag",
          "Smoking Initiation Age Mtag",
          "Smoking Initiation Ever Regular Vs Never Regular Mtag",
          "Smoking Quantity Cigarettes Per Day Mtag"
        ],
        "unit": "PRS percentile per substance",
        "range": "Alcohol: >80th elevated risk | Nicotine cessation: CYP2A6 slow metabolizer",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "dna_array",
        "name": "Personality & Behavioral Trait Genomic Profile",
        "desc": "Genetic contributions to 21 personality and behavioral traits: agreeableness, extraversion, empathy, impulsivity, anger response, optimism, exploratory behavior, warrior/worrier personality (COMT), leadership potential, pleasure response, and morning chronotype. Enables personalized behavioral health coaching.",
        "markers": [
          "Agreeableness",
          "Empathy",
          "Extraversion",
          "Leadership Potential",
          "Sociability",
          "Creativity",
          "Experiential Learning Impairment",
          "Mathematical Aptitude",
          "Memory Performance",
          "Music Performance Aptitude",
          "Musical Creativity",
          "Reading Aptitude",
          "Addictive Personality",
          "Anger Response",
          "Exploratory Behavior",
          "Impulsivity",
          "Morning Person",
          "Optimism",
          "Pleasure Response Impairment",
          "Warrior Personality",
          "Worrier Personality"
        ],
        "unit": "PRS score per trait",
        "range": "Quantitative trait \u2014 population distribution",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "blood",
        "name": "Addiction & Reward Pathway Biomarker Panel",
        "desc": "Blood markers reflecting reward pathway biology and addiction vulnerability: dopamine precursors, cortisol stress burden, liver enzyme markers of alcohol use, and inflammatory markers. Pairs with PGx data for medication-assisted treatment optimization (buprenorphine, methadone, naltrexone dosing).",
        "markers": [
          "GGT (alcohol use marker)",
          "MCV (alcohol-related macrocytosis)",
          "CDT (carbohydrate-deficient transferrin)",
          "tyrosine (dopamine precursor)",
          "cortisol AM",
          "DHEA-S",
          "hs-CRP",
          "ALT/AST ratio",
          "bilirubin",
          "platelet count"
        ],
        "unit": "U/L, mg/dL per marker",
        "range": "GGT: <25 U/L normal | CDT: <1.7% normal | MCV: 80\u2013100 fL",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Dermatology & Skin Disease Genomics",
        "src": "dna_array",
        "name": "Inflammatory Skin Disease Polygenic Risk",
        "desc": "Polygenic risk scores for 10 skin conditions: psoriasis, atopic dermatitis/eczema, rosacea, vitiligo, chronic urticaria, acne vulgaris, scleroderma, lichen planus, cellulitis, and Dupuytren's contracture. HLA-Cw*06 (psoriasis), FLG (atopic dermatitis), IRF4, and 100+ dermatological GWAS loci. Exome+ covers 131 rare skin conditions.",
        "markers": [
          "Acne Vulgaris",
          "Atopic Dermatitis",
          "Cellulitis",
          "Chronic Hives Urticaria",
          "Dupuytrens Contracture",
          "Lichen Planus",
          "Psoriasis",
          "Rosacea",
          "Scleroderma",
          "Vitiligo"
        ],
        "unit": "PRS percentile per condition",
        "range": "Psoriasis: HLA-Cw*06 = 10\u00d7 risk | Atopic dermatitis: FLG null = 3\u00d7 risk",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Dermatology & Skin Disease Genomics",
        "src": "dna_wgs",
        "name": "Dermatology Rare Disease Exome Panel",
        "desc": "Clinical exome analysis across 7 dermatology panels covering 131 rare conditions: epidermolysis bullosa, ichthyosis, ectodermal dysplasia, palmoplantar keratoderma, Darier disease, and hereditary skin tumor syndromes.",
        "markers": [
          "COL7A1/COL17A1 (EB)",
          "KRT1/KRT10 (bullous ichthyosiform)",
          "GJB2 (KID syndrome)",
          "ATP2A2 (Darier)",
          "PTCH1 (basal cell nevus)",
          "TP53 (Li-Fraumeni skin)",
          "CDKN2A (familial melanoma)",
          "BAP1",
          "SH3BP2 (cherubism)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Hematology & Blood Disorders",
        "src": "dna_exome",
        "name": "Hereditary Blood Disorder Exome Panel",
        "desc": "Clinical exome analysis across 4 hematology panels: bone-marrow-failure-syndrome, bleeding-disorder-coagulopathy, anemia, comprehensive-immune-and-cytopenia, and more. Covers 281 rare conditions including hereditary hemochromatosis, hemophilia A & B, von Willebrand disease, sickle cell disease, thalassemias, platelet disorders, and rare anemias.",
        "markers": [
          "HFE C282Y/H63D (hemochromatosis)",
          "F8/F9 (hemophilia A/B)",
          "VWF (von Willebrand)",
          "HBB (sickle cell / \u03b2-thal)",
          "HBA1/HBA2 (\u03b1-thalassemia)",
          "RUNX1 (platelet disorder)",
          "CALR/JAK2/MPL (MPN)",
          "TP53/SF3B1 (MDS)",
          "G6PD",
          "PIGA (PNH)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Carrier status | Affected | Pathogenic variant detected",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Hematology & Blood Disorders",
        "src": "blood",
        "name": "Comprehensive Hematology & Iron Panel",
        "desc": "Full blood count with differential, iron studies, coagulation screen, and hemoglobin electrophoresis for blood disorder monitoring. Enables detection of anemia subtypes, iron overload (hemochromatosis monitoring), polycythemia, thrombocytopenia, and early hematological malignancy signs.",
        "markers": [
          "CBC with 5-part differential",
          "reticulocyte count",
          "serum iron",
          "ferritin",
          "TIBC",
          "transferrin saturation",
          "haptoglobin",
          "LDH",
          "PT/INR",
          "aPTT",
          "fibrinogen",
          "D-dimer",
          "homocysteine",
          "folate",
          "vitamin B12",
          "peripheral blood smear"
        ],
        "unit": "Multi-marker panel",
        "range": "Ferritin: 30\u2013300 ng/mL | Transferrin sat: 20\u201350% | LDH: <250 U/L",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Developmental & Congenital Disorders",
        "src": "dna_exome",
        "name": "Congenital Malformation Exome Panel (21 Panels)",
        "desc": "The most comprehensive rare disease panel on the platform: 21 malformation categories covering 391 pathogenic variants. Includes: osteopetrosis-and-dense-bone-dysplasia, brachydactyly---syndactyly, gastrointestinal-atresia, vascular-malformations, seckel-syndrome, meier-gorlin-syndrome, arthrogryposes, micromelic-dysplasia, and more. Critical for preconception, prenatal, and pediatric precision medicine.",
        "markers": [
          "Panel: osteopetrosis-and-dense-bone-dysplasia",
          "Panel: brachydactyly---syndactyly",
          "Panel: gastrointestinal-atresia",
          "Panel: vascular-malformations",
          "Panel: seckel-syndrome",
          "Panel: meier-gorlin-syndrome",
          "Panel: arthrogryposes",
          "Panel: micromelic-dysplasia",
          "Panel: cornelia-de-lange-syndrome",
          "Panel: spondylometaphyseal---spondyloepi-(meta)-physeal-dysplasia",
          "Panel: metaphyseal-dysplasia",
          "Panel: 3-m-syndrome---primordial-dwarfism"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Oral Health Genomics",
        "src": "dna_array",
        "name": "Oral Health Genetic Risk Profile",
        "desc": "Polygenic risk for 5 oral conditions: periodontal disease (bleeding gums, loose teeth, painful gums), mouth ulcers, and dental hypersensitivity. Integrates IL-1\u03b2, TNF-\u03b1, and vitamin D receptor variants linked to periodontitis risk \u2014 the strongest genetic predictor of tooth loss.",
        "markers": [
          "Bleeding Gums",
          "Loose Teeth",
          "Mouth Ulcers",
          "Painful Gums",
          "Toothache",
          "IL-1\u03b2 rs1143634",
          "IL-1\u03b1 rs1800587",
          "TNF-\u03b1 rs1799964",
          "VDR BsmI/FokI",
          "MMP-3 rs3025058",
          "IL-6 rs1800795",
          "TLR4 rs4986790"
        ],
        "unit": "PRS percentile",
        "range": "High risk: >80th | Very high (IL-1 composite positive): 3\u00d7 tooth loss risk",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Epigenetic Disease Risk",
        "src": "epigenetics",
        "name": "Multi-Disease Epigenetic Age & Risk Methylation",
        "desc": "DNA methylation-based biomarkers of disease risk beyond genetic sequence: GrimAge acceleration predicts all-cause mortality better than any single blood marker; tissue-specific methylation signatures identify pre-cancer epigenetic states; inflammatory methylation indices link lifestyle to chronic disease trajectory.",
        "markers": [
          "GrimAge (mortality clock)",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking exposure)",
          "EpiTOC2 (cancer stem cell index)",
          "DNAm CRP (inflammatory methylation)",
          "MiAge (mitotic age/cancer risk)",
          "HypoClock (loss of methylation)",
          "TicTimeClock (immune aging)"
        ],
        "unit": "Methylation-based age/risk score",
        "range": "GrimAge accel >3 yr: actionable | EpiTOC2: high = cancer field effect",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Epigenetic Disease Risk",
        "src": "epigenetics",
        "name": "Pharmacoepigenomics & Treatment Response",
        "desc": "Epigenetic markers predicting response to precision treatments: methylation status of gene promoters that predict statin response (HMGCR), metformin response (OCT1 epigenetics), immunotherapy response (PD-L1 methylation), and DNA methylation patterns linked to antidepressant treatment outcomes.",
        "markers": [
          "HMGCR promoter methylation (statin)",
          "SLC22A1 methylation (metformin)",
          "PD-L1/CD274 methylation (immunotherapy)",
          "SLC6A4 methylation (SSRI)",
          "MGMT methylation (chemotherapy)",
          "BRCA1 promoter methylation (PARP inhibitor)",
          "MLH1 methylation (mismatch repair)"
        ],
        "unit": "Methylation % + treatment response score",
        "range": "Hypermethylation = gene silencing | Hypomethylation = active expression",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Cardiovascular Drug Optimization (PGx)",
        "desc": "Pharmacogenomics-guided cardiovascular drug selection from prescribing formulary: warfarin vs DOAC selection by CYP2C9/VKORC1, statin selection by SLCO1B1 (myopathy risk), clopidogrel vs alternatives by CYP2C19, ACE inhibitor response by ACE I/D polymorphism, and antihypertensive class selection by ADD1/AGT genotype.",
        "markers": [
          "CYP2C9 *1\u2013*8",
          "VKORC1 -1639G>A",
          "SLCO1B1 *5",
          "CYP2C19 *2/*17",
          "ACE I/D",
          "AGT M235T",
          "CYP4F2 V433M"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Oncology Treatment Personalization (PGx)",
        "desc": "Pharmacogenomics guidance for oncology drug selection: DPYD screening before fluorouracil/capecitabine, UGT1A1 before irinotecan, TPMT/NUDT15 before mercaptopurine/thiopurines, HER2/KRAS/BRAF tumor marker integration, tamoxifen vs aromatase inhibitor selection by CYP2D6.",
        "markers": [
          "DPYD *2A/*13",
          "UGT1A1 *28/*6",
          "TPMT *2/*3C",
          "NUDT15 *3",
          "CYP2D6 (tamoxifen)",
          "KRAS/BRAF",
          "HER2 amplification proxy"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Psychiatric Drug Selection & Dosing (PGx)",
        "desc": "Personalized psychiatric medication guidance: SSRI/SNRI selection by CYP2C19/2D6 metabolizer phenotype (antidepressant efficacy), antipsychotic dosing by CYP2D6 (risperidone, aripiprazole, haloperidol), mood stabilizer optimization (lithium, carbamazepine \u2014 HLA-A*31:01 SJS risk screening), and ADHD stimulant selection.",
        "markers": [
          "CYP2C19 *1\u2013*17",
          "CYP2D6 *1\u2013*10",
          "SLC6A4 methylation",
          "HLA-A*31:01",
          "HLA-B*15:02",
          "HTR2A",
          "COMT Val158Met",
          "ABCB1"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Pain & Opioid Pharmacogenomics (PGx)",
        "desc": "Personalized pain management: opioid selection by CYP2D6 metabolizer status (codeine/tramadol toxicity in UMs, inefficacy in PMs), fentanyl/morphine dosing by OPRM1 A118G, NSAIDs vs opioid decision by COMT pain sensitivity, and methadone safety by CYP2B6.",
        "markers": [
          "CYP2D6 metabolizer phenotype",
          "OPRM1 A118G",
          "COMT Val158Met",
          "CYP2B6 *6",
          "UGT2B7",
          "ABCB1 C3435T"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Diabetes Medication Optimization (PGx)",
        "desc": "Metformin response and tolerability by SLC22A1 (OCT1) genotype, sulfonylurea selection by CYP2C9, GLP-1 agonist response prediction by GLP1R/TCF7L2, and SGLT2i consideration by eGFR + genetic kidney risk.",
        "markers": [
          "SLC22A1 (OCT1)",
          "CYP2C9 *2/*3",
          "TCF7L2",
          "GLP1R variants",
          "eGFR",
          "KCNJ11",
          "PPARG"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Immunosuppressant Dosing Protocol (PGx)",
        "desc": "Transplant and autoimmune immunosuppressant personalization: tacrolimus dose by CYP3A5 *1/*3 genotype (50% dose difference), azathioprine/mercaptopurine safety by TPMT/NUDT15, mycophenolate by UGT1A9, and TNF-\u03b1 inhibitor response prediction by HLA-DRB1.",
        "markers": [
          "CYP3A5 *1/*3",
          "TPMT *2/*3C",
          "NUDT15 *3",
          "UGT1A9 *3",
          "HLA-DRB1 SE alleles",
          "ABCB1",
          "CYP3A4/3A5"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Chronic Disease Lifestyle Intervention Plan",
        "desc": "Comprehensive lifestyle modification program for chronic disease management: Mediterranean diet prescription (strongest evidence across CVD, T2DM, inflammation), exercise prescription by cardiovascular system age, stress management by HPA-axis resilience index, and sleep optimization by circadian profiling.",
        "markers": [
          "cardiovascular system age",
          "metabolic system age",
          "immune system age",
          "HOMA-IR",
          "hs-CRP",
          "cortisol AM",
          "sleep architecture",
          "HRV"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Preventive Supplementation Protocol",
        "desc": "Evidence-based preventive supplementation from client catalog for chronic disease risk reduction: omega-3 (CVD prevention if ApoB elevated), vitamin D (all-cause mortality reduction), magnesium (T2DM and CVD risk), CoQ10 (statin users), and folate/B12 (homocysteine reduction).",
        "markers": [
          "ApoB",
          "25-OH Vit D",
          "magnesium RBC",
          "homocysteine",
          "omega-3 index",
          "CoQ10",
          "MTHFR genotype",
          "statin PGx"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      }
    ]
  }
];
initOnboarding();
</script>
</body>
</html>
